
<html lang="en"     class="pb-page"  data-request-id="5edec5c0-f643-4525-8dc1-9b25b6a99aaf"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2011.54.issue-21;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm201045m"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structure–Activity Studies of Diazabicyclo[3.3.0]octane-Substituted Pyrazines and Pyridines as Potent α4β2 Nicotinic Acetylcholine Receptor Ligands" /></meta><meta name="dc.Creator" content="Marc J. C.  Scanio" /></meta><meta name="dc.Creator" content="Lei  Shi" /></meta><meta name="dc.Creator" content="William H.  Bunnelle" /></meta><meta name="dc.Creator" content="David J.  Anderson" /></meta><meta name="dc.Creator" content="Rosalind J.  Helfrich" /></meta><meta name="dc.Creator" content="John  Malysz" /></meta><meta name="dc.Creator" content="Kirsten K.  Thorin-Hagene" /></meta><meta name="dc.Creator" content="Ceclia E.  Van Handel" /></meta><meta name="dc.Creator" content="Kennan C.  Marsh" /></meta><meta name="dc.Creator" content="Chih-Hung  Lee" /></meta><meta name="dc.Creator" content="Murali  Gopalakrishnan" /></meta><meta name="dc.Description" content="A series of diazabicyclo[3.3.0]octane substituted pyridines and pyrazines was synthesized and characterized at the α4β2 neuronal nicotinic acetylcholine receptor (nAChR). The compounds were designe..." /></meta><meta name="Description" content="A series of diazabicyclo[3.3.0]octane substituted pyridines and pyrazines was synthesized and characterized at the α4β2 neuronal nicotinic acetylcholine receptor (nAChR). The compounds were designe..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 11, 2011" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm201045m" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm201045m" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm201045m" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm201045m" /></link>
        
    
    

<title>Structure–Activity Studies of Diazabicyclo[3.3.0]octane-Substituted Pyrazines and Pyridines as Potent α4β2 Nicotinic Acetylcholine Receptor Ligands | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm201045m" /></meta><meta property="og:title" content="Structure–Activity Studies of Diazabicyclo[3.3.0]octane-Substituted Pyrazines and Pyridines as Potent α4β2 Nicotinic Acetylcholine Receptor Ligands" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0017.jpeg" /></meta><meta property="og:description" content="A series of diazabicyclo[3.3.0]octane substituted pyridines and pyrazines was synthesized and characterized at the α4β2 neuronal nicotinic acetylcholine receptor (nAChR). The compounds were designed to mimic the profile of ABT-089, high affinity binding ligand for the α4β2 nAChR, with limited agonist activity. Carboxamide derivatives of 3-(diazabicyclo[3.3.0]octane)-substituted pyridines or 2-(diazabicyclo[3.3.0]octane)-substituted pyrazines were found to have the desired binding and activity profile. The structure–activity relationship of these compounds is presented." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm201045m"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm201045m">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm201045m&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm201045m&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm201045m&amp;href=/doi/10.1021/jm201045m" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 7678-7692</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm2010404" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm201059s" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure–Activity Studies of Diazabicyclo[3.3.0]octane-Substituted Pyrazines and Pyridines as Potent α4β2 Nicotinic Acetylcholine Receptor Ligands</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marc+J.+C.++Scanio">Marc J. C. Scanio</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lei++Shi">Lei Shi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+H.++Bunnelle">William H. Bunnelle</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+J.++Anderson">David J. Anderson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rosalind+J.++Helfrich">Rosalind J. Helfrich</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Malysz">John Malysz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kirsten+K.++Thorin-Hagene">Kirsten K. Thorin-Hagene</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ceclia+E.++Van+Handel">Ceclia E. Van Handel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kennan+C.++Marsh">Kennan C. Marsh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chih-Hung++Lee">Chih-Hung Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Murali++Gopalakrishnan">Murali Gopalakrishnan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6117, United States</span></div><div class="corresp-info">Phone: 847-935-1064. E-mail: <a href="/cdn-cgi/l/email-protection#563b37243578253537383f39163734343922227835393b"><span class="__cf_email__" data-cfemail="8be6eaf9e8a5f8e8eae5e2e4cbeae9e9e4ffffa5e8e4e6">[email protected]</span></a>. Address: Abbott Laboratories, Dept. R47W, Bldg. AP9A, 100 Abbott Park Road, Abbott Park, IL 60064-6117, United States</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm201045m&amp;href=/doi/10.1021%2Fjm201045m" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 7678–7692</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 30, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 August 2011</li><li><span class="item_label"><b>Published</b> online</span>11 October 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 November 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm201045m" title="DOI URL">https://doi.org/10.1021/jm201045m</a></div><div class="article_header-article-copyright"><strong>Copyright © 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7678%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMarc%2BJ.%2BC.%2BScanio%252C%2BLei%2BShi%252C%2BWilliam%2BH.%2BBunnelle%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D21%26contentID%3Djm201045m%26title%3DStructure%25E2%2580%2593Activity%2BStudies%2Bof%2BDiazabicyclo%255B3.3.0%255Doctane-Substituted%2BPyrazines%2Band%2BPyridines%2Bas%2BPotent%2B%25CE%25B14%25CE%25B22%2BNicotinic%2BAcetylcholine%2BReceptor%2BLigands%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7692%26publicationDate%3DNovember%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm201045m"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1524</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">5</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm201045m" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure–Activity Studies of Diazabicyclo[3.3.0]octane-Substituted Pyrazines and Pyridines as Potent α4β2 Nicotinic Acetylcholine Receptor Ligands&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Marc&quot;,&quot;last_name&quot;:&quot;J. C. Scanio&quot;},{&quot;first_name&quot;:&quot;Lei&quot;,&quot;last_name&quot;:&quot;Shi&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;H. Bunnelle&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;J. Anderson&quot;},{&quot;first_name&quot;:&quot;Rosalind&quot;,&quot;last_name&quot;:&quot;J. Helfrich&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Malysz&quot;},{&quot;first_name&quot;:&quot;Kirsten&quot;,&quot;last_name&quot;:&quot;K. Thorin-Hagene&quot;},{&quot;first_name&quot;:&quot;Ceclia&quot;,&quot;last_name&quot;:&quot;E. Van Handel&quot;},{&quot;first_name&quot;:&quot;Kennan&quot;,&quot;last_name&quot;:&quot;C. Marsh&quot;},{&quot;first_name&quot;:&quot;Chih-Hung&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Murali&quot;,&quot;last_name&quot;:&quot;Gopalakrishnan&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;11&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;7678-7692&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm201045m&quot;},&quot;abstract&quot;:&quot;A series of diazabicyclo[3.3.0]octane substituted pyridines and pyrazines was synthesized and characterized at the α4β2 neuronal nicotinic acetylcholine receptor (nAChR). The compounds were designed to mimic the profile of ABT-089, high affinity binding ligand for the α4β2 nAChR, with limited agonist activity. Carboxamide derivatives of 3-(diazabicyclo[3.3.0]octane)-substituted pyridines or 2-(diazabicyclo[3.3.0]octane)-substituted pyrazines were found to have the desired binding and activity profile. The structure–activity relationship of these compounds is presented.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201045m&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201045m" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201045m&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201045m" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201045m&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201045m" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm201045m&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201045m&amp;href=/doi/10.1021/jm201045m" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm201045m" /></input><a href="/doi/pdf/10.1021/jm201045m" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm201045m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm201045m%26sid%3Dliteratum%253Aachs%26pmid%3D21962147%26genre%3Darticle%26aulast%3DScanio%26date%3D2011%26atitle%3DStructure%25E2%2580%2593Activity%2BStudies%2Bof%2BDiazabicyclo%255B3.3.0%255Doctane-Substituted%2BPyrazines%2Band%2BPyridines%2Bas%2BPotent%2B%25CE%25B14%25CE%25B22%2BNicotinic%2BAcetylcholine%2BReceptor%2BLigands%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D21%26spage%3D7678%26epage%3D7692%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=290703" title="Pyridines">Pyridines</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a>,</li><li><a href="/action/doSearch?ConceptID=291978" title="Pyrazine">Pyrazine</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jmcmar.2011.54.issue-21/production/jmcmar.2011.54.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/medium/jm-2011-01045m_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201045m&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A series of diazabicyclo[3.3.0]octane substituted pyridines and pyrazines was synthesized and characterized at the α4β2 neuronal nicotinic acetylcholine receptor (nAChR). The compounds were designed to mimic the profile of ABT-089, high affinity binding ligand for the α4β2 nAChR, with limited agonist activity. Carboxamide derivatives of 3-(diazabicyclo[3.3.0]octane)-substituted pyridines or 2-(diazabicyclo[3.3.0]octane)-substituted pyrazines were found to have the desired binding and activity profile. The structure–activity relationship of these compounds is presented.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40462" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40462" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Neuronal nicotinic acetylcholine receptors (nAChRs) are pentameric ligand-gated cation channels that have emerged as important targets in drug discovery.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> nAChRs are activated by the endogenous neurotrasmitter acetylcholine (ACh) and the natural alkaloid nicotine.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The other major class of acetylcholine receptors are the muscarinic acetylcholine receptors (mAChRs).<a onclick="showRef(event, 'ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5 ref6">(3-6)</a> nAChR ligands have been explored for the treatment of Alzheimer’s disease, Parkinson’s disease, Tourette’s syndrome, schizophrenia, nicotine addiction, pain, various other central nervous system (CNS) disorders, and even non-CNS disorders such as cancer.<a onclick="showRef(event, 'ref7 ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19">(7-19)</a> Modulating the activity of nAChRs offers potential for the development of new drugs in areas of significant unmet medical need.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p">The nAChR complex, assembled from five transmembrane subunits, may be homomeric or heteromeric and is found in the CNS, peripheral nervous system, and at neuromuscular junctions.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Currently there are 17 known nAChR subunits (α1-α10, β1-β4, γ, δ, and ε) and 12 known neuronal nAChR subunits (α2-α10 and β2-β4).<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> The diversity of subunits, and the variation in how they are assembled gives rise to a large family of receptor subtypes with a variety of physiological and pharmacological properties. For example, the high-sensitivity α4β2 nAChR subtype is composed of two α4 subunits and three β2 subunits, (α4)<sub>2</sub>(β2)<sub>3</sub>, while the α7 nAChR subtype is composed of five α7 subunits, (α7)<sub>5</sub>.<a onclick="showRef(event, 'ref24 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref27">(24-27)</a> The α4β2 heteropentameric and α7 homopentameric subtypes represent the majority of neuronal nAChRs in the mammalian CNS and are currently the most actively pursued drug targets,<a onclick="showRef(event, 'ref2 ref25 ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref2 ref25 ref28 ref29 ref30">(2, 25, 28-30)</a> while activity at the α3β4* subtype, abundantly expressed in the peripheral nervous system, is correlated to adverse side effects.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p">ABT-089 (<b>1</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) has demonstrated cognition-enhancing and neuroprotective properties with an exceptionally low incidence of adverse effects.<a onclick="showRef(event, 'ref30 ref32 ref33 ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref30 ref32 ref33 ref34 ref35 ref36">(30, 32-36)</a> It advanced to clinical investigation for its ability to treat cognitive disorders, in particular, ADHD in adults and children and Alzheimer’s disease.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> Compound <b>1</b> binds the α4β2 nAChR subtype with low double digit nanomolar affinity (<i>K</i><sub>i</sub> = 16 ± 2 nM) but has limited agonist activity at that subtype (EC<sub>50</sub> >100 μM, max response 9 ± 1%, compared to (−)-nicotine).<a onclick="showRef(event, 'ref30 ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref30 ref32 ref33 ref34">(30, 32-34)</a> Binding experiments reflect the interaction of a compound with a desensitized inactive state of the receptor, while the agonist activity reflects the channel-opening activity. Compound <b>1</b> has also been found to stimulate neurotransmitter release from rat brain in vitro.<a onclick="showRef(event, 'ref24 ref30 ref35'); return false;" href="javascript:void(0);" class="ref ref24 ref30 ref35">(24, 30, 35)</a> Preclinical results suggest that the profile of <b>1</b> offers robust in vivo efficacy in models of cognitive deficits with a limited potential for adverse side effects. We were interested in designing molecules with a similar in vitro profile to compound <b>1</b>, namely potent α4β2 nAChR binding with limited partial agonist activity, which might also be of use in a variety of CNS disorders. Other compounds with potential therapeutic utility, such as sazetidine-A and its analogues, also manifest this in vitro profile in initial screening.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39, 40)</a> For our initial screening of compounds, binding and agonist activity were evaluated in a high throughput format. Compounds that showed high affinity binding and limited agonist activity could then be further evaluated in additional in vitro and pharmacokinetic (PK) assays.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/medium/jm-2011-01045m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0001.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. ABT-089 and new α4β2 nAChR ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201045m&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">3-(Diazabicycloalkane)-substitution of pyridine or 2-(diazabicycloalkane)-substitution of pyrazine, such as compounds <b>2</b>–<b>5</b>, was found to afford compounds with good affinity for α4β2 nAChRs but fairly potent agonist activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a> On the basis of ample precedent, we felt that there was potential to add an additional substituent on the pyridine or pyrazine such that potent α4β2 binding would be preserved while attenuating the agonist activity.<a onclick="showRef(event, 'ref9 ref41 ref43 ref44 ref45 ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref9 ref41 ref43 ref44 ref45 ref46 ref47">(9, 41, 43-47)</a> We quickly discovered that the proper diazabicyclooctane substitution of a pyridine or pyrazine in combination with a carboxamide substitution lead to compounds that generally possessed high affinity α4β2 binding with limited agonist activity (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). The structure–activity relationship of these compounds is presented.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35565" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35565" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds <b>1</b>–<b>4</b> and the Boc-protected diazabicyclo[3.3.0]octanes <b>38</b>, <b>60</b>, and <b>61</b> have previously been reported.<a onclick="showRef(event, 'ref41 ref42 ref48'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref48">(41, 42, 48)</a> Compounds <b>39</b>, <b>41</b>, <b>69</b>, <b>71</b>, and <b>74</b> are commercially available. The monosubstituted pyrazine <b>5</b> was prepared in a two-step procedure (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). The Boc-protected diazabicyclo[3.3.0]octane <b>38</b> was reacted with 2-chloropyrazine in DMSO at 120 °C using K<sub>2</sub>CO<sub>3</sub> as the base to afford the nucleophilic aromatic substitution (S<sub>N</sub>Ar) product <b>40</b>. The Boc protecting group of <b>40</b> was readily removed using TFA in dichloromethane at ambient temperature.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/medium/jm-2011-01045m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201045m&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) K<sub>2</sub>CO<sub>3</sub>, DMSO; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><div class="NLM_p">Methyl 6-chloro-2-pyrazinecarboxylate (<b>43</b>)<a onclick="showRef(event, 'ref49 ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref49 ref50 ref51">(49-51)</a> served as an excellent intermediate for exploration of 6-substituted 2-pyrazinecarboxamides and could be readily prepared in two steps on a multigram scale (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). 4-Oxo-2-pyrazinecarboxylate (<b>42</b>) was formed by oxidation of methyl pyrazinecarboxylate (<b>41</b>) with <i>m</i>CPBA.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a><i>N</i>-Oxide <b>42</b> was reacted in refluxing SOCl<sub>2</sub> to afford the key intermediate <b>43</b>.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> The regiochemistry of <b>43</b>, which is consistent with literature precedence,<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> was also confirmed by an HMBC NMR experiment, which showed a long-range correlation between H5 and C3, indicating the ester and chloro substitutions are at the 2- and 6-positions.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/medium/jm-2011-01045m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201045m&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) <i>m</i>CPBA, 1,2-dichloroethane; (b) SOCl<sub>2</sub>.</p></p></figure><div class="NLM_p">The most common method employed for generating pyrazine analogues is illustrated in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Reacting the Boc-protected diazabicyclo[3.3.0]octane <b>38</b> with methyl 6-chloro-2-pyrazinecarboxylate (<b>43</b>) in DMSO with Na<sub>2</sub>CO<sub>3</sub> as the base afforded the base-mediated S<sub>N</sub>Ar product <b>44</b>. Saponification of <b>44</b> gave carboxylic acid <b>45</b>, which was readily converted into amides <b>46</b>–<b>52</b> under standard 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDCI) coupling conditions. The Boc protecting group of amides <b>46</b>–<b>52</b> was readily removed using TFA in dichloromethane at ambient temperature to afford pyrazines <b>14</b>, <b>17</b>–<b>20</b>, <b>22</b>, and <b>23</b>.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/medium/jm-2011-01045m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201045m&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) Na<sub>2</sub>CO<sub>3</sub>, DMSO; (b) NaOH, H<sub>2</sub>O/EtOH; (c) H<sub>2</sub>NR, EDCI, HOBt, DMAP, CH<sub>2</sub>Cl<sub>2</sub>; (d) TFA, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><div class="NLM_p">An alternative method for the preparation of the pyrazine analogues involved direct, MgCl<sub>2</sub>-mediated conversion of methyl ester <b>44</b> to amides <b>53</b>–<b>55</b>, followed by Boc deprotection (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> This method could be used to form the amides of primary and secondary amines but not of anilines.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/medium/jm-2011-01045m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201045m&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) MgCl<sub>2</sub>, NHR<sup>1</sup>R<sup>2</sup>, THF; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><div class="NLM_p">In cases where late stage diversification of the diamine portion of the molecule was desired, the amide could be installed before incorporating the protected diazabicyclo[3.3.0]octane (Schemes <a class="ref internalNav" href="#sch5" aria-label="5">5</a> and <a class="ref internalNav" href="#sch6" aria-label="6">6</a>). For example, compound <b>56</b> was generated by MgCl<sub>2</sub>-mediated conversion of methyl ester <b>43</b> with 2-methylbenzylamine.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> A variety of diazabicyclo[3.3.0]octanes were reacted with <b>56</b> to afford the S<sub>N</sub>Ar products <b>57</b>–<b>59</b>, which were readily deprotected to yield final compounds <b>6</b>–<b>8</b>. The late stage diamine diversification of anilides is demonstrated in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>. Saponification of <b>43</b> lead to carboxylic acid <b>62</b> that was subsequently converted to acid chloride <b>63</b>. Reacting <b>63</b> with various anilines afforded amides <b>64</b> and <b>65</b>. Diazabicyclo[3.3.0]octanes were reacted with <b>64</b> and <b>65</b> to afford the S<sub>N</sub>Ar products <b>66</b>–<b>68</b>, which were readily deprotected to yield pyrazines <b>9</b>, <b>10</b>, and <b>21</b>.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/medium/jm-2011-01045m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201045m&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) MgCl<sub>2</sub>, 2-methylbenzylamine, THF; (b) <b>38</b>, <b>60</b>, or <b>61</b>, Na<sub>2</sub>CO<sub>3</sub>, DMSO; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub></p></p></figure><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/medium/jm-2011-01045m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201045m&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) NaOH, H<sub>2</sub>O/EtOH; (b) oxalyl chloride, cat. DMF, CH<sub>2</sub>Cl<sub>2</sub>; (c) NH<sub>2</sub>R<sup>1</sup>, TEA, CH<sub>2</sub>Cl<sub>2</sub>; (d) <b>38</b> or <b>61</b>, Na<sub>2</sub>CO<sub>3</sub>, DMSO; (e) TFA, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><div class="NLM_p">The substituted pyridines for this study were synthesized by two general methods (Schemes <a class="ref internalNav" href="#sch7" aria-label="7">7</a> and <a class="ref internalNav" href="#sch8" aria-label="8">8</a>). In the first method, the amide was installed before incorporating the protected diazabicyclo[3.3.0]octane (Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>). 5-Bromonicotinic acid was converted into amide <b>70</b> under standard EDCI coupling conditions. The Boc-protected diazabicyclo[3.3.0]octane, <b>38</b> or <b>60</b>, was incorporated into the molecule using Buchwald–Hartwig coupling methods.<a onclick="showRef(event, 'ref41 ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref41 ref55 ref56">(41, 55, 56)</a> The Boc group was easily removed with TFA to afford the desired substituted pyridines <b>11</b> and <b>12</b>. In the second method, the 3,7-Boc-protected diazabicyclo[3.3.0]octane, <b>38</b>, was incorporated using Buchwald–Hartwig coupling methods to give <b>72</b> before the amide was installed (Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a>). Ethyl ester <b>72</b> was saponified to give carboxylic acid <b>73</b> that was converted to amides <b>24</b>–<b>37</b> using EDCI coupling conditions followed by Boc deprotection with TFA.</div><figure id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/medium/jm-2011-01045m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201045m&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) NHR<sup>1</sup>R<sup>2</sup>, EDCI, HOBt, DMAP, CH<sub>2</sub>Cl<sub>2</sub>; (b) <b>38</b> or <b>60</b>, Pd<sub>2</sub>(dba)<sub>3</sub>, BINAP, NaO<i>t</i>Bu, toluene; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure id="sch8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/medium/jm-2011-01045m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 8. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201045m&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) <b>38</b>, Pd<sub>2</sub>(dba)<sub>3</sub>, xantphos, Cs<sub>2</sub>CO<sub>3</sub>, dioxane; (b) NaOH, H<sub>2</sub>O/EtOH; (c) NHR<sup>1</sup>R<sup>2</sup>, EDCI, HOBt, DMAP, CH<sub>2</sub>Cl<sub>2</sub>; (d) TFA, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><div class="NLM_p">The substituted pyrazine <b>76</b> was prepared in a two-step procedure (Scheme <a class="ref internalNav" href="#sch9" aria-label="9">9</a>). The Boc-protected diazabicyclo[3.3.0]octane <b>38</b> was reacted with 2-benzyloxy-6-chloropyrazine in DMSO at 120 °C using K<sub>2</sub>CO<sub>3</sub> as the base to afford the S<sub>N</sub>Ar product <b>75</b>. The Boc protecting group of <b>75</b> was readily removed using TFA in dichloromethane at ambient temperature.</div><figure id="sch9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/medium/jm-2011-01045m_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 9. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201045m&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) <b>38</b>, K<sub>2</sub>CO<sub>3</sub>, DMSO; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Biological Evaluation</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22730" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22730" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The affinities of these ligands for the native α4β2 and α7 nAChR subtype in rat brain membranes were measured by radioligand binding using previously reported methods.<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57, 58)</a> Briefly, displacement of [<sup>3</sup>H]-cytisine was taken to represent binding to the α4β2 subtype, while the α7 affinities were determined by displacement of the α7-selective agonist [<sup>3</sup>H]-A-585539.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div><div class="NLM_p">Selected compounds were also evaluated for agonist activity at the α4β2 receptor subtype. Functional activity was determined from calcium influx detected by fluorescent imaging plate reader (FLIPR) methodology according to the reported methods employing an HEK-293 cell line expressing recombinant human α4β2 nAChR.<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59, 60)</a> Experiments were conducted in 96-well plate format, and responses were normalized to that of 100 μM (−)-nicotine = 100% on the same plate. The maximum concentration of test compounds was either 100 or 30 μM.</div><div class="NLM_p">The ability of these compounds to activate ganglionic nAChRs was evaluated because these receptors are thought to mediate some of the toxicities of nicotinic agonists.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> For this assay, calcium influx to IMR-32 human neuroblastoma cells, which express ganglionic nAChRs (including the α3β4* subtype), was detected using FLIPR methodology as described previously.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> This assay is taken to reflect activation of α3β4-containing nAChRs and by extension the potential for evoking gastrointestinal and cardiovascular side effects.</div><div class="NLM_p last">The PK profile of compound <b>6</b> was determined following a 2 μmol/kg iv, ip, and po dose in rats (three rats per dosing regiment). The plasma concentration of <b>6</b> was determined (ng/mL) over a time course of 0.25–8 h following compound administration.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56300" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56300" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In an effort to generate compounds that might be of use in a variety of CNS disorders, we set out to design compounds that possessed a similar in vitro profile to <b>1</b>, i.e., potent α4β2 nAChR binding with limited agonist activity. A large body of previous work has demonstrated that substitution of pyridines at the 3-position by groups containing various linkers and an ionizable amine can provide potent binding to nicotinic receptors. The ionizable amine is a critical element of the nicotinic pharmacophore, creating a cation−π interaction with the nAChR, while the pyridine nitrogen serves as a hydrogen bond acceptor.<a onclick="showRef(event, 'ref61 ref62 ref63 ref64 ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref61 ref62 ref63 ref64 ref65 ref66">(61-66)</a> We initially chose to examine 3-(diazabicyclo[3.3.0]octane)-substituted pyridines (<b>2</b>–<b>4</b>) based on previous work from our group.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, compounds <b>2</b>–<b>4</b> all bind to the α4β2 nAChR with high potency. The 3,7-diazabicyclo[3.3.0]octane <b>2</b> had the most potent binding to the α4β2 nAChR subtype (<i>K</i><sub>i</sub> = 0.13 nM) and also showed the most potent and efficacious agonist activity (EC<sub>50</sub> = 0.018 μM, 220 ± 12% max response). The enantiomeric pair, <b>3</b> and <b>4</b>, showed an approximately 10-fold difference in binding potency, and a comparable, 5-fold, difference in agonist potency, with <b>3</b> as the more potent compound in both cases. Compound <b>3</b> also produced a larger maximal response than <b>4</b> in the agonist assay. In compound <b>5</b>, a pyrazine ring is substituted for the pyridine of compound <b>2</b>. This substitution had the effect of reducing binding to the α4β2 nAChR subtype (<i>K</i><sub>i</sub> = 7.8 nM in <b>5</b> vs <i>K</i><sub>i</sub> = 0.13 nM in <b>2</b>) while also decreasing agonist potency and efficacy. The clear trend observed in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> with the monosubstituted pyridines/pyrazine is that decreased binding potency to the α4β2 nAChR subtype correlates with diminished agonist activity. We were interested in determining if additional substitution of the pyridine or pyrazine ring could generate compounds with comparable binding to those in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> while diminishing the potent agonist activity.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Characterization of <b>1</b> and Diazabicyclo[3.3.0]octane-Substituted Pyridines and a Pyrazine</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/medium/jm-2011-01045m_0011.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Data from ref <a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">33</a>.</p></div></div><div></div></div><div class="NLM_p">The effects of pyridine substituents on α4β2 activity have been extensively investigated.<a onclick="showRef(event, 'ref9 ref18 ref40 ref41 ref43 ref44 ref45 ref46 ref47 ref67'); return false;" href="javascript:void(0);" class="ref ref9 ref18 ref40 ref41 ref43 ref44 ref45 ref46 ref47 ref67">(9, 18, 40, 41, 43-47, 67)</a> In general, substitution at the 5-position can accommodate a broad range of groups while maintaining affinity, especially compared to substitution at the 6 position, which is generally limited to small groups (e.g., halogens). Several compounds with a large substitution in the 5-position have been shown to be high affinity partial agonists.<a onclick="showRef(event, 'ref39 ref40 ref68'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref68">(39, 40, 68)</a> The pyrazine, <b>5</b>, was the least potent α4β2 agonist of the monosubstituted compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, thus the pyrazines seemed like an attractive starting point. The 3,5-substitution pattern in pyridines maps to a 2,6-substitution pattern in pyrazines due to the numbering of the ring systems.</div><div class="NLM_p">It was hypothesized that a large carboxamide group would reduce the agonist activity of these compounds and potentially also decrease α4β2 binding. We were delighted to find that carboxamide substitution of a pyrazine that also contained the 3,7-diazabicyclo[3.3.0]octane, <b>6</b>, showed limited agonist activity (EC<sub>50</sub> > 100 μM, 5 ± 1% max response) but still showed potent binding to the α4β2 nAChR (<i>K</i><sub>i</sub> = 1.7 nM) (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Substituting other diazabicyclo[3.3.0]octane isomers afforded compounds that showed very weak binding affinities (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). For example, switching the 3,7-diazabicyclo[3.3.0]octane of <b>6</b> for 2,7-diazabicyclo[3.3.0]octane isomers in <b>7</b> and <b>8</b> yielded compounds that were >1000-fold less potent in their binding to α4β2 nAChR and were therefore not evaluated for agonist activity. The trend of potent α4β2 nAChR binding with 3,7-diazabicyclo[3.3.0]octane compared to other isomers was observed in two other sets of compounds. The 3,7-diazabicyclo[3.3.0]octane pyrazine <b>9</b> was significantly more potent than its isomer <b>10</b> (<i>K</i><sub>i</sub> = 7.6 vs 2630 nM). This trend was also observed with pyridines where 3,7-diazabicyclo[3.3.0]octane pyridine <b>11</b> was significantly more potent than its isomer <b>12</b> (<i>K</i><sub>i</sub> = 2.7 vs 871 nM). Both <b>9</b> and <b>11</b> demonstrated limited agonist activity (EC<sub>50</sub> >100 μM, both 10 ± 2% and 7 ± 1% max response, respectively). The compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> that were potent α4β2 nAChR binders, <b>6</b>, <b>9</b>, and <b>11</b>, were also evaluated for α3β4* agonist activity, as a potential liability, using IMR-32 cells. Compounds <b>6</b>, <b>9</b>, and <b>11</b> all had fairly weak α3β4* agonist activity (EC<sub>50</sub> >100 μM). Compounds <b>9</b> and <b>11</b> have max response values comparable to <b>1</b>, which also has weak α3β4* agonist activity (EC<sub>50</sub> >100 μM, 8 ± 4% max response)<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and has an exceptionally low incidence of adverse effects.<a onclick="showRef(event, 'ref30 ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref30 ref32 ref33 ref34">(30, 32-34)</a> Additionally, all of the study compounds <b>6</b>, <b>9</b>, <b>11</b>, and <b>13</b>–<b>37</b> evaluated were found to selectively bind α4β2 compared to α7 (data not shown).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Characterization of Various Diazabicyclo[3.3.0]octanes-Substituted Pyrazinecarboxamides and Pyradinecarboxamides</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/medium/jm-2011-01045m_0012.gif" alt="" id="fx2" /></img><div></div></div><div class="NLM_p">Given the results of Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, we decided to focus our efforts on 3,7-diazabicyclo[3.3.0]octane substituted pyrazines and pyrazines. The 2,6-disubstituted pyrazines were examined first (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The overall observation is that the pyrazinecarboxamides that were evaluated can be potent α4β2 nAChR binders with a range of partial agonist activities. The simple benzyl carboxamide, <b>13</b> (<i>K</i><sub>i</sub> = 3.9 nM, EC<sub>50</sub> > 100 μM, 9 ± 1% max response), has a similar profile to the 2-methylbenzyl derivative, <b>6</b> (<i>K</i><sub>i</sub> = 1.7 nM, EC<sub>50</sub> > 100 μM, 5 ± 1% max response), from Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. Adding a methylene to give the phenethylamine analogue <b>14</b> results in a slight decrease in binding affinity but similar agonist activity. While <b>6</b> and <b>13</b> were potent α4β2 nAChR ligands, the <i>N</i>-benzyl-<i>N</i>-methyl derivative <b>15</b>, which blocks the amide NH bond, and the α-methylbenzylamine derivative <b>16</b> showed a fairly dramatic decrease in α4β2 nAChR binding affinity (<i>K</i><sub>i</sub> = 174 and 132 nM, respectively). The dichloro-substituted benzyl amide <b>17</b> was also a potent α4β2 nAChR binder, with limited agonist activity.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro Characterization of Various 3,7-Diazabicyclo[3.3.0]octanes-Substituted Pyrazinecarboxamides</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/medium/jm-2011-01045m_0013.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/medium/jm-2011-01045m_0014.gif" alt="" id="_i8" /></img><div></div></div><div class="NLM_p">The benzamide derivatives, <b>18</b>–<b>23</b>, were all potent α4β2 nAChR ligands (<i>K</i><sub>i</sub> < 100 nM in all cases), although a broad range of binding affinities was noted (<i>K</i><sub>i</sub> range of 0.7–51 nM). The <i>meta</i>-chloro and <i>meta</i>-iodo analogues <b>18</b> and <b>19</b> were the most potent α4β2 nAChR ligands (<i>K</i><sub>i</sub> = 0.7 and 3.3 nM, respectively). Substitution of larger groups in the <i>meta</i> position, as found in <b>20</b> and <b>21</b>, lead to a decrease in binding potency. The 3,5-disubstituted analogues <b>22</b> and <b>23</b> were also less potent binders than <b>18</b> or <b>19</b>. The benzamide derivatives <b>18</b>–<b>23</b> showed a wide range of agonist activities, all of which had maximum efficacy in excess 10% of 100 μM (−)-nicotine when tested at maximum concentration (30 or 100 μM). The halogen substituted benzamides <b>18</b>, <b>19</b>, and <b>23</b> showed the highest agonist efficacy. Compounds <b>20</b> and <b>21</b> differ only by the substitution of an isopropyl versus and isopropoxy group in the <i>meta</i>-position. The α4β2 nAChR binding affinity of the compounds is quite similar (<i>K</i><sub>i</sub> = 35 vs 19 nM), however their agonist activities differ substantially. The isopropoxy analogue <b>21</b> has weak partial agonist activity (EC<sub>50</sub> >100 μM, 11 ± 3% max response), while the isopropyl analogue <b>20</b> is a significantly stronger partial agonist (EC<sub>50</sub> = 11.5 μM, 26% ± 1% max response). Our goal during this investigation was to discover compounds with limited agonist activity. Compounds <b>18</b>–<b>20</b> and <b>23</b> demonstrated moderate partial agonist activity. Compound <b>18</b> also gave the most potent α3β4* agonist response (26 ± 4% max response) of any of the carboxamides evaluated. It should be noted that compounds with potent α4β2 nAChR binding and moderate partial agonist activity also have therapeutic potential. Compounds with this profile include varenicline, ispronicline, and dianicline.<a onclick="showRef(event, 'ref19 ref69 ref70 ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref19 ref69 ref70 ref71 ref72">(19, 69-72)</a> Compounds <b>19</b> and <b>23</b> demonstrate that it is possible to generate compounds in this series that are moderate α4β2 partial agonist, with weak α3β4* agonist activity.</div><div class="NLM_p">We next decided to explore 3,7-diazabicyclo[3.3.0]octane substituted pyridines (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). This was based on the observation that both pyrazines and pyridines afforded potent α4β2 nAChR binders (Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) and that with 3,7-diazabicyclo[3.3.0]octane substitution is was possible to achieve the desired profile of potent α4β2 nAChR binders with limited partial agonist activity with the proper substitution. The overall observation is that a variety of pyridinecarboxamines that were evaluated exhibited high affinity at α4β2 nAChRs with limited agonist activity. The pyridinecarboxamides showed more potent α4β2 nAChR binding than the pyrazinecarboxamides. Of note, compounds <b>27</b>, <b>28</b>, <b>30</b>, <b>31</b>, and <b>33</b>–<b>37</b> all demonstrate α4β2 nAChR binding <1 nM. These subnanomolar binders include benzyl amides <b>27</b>, isoquinoline amide <b>28</b>, anilides (<b>31</b> and <b>33</b>–<b>37</b>), and phenethylamides (<b>30</b>). In the examples where a direct comparison between the pyrazines and pyridines can be made (<b>15</b> vs <b>26</b>, <b>19</b> vs <b>31</b>, <b>21</b> vs <b>32</b>, <b>22</b> vs <b>35</b>, and <b>23</b> vs <b>37</b>), the pyridines were always more potent binders, ranging from 17- to 350-fold.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro Characterization of Various 3,7-Diazabicyclo[3.3.0]octanes-Substituted Pyridinecarboxamides</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/medium/jm-2011-01045m_0015.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/medium/jm-2011-01045m_0016.gif" alt="" id="_i10" /></img><div></div></div><div class="NLM_p">In similar fashion to the pyrazines, the α-alkylbenzylamines derivates <b>24</b>, <b>25</b>, and <b>29</b> and <i>N</i>-benzyl-<i>N</i>-methyl derivative <b>26</b> represented the weakest α4β2 nAChR binders in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Both enantiomers of the α-methylbenzylamine derivatives (<b>24</b> and <b>25</b>) showed binding <i>K</i><sub>i</sub> values over 1 nM (<i>K</i><sub>i</sub> = 39 and 2.2 nM, respectively). Compound <b>28</b> demonstrates that an amide NH bond is not necessary for subnanomolar binding potency but that perhaps a flatter, more constrained amide-alkyl system is desirable (comparing <b>26</b> to <b>28</b>). All of the pyridine anilides <b>31</b>–<b>37</b> had excellent α4β2 nAChR binding affinities (<i>K</i><sub>i</sub> = 0.02–1.1 nM). All of the pyridinecarboxamides were also fairly weak partial agonists (EC<sub>50</sub> > 30 μM in all cases, max response 4–15%). This is in contrast to the pyrazines where stronger partial agonist activity was observed, particularly when comparing the halogen substituted benzamides, <b>19</b> vs <b>31</b> and <b>23</b> vs <b>37</b>.</div><div class="NLM_p">Having achieved our desired in vitro profile, potent α4β2 binding with limited agonist activity, in several compounds, we selected various compounds to be evaluated in vivo. As one of the first hits in this series, compound <b>6</b> was selected for PK evaluation in rats. Following iv, ip, and po dosing at 2 μmol/kg, drug plasma concentrations were monitored out to 8 h. Pyrazine <b>6</b> was found to have a moderate half-life (<i>t</i><sub>1/2</sub> = 1.7 h iv, 2.4 h ip, 2.1 h po) and moderate bioavailability (<i>F</i><sub>ip</sub> = 77%; <i>F</i><sub>po</sub> = 35%). Encouraged by these results, we were next interested in evaluating whether the pyrazine and pyridine carboxamides would reach the CNS following ip administration in rats. Compounds were dosed at 2 μmol/kg, and the concentration in brain and plasma was determined (ng/mL) at 0.75 h following compound administration (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). The brain-to-plasma (b/p) ratio was also determined at 0.25 and 2 h (data not shown) with similar ratios observed. Unfortunately, none of the carboxamide compounds tested showed significant partitioning into the brain. Of the carboxamides, only <b>25</b> and <b>34</b> showed b/p ratios >0.1. We suspected that the amide was responsible for the poor b/p ratios. Compound <b>26</b> was specifically selected for b/p evaluation to see if the ratio could be improved by converting the amide N–H into an <i>N</i>-methyl bond. This transformation did not substantially alter the b/p ratio compared to the other compounds. These poor b/p results precluded the carboxamide series from further advancement. The results from compound <b>78</b> further suggest that the amide is responsible for the poor b/p ratios observed with the carboxamides. Compound <b>78</b> preserves the 3,7-diazabicyclo[3.3.0]octane moiety, while the substituted amide is replaced with a benzyloxy group. This change affords a compound with a b/p ratio of 3.27 at 0.75 h, a 20- to 160-fold increase compared to the carboxamides in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Brain-to-Plasma (b/p) Ratio at 0.75 h for Select Compounds Following 2 μmol/kg ip Administration</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">brain conc (ng/mL)</th><th class="colsep0 rowsep0" align="center" char="±">plasma conc (ng/mL)</th><th class="colsep0 rowsep0" align="center" char=".">b/p at 0.75 h</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char="±">8.0 ± 2.5</td><td class="colsep0 rowsep0" align="char" char="±">178.0 ± 6.6</td><td class="colsep0 rowsep0" align="char" char=".">0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char="±">3.3 ± 0.9</td><td class="colsep0 rowsep0" align="char" char="±">142.5 ± 12.5</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char="±">3.0 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">81.3 ± 5.0</td><td class="colsep0 rowsep0" align="char" char=".">0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="char" char="±">20.6 ± 1.2</td><td class="colsep0 rowsep0" align="char" char="±">139.0 ± 6.0</td><td class="colsep0 rowsep0" align="char" char=".">0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="char" char="±">6.0 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">89.8 ± 3.3</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="char" char="±">6.9 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">163.5 ± 0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="char" char="±">6.4 ± 2.0</td><td class="colsep0 rowsep0" align="char" char="±">52.1 ± 26.5</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="char" char="±">5.5 ± 1.5</td><td class="colsep0 rowsep0" align="char" char="±">74.5 ± 21.5</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>76</b></td><td class="colsep0 rowsep0" align="char" char="±">76.8 ± 7.4</td><td class="colsep0 rowsep0" align="char" char="±">23.5 ± 0.7</td><td class="colsep0 rowsep0" align="char" char=".">3.27</td></tr></tbody></table></div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46471" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46471" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A variety of diazabicyclo[3.3.0]octane substituted pyrazines and pyridines were synthesized and evaluated for their activity at the human α4β2 nAChR. 3,7-Diazabicyclo[3.3.0]octane substituted pyrazinecarboxamides and pyrazinecarboxamides were found to be potent α4β2 nAChR binders with a profile of limited-to-moderate agonist activity. Although, generally poor b/p ratios, likely as a result of the amide group, precluded these compounds from further advancement, our studies show that compounds with ABT-089-like profiles could be generated via systematic modifications of the diazabicyclo[3.3.0]octane-substituted pyrazines and pyridines.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85812" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85812" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> General Procedures</h3><div class="NLM_p last">Nuclear magnetic resonance spectra were obtained on a General Electric QE 300 or QZ 400 MHz instrument with chemical shifts (δ) reported relative to tetramethylsilane as internal standard. Mass spectra determinations were obtained using an electrospray ionization (ESI) technique or by direct chemical ionization (DCI) methods employing ammonia. Melting points were determined with capillary apparatus and are uncorrected. Elemental analyses were performed by Robertson Microlit Laboratories, Inc., Madison, NJ. Analytical thin layer chromatography was done on 2 cm × 6 cm Kieselgel 60 F-254 plates precoated with 0.25 mm thick silica gel distributed by E. Merck. LC-MS analyses were performed on ThermoQuest Navigator systems using 10–100% acetonitrile:10 mM ammonium acetate gradient with MS data obtained using atmospheric pressure chemical ionization positive ionization over the range of <i>m</i>/<i>z</i> from 170 to 1200. Unless otherwise specified, column chromatography was performed on silica gel (230–400 mesh). The term concentrated refers to solvent removal using a rotary evaporator. Unless otherwise specified, solvents and reagents were purchased from Aldrich Chemical Co. and were used without further purification unless otherwise specified. Compounds for biological testing were typically prepared as water-soluble salts in ≥95% purity, in accord with results from combustion analysis.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> (3a<i>R</i>,6a<i>S</i>)-2-(Pyrazin-2-yl)octahydropyrrolo[3,4-<i>c</i>]pyrrole (<b>5</b>)</h3><div class="NLM_p last">Compound <b>40</b> (90.0 mg, 0.31 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (3 mL). TFA (1 mL, 13.0 mmol) was added, and the reaction was stirred at ambient temperature for 1 h and then concentrated. The residue was dissolved in a minimal amount of MeOH and then triturated by slow addition of Et<sub>2</sub>O/MeOH 9:1 (∼10 mL). The product was isolated by filtration, washed with additional Et<sub>2</sub>O (5 × 1 mL), and dried in the vacuum oven overnight (25 Torr, 50 °C) to afford the TFA salt of title compound as a white powder (74.3 mg, 79%). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>, 300 MHz) δ 3.21–3.34 (m, 4H), 3.58–3.72 (m, 6H), 7.82 (d, <i>J</i> = 2.7 Hz, 1H), 7.98 (d, <i>J</i> = 1.4 Hz, 1H), 8.09 (dd, <i>J</i> = 2.7, 1.7 Hz, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 338 (M + H)<sup>+</sup>. Anal. (C<sub>10</sub>H<sub>14</sub>N<sub>4</sub>·TFA) C, H, N.</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 6-((3a<i>R</i>,6a<i>S</i>)-Hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)-<i>N</i>-(2-methylbenzyl)pyrazine-2-carboxamide (<b>6</b>)</h3><div class="NLM_p last">Prepared from <b>57</b> according to the procedures for <b>22</b>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz) δ 2.33 (s, 3H), 3.09–3.16 (m, 4H), 3.46–3.49 (m, 2H), 3.59–3.64 (m, 2H), 3.68–3.75 (m, 2H), 4.49 (d, <i>J</i> = 6.10 Hz, 2H), 7.13–7.21 (m, 4H), 8.21 (s, 1H), 8.39 (s, 1H), 8.86–8.93 (m, 2H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 338 (M + H)<sup>+</sup>. Anal. (C<sub>19</sub>H<sub>23</sub>N<sub>5</sub>O·TFA) C, H, N.</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 6-((3a<i>S</i>,6a<i>S</i>)-Hexahydropyrrolo[3,4-<i>b</i>]pyrrol-5(1<i>H</i>)-yl)-<i>N</i>-(2-methylbenzyl)pyrazine-2-carboxamide (<b>7</b>)</h3><div class="NLM_p last">Prepared from <b>58</b> according to the procedures for <b>22</b>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz) δ 1.87–1.95 (m, 1H), 2.14–2.26 (m, 1H), 2.33 (s, 3H), 3.18–3.57 (m, 4H), 3.71–3.78 (m, 2H), 4.01–4.05 (m, 1H), 4.32–4.36 (m, 1H), 4.43–4.57 (m, 2H), 7.13–7.21 (m, 4H), 8.26 (s, 1H), 8.43 (s, 1H), 8.86–8.96 (m, 2H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 338 (M + H)<sup>+</sup>.</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 6-((3a<i>R</i>,6a<i>R</i>)-Hexahydropyrrolo[3,4-<i>b</i>]pyrrol-1(2<i>H</i>)-yl)-<i>N</i>-(2-methylbenzyl)pyrazine-2-carboxamide (<b>8</b>)</h3><div class="NLM_p last">Prepared from <b>59</b> according to the procedures for <b>22</b>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz) δ 1.96–2.01 (m, 1H), 2.13–2.20 (m, 1H), 2.34 (s, 3H), 3.15–3.19 (m, 2H), 3.35–3.72 (m, 5H), 4.50 (d, <i>J</i> = 6.10 Hz, 2H), 7.13–7.20 (m, 4H), 8.28 (s, 1H), 8.42 (s, 1H), 8.94 (t, <i>J</i> = 6.44 Hz, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 338 (M + H)<sup>+</sup>.</div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 6-((3a<i>R</i>,6a<i>S</i>)-Hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)-<i>N</i>-<i>m</i>-tolylpyrazine-2-carboxamide (<b>9</b>)</h3><div class="NLM_p last">Prepared from <b>66</b> according to the procedures for <b>22</b>. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>, 300 MHz) δ 2.37 (s, 3H), 3.27–3.38 (m, 4H), 3.62–3.69 (m, 2H), 3.79–3.87 (m, 4H), 7.01 (d, <i>J</i> = 7.46 Hz, 1H), 7.23–7.29 (m, 1H), 7.54 (s, 2H), 8.20 (s, 1H), 8.55 (s, 1H), 9.90 (br s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 324 (M + H)<sup>+</sup>. Anal. (C<sub>18</sub>H<sub>21</sub>N<sub>5</sub>O·1.05TFA) C, H, N, F.</div></div><div id="sec6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 6-((3a<i>S</i>,6a<i>S</i>)-Hexahydropyrrolo[3,4-<i>b</i>]pyrrol-5(1<i>H</i>)-yl)-<i>N</i>-<i>m</i>-tolylpyrazine-2-carboxamide (<b>10</b>)</h3><div class="NLM_p last">Prepared from <b>66</b> according to the procedures for <b>22</b>. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>, 300 MHz) δ 2.09–2.17 (m, 1H), 2.34–2.47 (m, 4H), 3.39–3.46 (m, 3H), 3.71–3.91 (m, 3H), 4.21 (dd, <i>J</i> = 13.22, 1.70 Hz, 1H), 4.46–4.51 (m, 1H), 7.01 (d, <i>J</i> = 8.14 Hz, 1H), 7.24–7.30 (m, 1H), 7.53–7.55 (m, 2H), 8.25 (s, 1H), 8.60 (s, 1H), 9.91 (br s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 324 (M + H)<sup>+</sup>. Anal. (C<sub>18</sub>H<sub>21</sub>N<sub>5</sub>O·1.25TFA) C, H, N, F.</div></div><div id="sec6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 5-((3a<i>R</i>,6a<i>S</i>)-Hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)-<i>N</i>-(2-methylbenzyl)nicotinamide (<b>11</b>)</h3><div class="NLM_p last">Boc-protected diazabicyclo[3.3.0]octane <b>38</b> (80 mg, 0.38 mmol), bromopyridine <b>70</b> (155 mg, 0.51 mmol), (<i>R</i>)-(+)-2,2′-bis(diphenylphosphino)-1,1′-binaphthyl (34 mg, 0.034 mmol), tris(dibenzylideneacetone)dipalladium(0) (10.4 mg, 0.011 mmol), and sodium <i>tert</i>-butoxide (54.2 mg, 0.054 mmol) were combined with toluene (5 mL). The suspension was evacuated and purged with nitrogen. The mixture was heated at 95 °C under nitrogen for 4 h. The residue was partitioned between saturated sodium bicarbonate solution (aq) (100 mL) and EtOAc (2 × 50 mL). The combined organic extract was washed with brine (100 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under vacuum. The residue was purified by flash chromatography on silica to provide the Boc protected intermediate (150 mg): MS (APCI) <i>m</i>/<i>z</i> 437 (M + H)<sup>+</sup>. The Boc protected intermediate (150 mg, 0.34 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (5 mL). TFA (10 mL) was added. The reaction mixture was stirred at ambient temperature for 1 h and then concentrated. The residue was diluted with 1.0 M Na<sub>2</sub>CO<sub>3(aq)</sub> (100 mL) and extracted with CHCl<sub>3</sub>–iPrOH (4:1, 2 × 50 mL). The combined organic extract was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under vacuum. The residue was purified on a silica flash chromatography column and eluted with NH<sub>4</sub>OH–CH<sub>3</sub>CN (10:90 to 20:80). The product fractions were combined and concentrated to dryness. This was dissolved in a minimal amount of methanol. A solution of fumaric acid (80 mg, 0.69 mmol) in ether–methanol (10:1, 8.0 mL) was slowly added. After stirring for 1 h, the precipitate was collected by filtration, rinsed with ether, and dried to afford the title compound as the fumarate (129 mg, 78%, 2 steps). <sup>1</sup>H NMR (300 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 2.37 (s, 3H), 3.20–3.28 (m, 3H), 3.38–3.73 (m, 7H), 4.59 (s, 2H), 6.70 (s, 2H; C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>), 7.11–7.21 (m, 3H), 7.24–7.32 (m, 1H), 7.50–7.57 (m, 1H), 8.14 (d, <i>J</i> = 2.7 Hz, 1H), 8.37 (d, <i>J</i> = 1.7 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> 337 (M + H)<sup>+</sup>. Anal. (C<sub>20</sub>H<sub>24</sub>N<sub>4</sub>O·1.3C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 5-((3a<i>S</i>,6a<i>S</i>)-Hexahydropyrrolo[3,4-<i>b</i>]pyrrol-1(2<i>H</i>)-yl)-<i>N</i>-(2-methylbenzyl)nicotinamide (<b>12</b>)</h3><div class="NLM_p last">Prepared form <b>60</b> and <b>70</b> according to the procedures for <b>11</b>. <sup>1</sup>H NMR (300 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 1.95–2.11 (m, 1H), 2.24–2.37 (m, 1H), 2.38 (s, 3H), 3.27–3.38 (m, 2H), 3.40–3.63 (m, 4H), 3.68–3.80 (m, 1H), 4.48 (ddd, <i>J</i> = 7.5, 5.5, 2.0 Hz, 1H), 4.59 (s, 2H), 6.69 (s, 2H; C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>), 7.11–7.21 (m, 3H), 7.24–7.34 (m, 1H), 7.45 (dd, <i>J</i> = 2.9, 1.9 Hz, 1H), 8.10 (d, <i>J</i> = 2.7 Hz, 1H), 8.39 (d, <i>J</i> = 2.0 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> 337 (M + H)<sup>+</sup>. Anal. (C<sub>20</sub>H<sub>24</sub>N<sub>4</sub>O·1.25C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> <i>N</i>-Benzyl-6-((3a<i>R</i>,6a<i>S</i>)-hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)pyrazine-2-carboxamide (<b>13</b>)</h3><div class="NLM_p last">Prepared from <b>53</b> according to the procedures for <b>22</b>. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>, 300 MHz) δ 3.21–3.34 (m, 4H), 3.58–3.64 (m, 2H), 3.69–3.78 (m, 4H), 4.61 (s, 2H), 7.24–7.36 (m, 5H), 8.16 (s, 1H), 8.48 (s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 324 (M + H)<sup>+</sup>. Anal. (C<sub>18</sub>H<sub>21</sub>N<sub>5</sub>O·TFA) C, H, N, F.</div></div><div id="sec6_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 6-((3a<i>R</i>,6a<i>S</i>)-Hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)-<i>N</i>-phenethylpyrazine-2-carboxamide (<b>14</b>)</h3><div class="NLM_p last">Prepared from <b>46</b> according to the procedures for <b>22</b>. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>, 300 MHz) δ 2.92 (t, <i>J</i> = 2.92 Hz, 2H), 3.21–3.34 (m, 4H), 3.62–3.75 (m, 8H), 7.20–7.33 (m, 5H), 8.15 (s, 1H), 8.43 (s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 338 (M + H)<sup>+</sup>. Anal. (C<sub>19</sub>H<sub>23</sub>N<sub>5</sub>O·1.62TFA) C, H, N.</div></div><div id="sec6_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>N</i>-Benzyl-6-((3a<i>R</i>,6a<i>S</i>)-hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)-<i>N</i>-methylpyrazine-2-carboxamide (<b>15</b>)</h3><div class="NLM_p last">Prepared from <b>54</b> according to the procedures for <b>20</b>. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>, 300 MHz) δ 3.01 (d, <i>J</i> = 5.09 Hz, 3H), 3.07–3.74 (m, 10H), 4.67–4.75 (m, 2H), 6.68 (s, 2H), 7.29–7.39 (m, 5H), 8.01–8.07 (m, 2H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 338 (M + H)<sup>+</sup>. Anal. (C<sub>19</sub>H<sub>23</sub>N<sub>5</sub>O·1.2C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec6_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 6-((3a<i>R</i>,6a<i>S</i>)-Hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)-<i>N</i>-(1-phenylethyl)pyrazine-2-carboxamide (<b>16</b>)</h3><div class="NLM_p last">Prepared from <b>55</b> according to the procedures for <b>22</b>. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>, 300 MHz) δ 1.60 (d, <i>J</i> = 7.12 Hz, 6H), 3.23–3.33 (m, 4H), 3.60–3.82 (m, 6H), 5.19–5.29 (m, 1H), 7.23–7.41 (m, 5H), 8.17 (s, 1H), 8.44 (s, 1H), 8.51 (d, <i>J</i> = 8.45 Hz, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 338 (M + H)<sup>+</sup>. Anal. (C<sub>19</sub>H<sub>23</sub>N<sub>5</sub>O·1.15TFA) C, H, N, F.</div></div><div id="sec6_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>N</i>-(3,4-Dichlorobenzyl)-6-((3a<i>R</i>,6a<i>S</i>)-hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)pyrazine-2-carboxamide (<b>17</b>)</h3><div class="NLM_p last">Prepared from <b>47</b> according to the procedures for <b>22</b>. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>, 300 MHz) δ 3.21–3.34 (m, 4H), 3.59–3.66 (m, 2H), 3.70–3.80 (m, 4H), 4.58 (d, <i>J</i> = 6.44 Hz, 2H), 7.28 (dd, <i>J</i> = 8.14, 2.03 Hz, 1H), 7.46–7.50 (m, 2H), 8.17 (s, 1H), 8.48 (s, 1H), 9.11 (t, <i>J</i> = 6.43) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 346 (M + H)<sup>+</sup>. Anal. (C<sub>18</sub>H<sub>19</sub>Cl<sub>2</sub>N<sub>5</sub>O·1.1TFA) C, H, N, F.</div></div><div id="sec6_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>N</i>-(3-Chlorophenyl)-6-((3a<i>R</i>,6a<i>S</i>)-hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)pyrazine-2-carboxamide (<b>18</b>)</h3><div class="NLM_p last">Prepared from <b>48</b> according to the procedures for <b>22</b>. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>, 300 MHz) δ 3.26–3.36 (m, 4H), 3.63–3.69 (m, 2H), 3.76–3.87 (m, 4H), 7.16–7.19 (m, 1H), 7.36 (t, <i>J</i> = 8.14 Hz, 1H), 7.64–7.67 (m, 1H), 7.91–7.92 (m, 1H), 8.22 (s, 1H), 8.55 (s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 344 (M + H)<sup>+</sup>. Anal. (C<sub>17</sub>H<sub>18</sub>ClN<sub>5</sub>O·TFA·0.5H<sub>2</sub>O) C, H, N, F.</div></div><div id="sec6_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 6-((3a<i>R</i>,6a<i>S</i>)-Hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)-<i>N</i>-(3-iodophenyl)pyrazine-2-carboxamide (<b>19</b>)</h3><div class="NLM_p last">Prepared from <b>49</b> according to the procedures for <b>22</b>. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>, 300 MHz) δ 3.26–3.38 (m, 4H), 3.63–3.69 (m, 2H), 3.76–3.87 (m, 4H), 7.15 (t, <i>J</i> = 8.1 Hz, 1H), 7.51–7.54 (m, 1H), 7.76–7.79 (m, 1H), 8.20–8.21 (m, 2H), 8.55 (s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 338 (M + H)<sup>+</sup>. Anal. (C<sub>17</sub>H<sub>18</sub>IN<sub>5</sub>O·TFA) C, H, N, F.</div></div><div id="sec6_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Representitive Procedure for Boc-Deprotection, Isolation of the Fumaric Acid Salt. 6-((3a<i>R</i>,6a<i>S</i>)-Hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)-<i>N</i>-(3-isopropylphenyl)pyrazine-2-carboxamide (<b>20</b>)</h3><div class="NLM_p last">Compound <b>50</b> (71.7 mg, 0.16 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (5 mL). TFA (0.5 mL, 6.5 mmol) was added to the reaction mixture. The reaction was stirred at ambient temperature for 1 h and then concentrated. The residue was partition between 1 M NaOH (50 mL) and CH<sub>2</sub>Cl<sub>2</sub> (3 × 35 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. The residue was dissolved in Et<sub>2</sub>O/MeOH 9:1 (10 mL) and salted out with fumaric acid to afford the title compound as fumaric acid salt. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>, 300 MHz) δ 1.28 (d, <i>J</i> = 6.78, 6H), 2.93 (sept, <i>J</i> = 6.88 Hz, 1H), 3.26–3.37 (m, 4H), 3.60–3.67 (m, 2H), 3.76–3.87 (m, 4H), 6.66 (s, 2H) 7.07 (d, <i>J</i> = 7.46 Hz, 1H), 7.30 (t, <i>J</i> = 7.97 Hz, 1H), 7.55–7.57 (m, 1H), 7.62 (t, <i>J</i> = 1.86 Hz, 1H), 8.20 (s, 1H), 8.55 (s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 352 (M + H)<sup>+</sup>. Anal. (C<sub>20</sub>H<sub>25</sub>N<sub>5</sub>O·1.15C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec6_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 6-((3a<i>R</i>,6a<i>S</i>)-Hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)-<i>N</i>-(3-isopropoxyphenyl)pyrazine-2-carboxamide (<b>21</b>)</h3><div class="NLM_p last">Prepared from <b>68</b> according to the procedures for <b>20</b>. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>, 300 MHz) δ 1.33 (d, <i>J</i> = 6.1 Hz, 6H), 3.26–3.38 (m, 4H), 3.63–3.67 (m, 2H), 3.76–3.85 (m, 4H), 4.62 (sept, <i>J</i> = 6.1 Hz, 1H), 6.66 (s, 2H), 6.71–6.75 (m, 1H), 7.19–7.29 (m, 2H), 7.46 (t, <i>J</i> = 2.2 Hz, 1H), 8.20 (s, 1H), 8.54 (s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 368 (M + H)<sup>+</sup>. Anal. (C<sub>20</sub>H<sub>25</sub>N<sub>5</sub>O<sub>2</sub>·C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec6_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Representative Procedure for Boc-Deprotection, Isolation of the TFA Salt. (3a<i>R</i>,6a<i>S</i>)-<i>tert</i>-Butyl <i>N</i>-(3,5-Dimethylphenyl)-6-((3a<i>R</i>,6a<i>S</i>)-hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)pyrazine-2-carboxamide (<b>22</b>)</h3><div class="NLM_p last">Compound <b>51</b> (106.8 mg, 0.24 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (5 mL). TFA (1 mL, 13 mmol) was added to the reaction mixture. The reaction was stirred at ambient temperature for 1 h and then concentrated. The residue was dissolved in a minimal amount of MeOH and then triturated by slow addition of Et<sub>2</sub>O/MeOH 9:1. The product was isolated by filtration, washed with additional Et<sub>2</sub>O (5 × 1 mL), and dried in the vacuum oven overnight to afford the TFA salt of title compound as a white powder (74.6 mg, 69%). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>, 400 MHz) δ 2.32 (s, 6H), 3.29–3.35 (m, 4H), 3.63–3.68 (m, 2H), 3.74–3.84 (m, 4H), 6.83 (s, 1H), 7.34 (s, 2H), 8.17 (s, 1H), 8.53 (s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 338 (M + H)<sup>+</sup>. Anal. (C<sub>19</sub>H<sub>23</sub>N<sub>5</sub>O·TFA) C, H, N, F.</div></div><div id="sec6_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>N</i>-(3,5-Difluorophenyl)-6-((3a<i>R</i>,6a<i>S</i>)-hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)pyrazine-2-carboxamide (<b>23</b>)</h3><div class="NLM_p last">Prepared from <b>52</b> according to the procedures for <b>22</b>. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>, 300 MHz) δ 3.26–3.36 (m, 4H), 3.63–3.69 (m, 2H), 3.77–3.84 (m, 4H), 6.75 (tt, <i>J</i> = 9.11, 2.25 Hz, 1H) 7.47–7.54 (m, 2H), 8.22 (s, 1H), 8.55 (s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 346 (M + H)<sup>+</sup>. Anal. (C<sub>17</sub>H<sub>17</sub>F<sub>2</sub>N<sub>5</sub>O·TFA) C, H, N, F.</div></div><div id="sec6_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 5-((3a<i>R</i>,6a<i>S</i>)-Hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)-<i>N</i>-((<i>S</i>)-1-phenylethyl)nicotinamide (<b>24</b>)</h3><div class="NLM_p last">Prepared from <b>73</b> and (<i>S</i>)-1-phenylethanamine according to the procedures for <b>51</b> and <b>20</b>. <sup>1</sup>H NMR (300 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 1.57 (d, <i>J</i> = 6.8 Hz, 3H), 3.16–3.28 (m, 4H), 3.39–3.65 (m, 6H), 5.24 (q, <i>J</i> = 7.0 Hz, 1H), 6.66 (s, 2 H; C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>), 7.20–7.27 (m, 1H), 7.29–7.42 (m, 4H), 7.48 (dd, <i>J</i> = 2.9, 1.9 Hz, 1H), 8.12 (d, <i>J</i> = 2.7 Hz, 1H), 8.36 (d, <i>J</i> = 1.7 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> 337 (M + H)<sup>+</sup>; [α]<sup>20</sup><sub>D</sub> = −11.2° (<i>c</i> = 0.10, MeOH). Anal. (C<sub>20</sub>H<sub>24</sub>N<sub>4</sub>O·1.5C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>·0.1H<sub>2</sub>O) C, H, N.</div></div><div id="sec6_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 5-((3a<i>R</i>,6a<i>S</i>)-Hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)-<i>N</i>-((<i>R</i>)-1-phenylethyl)nicotinamide (<b>25</b>)</h3><div class="NLM_p last">Prepared from <b>73</b> and (<i>R</i>)-1-phenylethanamine according to the procedures for <b>51</b> and <b>20</b>. <sup>1</sup>H NMR (300 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 1.57 (d, <i>J</i> = 6.8 Hz, 3H), 3.17–3.28 (m, 4H), 3.39–3.66 (m, 6H), 5.24 (q, <i>J</i> = 7.0 Hz, 1H), 6.66 (s, 2 H; C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>), 7.20–7.27 (m, 1H), 7.29–7.42 (m, 4H), 7.48 (dd, <i>J</i> = 2.9, 1.9 Hz, 1H), 8.12 (d, <i>J</i> = 2.7 Hz, 1H), 8.36 (d, <i>J</i> = 1.7 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> 337 (M + H)<sup>+</sup>; [α]<sup>20</sup><sub>D</sub> = +11.7° (<i>c</i> = 0.11, MeOH). Anal. (C<sub>20</sub>H<sub>24</sub>N<sub>4</sub>O·1.1C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>·0.2H<sub>2</sub>O) C, H, N.</div></div><div id="sec6_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>N</i>-Benzyl-5-((3a<i>R</i>,6a<i>S</i>)-hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)-<i>N</i>-methylnicotinamide (<b>26</b>)</h3><div class="NLM_p last">Prepared from <b>73</b> and <i>N</i>-methylbenzylamine according to the procedures for <b>51</b> and <b>20</b>. <sup>1</sup>H NMR (300 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 2.92, 3.07 (s, s, 3H; rotamers), 3.20–3.33 (m, 4H), 3.36–3.67 (m, 6H), 4.55, 4.76 (s, s, 2H; rotamers), 6.70 (s, 3H; C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>), 7.07–7.24 (m, 2H), 7.27–7.42 (m, 4H), 7.99 (s, 1H), 8.04–8.14 (m, <i>J</i> = 10.9, 1.7 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> 337 (M + H)<sup>+</sup>. Anal. (C<sub>20</sub>H<sub>24</sub>N<sub>4</sub>O·1.6C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>·0.45H<sub>2</sub>O) C, H, N.</div></div><div id="sec6_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 5-((3a<i>R</i>,6a<i>S</i>)-Hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)-<i>N</i>-(2-(trifluoromethyl)benzyl)nicotinamide (<b>27</b>)</h3><div class="NLM_p last">Prepared from <b>73</b> and 2-trifluoromethylbenzylamine according to the procedures for <b>51</b> and <b>20</b>. <sup>1</sup>H NMR (300 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 2.37 (s, 3H), 3.20–3.28 (m, 3H), 3.38–3.73 (m, 7H), 4.59 (s, 2), 6.70 (s, 2H; C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>), 7.11–7.21 (m, 3H), 7.24–7.32 (m, 1H), 7.50–7.57 (m, 1H), 8.14 (d, <i>J</i> = 2.7 Hz, 1H), 8.37 (d, <i>J</i> = 1.7 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> 337 (M + H)<sup>+</sup>. Anal. (C<sub>20</sub>H<sub>24</sub>N<sub>4</sub>O·1.3C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec6_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (3,4-Dihydroisoquinolin-2(1<i>H</i>)-yl)(5-((3a<i>R</i>,6a<i>S</i>)-hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)pyridin-3-yl)methanone (<b>28</b>)</h3><div class="NLM_p last">Prepared from <b>73</b> and 1,2,3,4-tetrahydroisoquinoline according to the procedures for <b>51</b> and <b>20</b>. <sup>1</sup>H NMR (300 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 2.86–3.02 (m, 2H), 3.19–3.29 (m, 4H), 3.39–3.72 (m, 8H), 3.91–4.05 (m, 1H), 4.61 (br s, 1H), 6.68 (s, 2 H; C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>), 7.04–7.25 (m, 5H), 8.00 (br s, 1H), 8.12 (d, <i>J</i> = 2.7 Hz, 1H). MS (APCI) <i>m</i>/<i>z</i> 349 (M + H)<sup>+</sup>. Anal. (C<sub>21</sub>H<sub>24</sub>N<sub>4</sub>O·1.4C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec6_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>N</i>-(2,3-Dihydro-1<i>H</i>-inden-1-yl)-5-((3a<i>R</i>,6a<i>S</i>)-hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)nicotinamide (<b>29</b>)</h3><div class="NLM_p last">Prepared from <b>73</b> and 1-aminoindane according to the procedures for <b>51</b> and <b>20</b>. <sup>1</sup>H NMR (300 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 1.93–2.12 (m, 1H), 2.52–2.66 (m, 1H), 2.85–2.99 (m, 1H), 3.01–3.13 (m, 1H), 3.20–3.35 (m, 4H), 3.41–3.66 (m, 6H), 5.65 (t, <i>J</i> = 7.8 Hz, 1H), 6.67 (s, 2 H; C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>), 7.15–7.32 (m, 4H), 7.55 (dd, <i>J</i> = 2.9, 1.9 Hz, 1H), 8.13 (d, <i>J</i> = 3.1 Hz, 1H), 8.37 (d, <i>J</i> = 2.0 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> 349 (M + H)<sup>+</sup>. Anal. (C<sub>21</sub>H<sub>24</sub>N<sub>4</sub>O·1.4C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec6_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>N</i>-(2-Fluorophenethyl)-5-((3a<i>R</i>,6a<i>S</i>)-hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)nicotinamide (<b>30</b>)</h3><div class="NLM_p last">Prepared from <b>73</b> and 2-(2-fluorophenyl)ethanamine according to the procedures for <b>51</b> and <b>22</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.89 (t, <i>J</i> = 7.1 Hz, 2H), 3.04–3.24 (m, 4H), 3.33–3.48 (m, 9H), 7.08–7.21 (m, 2H), 7.22–7.36 (m, 2H), 7.38–7.45 (m, 1H), 8.14 (d, <i>J</i> = 3.1 Hz, 1H), 8.33 (d, <i>J</i> = 1.7 Hz, 1H), 8.74 (t, <i>J</i> = 5.8 Hz, 1H), 8.82 (br s, 2 H; TFA). MS (ESI) <i>m</i>/<i>z</i> 355 (M + H)<sup>+</sup>. Anal. (C<sub>20</sub>H<sub>23</sub>FN<sub>4</sub>O·2TFA) C, H, N.</div></div><div id="sec6_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 5-((3a<i>R</i>,6a<i>S</i>)-Hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)-<i>N</i>-(3-iodophenyl)nicotinamide (<b>31</b>)</h3><div class="NLM_p last">Prepared from <b>73</b> and 3-iodoaniline according to the procedures for <b>51</b> and <b>20</b>. <sup>1</sup>H NMR (300 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 3.23–3.35 (m, 4H), 3.42–3.68 (m, 6H), 6.69 (s, 2H; C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>), 7.13 (t, <i>J</i> = 8.1 Hz, 1H), 7.52 (ddd, <i>J</i> = 7.9, 1.6, 1.0 Hz, 1H), 7.59 (dd, <i>J</i> = 2.7, 2.0 Hz, 1H), 7.69 (ddd, <i>J</i> = 8.1, 2.0, 1.0 Hz, 1H), 8.15–8.25 (m, 2H), 8.44 (d, <i>J</i> = 2.0 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> 435 (M + H)<sup>+</sup>. Anal. (C<sub>18</sub>H<sub>19</sub>IN<sub>4</sub>O·1.7C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>·0.1 H<sub>2</sub>O) C, H, N.</div></div><div id="sec6_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 5-((3a<i>R</i>,6a<i>S</i>)-Hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)-<i>N</i>-(3-isopropoxyphenyl)nicotinamide (<b>32</b>)</h3><div class="NLM_p last">Prepared from <b>73</b> and 3-isopropoxyaniline according to the procedures for <b>51</b> and <b>20</b>. <sup>1</sup>H NMR (300 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 1.33 (d, <i>J</i> = 6.1 Hz, 6H), 3.19–3.37 (m, 4H), 3.42–3.69 (m, 6H), 4.60 (hept, <i>J</i> = 6.1 Hz, 1H), 6.66 (s, 2 H; C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>), 6.72 (td, <i>J</i> = 4.6, 2.4 Hz, 1H), 7.16–7.29 (m, 2H), 7.38 (t, <i>J</i> = 1.9 Hz, 1H), 7.58 (dd, <i>J</i> = 2.7, 2.0 Hz, 1H), 8.17 (d, <i>J</i> = 2.7 Hz, 1H), 8.44 (d, <i>J</i> = 1.7 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> 367 (M + H)<sup>+</sup>. Anal. (C<sub>21</sub>H<sub>26</sub>N<sub>4</sub>O<sub>2</sub>·1.1C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>·0.1H<sub>2</sub>O) C, H, N.</div></div><div id="sec6_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>N</i>-(4-Chlorophenyl)-5-((3a<i>R</i>,6a<i>S</i>)-hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)nicotinamide (<b>33</b>)</h3><div class="NLM_p last">Prepared from <b>73</b> and 4-chloroaniline according to the procedures for <b>51</b> and <b>20</b>. <sup>1</sup>H NMR (300 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 3.22–3.35 (m, 4H), 3.43–3.68 (m, 6H), 6.70 (s, 3 H; C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>), 7.33–7.41 (m, 2H), 7.59 (dd, <i>J</i> = 2.7, 2.0 Hz, 1H), 7.67–7.80 (m, 2H), 8.18 (d, <i>J</i> = 2.7 Hz, 1H), 8.45 (d, <i>J</i> = 1.7 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> 343 (M + H)<sup>+</sup>. Anal. (C<sub>18</sub>H<sub>19</sub>ClN<sub>4</sub>O·1.65C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec6_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 5-((3a<i>R</i>,6a<i>S</i>)-Hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)-<i>N</i>-<i>m</i>-tolylnicotinamide (<b>34</b>)</h3><div class="NLM_p last">Prepared from <b>73</b> and <i>m</i>-toluidine according to the procedures for <b>51</b> and <b>20</b>. <sup>1</sup>H NMR (300 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 2.36 (s, 3H), 3.21–3.35 (m, 4H), 3.43–3.53 (m, 2H), 3.54–3.68 (m, 4H), 6.69 (s, 2 H; C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>), 6.95–7.03 (m, 1H), 7.25 (t, <i>J</i> = 7.8 Hz, 1H), 7.45–7.53 (m, 2H), 7.59 (dd, <i>J</i> = 2.9, 1.9 Hz, 1H), 8.18 (d, <i>J</i> = 2.7 Hz, 1H), 8.45 (d, <i>J</i> = 2.0 Hz, 1H). MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 323 (M + H)<sup>+</sup>. Anal. (C<sub>20</sub>H<sub>24</sub>N<sub>4</sub>O·0.95C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec6_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>N</i>-(3,5-Dimethylphenyl)-5-((3a<i>R</i>,6a<i>S</i>)-hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)nicotinamide(<b>35</b>)</h3><div class="NLM_p last">Prepared from <b>73</b> and 3,5-dimethylaniline according to the procedures for <b>51</b> and <b>20</b>. <sup>1</sup>H NMR (300 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 2.31 (s, 6H), 3.22–3.36 (m, 4H), 3.44–3.69 (m, 6H), 6.69 (s, 2 H; C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>), 6.83 (s, 1H), 7.31 (s, 2H), 7.58 (dd, <i>J</i> = 2.7, 2.0 Hz, 1H), 8.17 (d, <i>J</i> = 3.1 Hz, 1H), 8.44 (d, <i>J</i> = 1.7 Hz, 1H). MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 337 (M + H)<sup>+</sup>. Anal. (C<sub>20</sub>H<sub>24</sub>N<sub>4</sub>O·1.5C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec6_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>N</i>-(3,5-Dimethoxyphenyl)-5-((3a<i>R</i>,6a<i>S</i>)-hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)nicotinamide (<b>36</b>)</h3><div class="NLM_p last">Prepared from <b>73</b> and 3,5-dimethoxyaniline according to the procedures for <b>50</b> and <b>20</b>. <sup>1</sup>H NMR (300 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 3.20–3.29 (m, 4H), 3.42–3.68 (m, 6H), 3.79 (s, 6H), 6.32 (t, <i>J</i> = 1.9 Hz, 1H), 6.66 (s, 2 H; C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>), 6.97 (d, <i>J</i> = 2.0 Hz, 2H), 7.55–7.60 (m, 1H), 8.17 (d, <i>J</i> = 2.7 Hz, 1H), 8.43 (s, 1H). MS (APCI) <i>m</i>/<i>z</i> 369 (M + H)<sup>+</sup>. Anal. (C<sub>20</sub>H<sub>24</sub>N<sub>4</sub>O<sub>3</sub>·1.5C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec6_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>N</i>-(3,5-Difluorophenyl)-5-((3a<i>R</i>,6a<i>S</i>)-hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)nicotinamide (<b>37</b>)</h3><div class="NLM_p last">Prepared from <b>73</b> and 3,5-difluoroaniline according to the procedures for <b>51</b> and <b>20</b>. <sup>1</sup>H NMR (300 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 3.23–3.26 (m, 1H), 3.28–3.35 (m, 3H), 3.44–3.68 (m, 6H), 6.68 (s, 2 H; C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>), 6.75 (tt, <i>J</i> = 9.2, 2.4 Hz, 1H), 7.36–7.50 (m, 2H), 7.59 (dd, <i>J</i> = 2.9, 1.9 Hz, 1H), 8.19 (d, <i>J</i> = 2.7 Hz, 1H), 8.45 (d, <i>J</i> = 1.7 Hz, 1H), 8.29 (d, <i>J</i> = 1.7 Hz, 1H). MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 345 (M + H)<sup>+</sup>. Anal. (C<sub>18</sub>H<sub>18</sub>F<sub>2</sub>N<sub>4</sub>O·1.5C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec6_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (3a<i>R</i>,6a<i>S</i>)-<i>tert</i>-Butyl 5-(Pyrazin-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2(1<i>H</i>)-carboxylate (<b>40</b>)</h3><div class="NLM_p last">Boc-protected diazabicyclo[3.3.0]octane <b>38</b> (201.8 mg, 0.95 mmol) and 2-chloropyrazine <b>39</b> (100 μL, 1.14 mmol) were dissolved in DMSO (1 mL). Potassium carbonate (212.3 mg, 1.54 mmol) was added, and the reaction was heated to 120 °C for 21 h. After cooling, the potassium carbonate was filtered off. The reaction mixture was diluted with MeOH (1 mL) and purified by preparative HPLC on a Waters Nova-Pak HR C18 6 μm 60 Å Prep-Pak cartridge column (40 mm ×100 mm) using a gradient of 10–100% acetonitrile in 10 mM aqueous ammonium acetate over 12 min at a flow rate of 70 mL/min to provide the title compound as a white solid (95.9 mg, 35%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 1.46 (s, 9H), 3.00–3.06 (m, 2H), 3.26–3.45 (m, 4H), 3.66–3.74 (m, 4H), 7.82 (d, <i>J</i> = 2.7 Hz, 1H), 7.87 (d, <i>J</i> = 1.4 Hz, 1H), 8.04 (dd, <i>J</i> = 2.7, 1.4 Hz, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 291 (M + H)<sup>+</sup>.</div></div><div id="sec6_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Methyl 4-Oxy-2-pyrazinecarboxylate (<b>42</b>)</h3><div class="NLM_p last">Methyl 2-pyrazinecarboxylate (<b>41</b>) (Pyrazine Specialists, 10.04 g, 72.2 mmol) was suspended in 1,2-dichloroethane (100 mL). To the reaction mixture was added <i>m</i>CPBA (32.35 g, 77%, 144 mmol). The reaction was stirred at 60 °C for 16 h. The reaction was then allowed to cool to ambient temperature and diluted with CH<sub>2</sub>Cl<sub>2</sub> (300 mL). The precipitate was filtered off and washed with additional CH<sub>2</sub>Cl<sub>2</sub> (3 × 35 mL). The filtrates were combined, dried over K<sub>2</sub>CO<sub>3</sub>, filtered, and concentrated. The residue was suspended in hexane (50 mL). The title compound was isolated by filtration and washed with additional hexane (2 × 50 mL) to afford a slightly yellow solid (7.22 g, 64%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz) δ 3.91 (s, 3H), 8.54 (dd, <i>J</i> = 4.07, 1.69 Hz, 1H), 8.64–8.67 (m, 2H) ppm. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz) δ 53.0, 135.2, 136.2, 147.1, 148.8, 162.7 ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 155 (M + H)<sup>+</sup>. Anal. (C<sub>6</sub>H<sub>6</sub>N<sub>2</sub>O<sub>3</sub>) C, H, N.</div></div><div id="sec6_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Methyl 6-Chloro-2-pyrazinecarboxylate (<b>43</b>)</h3><div class="NLM_p last">Methyl 4-oxy-2-pyrazinecarboxylate (<b>42</b>) (7.18 g, 45.9 mmol) was dissolved in SOCl<sub>2</sub> (50 mL, 687 mmol). The reaction was heated to reflux for 8 h and then allowed to cool to ambient temperature. The SOCl<sub>2</sub> was removed under reduced pressure, and the residue was quenched with water (50 mL) at 0 °C. The mixture was neutralized by the addition of 1 M K<sub>2</sub>CO<sub>3</sub> (aq) and extracted with CH<sub>2</sub>Cl<sub>2</sub> (5 × 100 mL). The organic extracts were combined and washed with brine (100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by silica gel chromatography (5% EtOAc in CH<sub>2</sub>Cl<sub>2</sub>, <i>R</i><sub>f</sub> = 0.35) to afford the title compound as a thick oil that slowly solidified (7.16 g, 67%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 3.95 (s, 3H), 9.07 (s, 1H), 9.18 (s, 1H) ppm. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 125 MHz) δ 52.9, 142.1, 143.6, 144.9, 148.1, 162.8 ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 190 (M + NH<sub>4</sub>)<sup>+</sup>. Anal. (C<sub>6</sub>H<sub>5</sub>ClN<sub>2</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec6_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (3a<i>R</i>,6a<i>S</i>)-<i>tert</i>-Butyl 5-(6-(Methoxycarbonyl)pyrazin-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2(1<i>H</i>)-carboxylate (<b>44</b>)</h3><div class="NLM_p last">Chloropyrazine <b>43</b> (1.74 g, 10.08 mmol) and (3a<i>R</i>,6a<i>S</i>)-<i>tert</i>-butyl hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2(1<i>H</i>)-carboxylate <b>38</b> were dissolved in DMSO (10 mL). Sodium carbonate (1.61 g, 15.19 mmol) was added to the reaction mixture. The reaction was stirred at 120 °C for 16 h. The reaction was then allowed to cool to ambient temperature, diluted with water (100 mL), and extracted with CH<sub>2</sub>Cl<sub>2</sub> (4 × 100 mL). The organic extracts were combined and washed with water (100 mL) and brine (100 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by silica gel chromatography (EtOAc, <i>R</i><sub>f</sub> = 0.36) to afford the title compound as a thick oil that slowly solidified (2.78 g, 78%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 1.45 (s, 9H), 3.01–3.08 (m, 2H), 3.28–3.37 (m, 2H), 3.50–3.54 (m, 2H), 3.60–3.72 (m, 2H), 3.82 (dd, <i>J</i> = 11.0, 7.3 Hz, 2H), 3.97 (s, 3H), 8.03 (s, 1H), 8.52 (s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 349 (M + H)<sup>+</sup>.</div></div><div id="sec6_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 6-((3a<i>R</i>,6a<i>S</i>)-5-(<i>tert</i>-Butoxycarbonyl)hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)pyrazine-2-carboxylic acid (<b>45</b>)</h3><div class="NLM_p last">Methyl ester <b>44</b> (1.13 g, 3.24 mmol) was dissolved in EtOH (16 mL), 1 M NaOH (16 mL) was added, and the reaction stirred at ambient temperature for 1 h. The reaction mixture was acidified to pH ≈ 3 with 1 M HCl (aq). The mixture was then diluted with water (100 mL) and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 100 mL). The organic extracts were combined, washed with brine (100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to provide the title compound as an amorphous solid (1.05 g, 97%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 1.46 (s, 9H), 3.07–3.13 (m, 2H), 3.28–3.40 (m, 2H), 3.50 (dd, <i>J</i> = 10.9, 4.1 Hz, 2H), 3.66–3.75 (m, 2H), 3.83 (dd, <i>J</i> = 10.9, 7.1 Hz, 2H), 8.17 (s, 1H), 8.66 (s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 335 (M + H)<sup>+</sup>.</div></div><div id="sec6_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (3a<i>R</i>,6a<i>S</i>)-<i>tert</i>-Butyl 5-(6-(Phenethylcarbamoyl)pyrazin-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2(1<i>H</i>)-carboxylate (<b>46</b>)</h3><div class="NLM_p last">Prepared from <b>45</b> and phenethylamine according to the procedures for <b>51</b>. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>, 300 MHz) δ 1.40 (s, 9H), 2.95 (t, <i>J</i> = 2.9 Hz, 2H), 3.20–3.24 (m, 4H), 3.39–3.75 (m, 8H), 7.20–7.33 (m, 5H), 8.15 (s, 1H), 8.33 (s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 438 (M + H)<sup>+</sup>.</div></div><div id="sec6_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (3a<i>R</i>,6a<i>S</i>)-<i>tert</i>-Butyl 5-(6-(3,4-Dichlorobenzylcarbamoyl)pyrazin-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2(1<i>H</i>)-carboxylate (<b>47</b>)</h3><div class="NLM_p last">Prepared from <b>45</b> and 3,4-dichlorobenzylamine according to the procedures for <b>51</b>. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>, 300 MHz) δ 1.39 (s, 9H), 3.00–3.04 (m, 2H), 3.17–3.22 (m, 2H), 3.39–3.55 (m, 4H), 3.73–3.77 (m, 2H), 4.48 (d, <i>J</i> = 6.4 Hz, 1H), 7.31 (dd, <i>J</i> = 8.1, 2.0 Hz, 1H), 7.55–7.60 (m, 5H), 8.14 (s, 1H), 8.31 (s, 1H), 9.16 (t, <i>J</i> = 6.4 Hz, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 492 (M + H)<sup>+</sup>.</div></div><div id="sec6_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (3a<i>R</i>,6a<i>S</i>)-<i>tert</i>-Butyl 5-(6-(3-Chlorophenylcarbamoyl)pyrazin-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2(1<i>H</i>)-carboxylate (<b>48</b>)</h3><div class="NLM_p last">Prepared from <b>45</b> and 3-chloroaniline according to the procedures for <b>51</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 1.47 (s, 9H), 3.06–3.16 (m, 2H), 3.30–3.45 (m, 2H), 3.51–3.56 (m, 2H), 3.69–3.75 (m, 2H), 3.81–3.91 (m, 2H), 7.13 (ddd, <i>J</i> = 8.1, 2.0, 1.0 Hz, 1H), 7.31 (t, <i>J</i> = 8.1 Hz, 1H), 7.63 (ddd, <i>J</i> = 8.1, 2.0, 1.0 Hz, 1H), 7.79 (t, <i>J</i> = 1.9 Hz, 1H), 8.11 (s, 1H), 8.74 (s, 1H), 9.57 (s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 444 (M + H)<sup>+</sup>.</div></div><div id="sec6_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (3a<i>R</i>,6a<i>S</i>)-<i>tert</i>-Butyl 5-(6-(3-Iodophenylcarbamoyl)pyrazin-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2(1<i>H</i>)-carboxylate (<b>49</b>)</h3><div class="NLM_p last">Prepared from <b>45</b> and 3-iodoaniline according to the procedures for <b>51</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 1.47 (s, 9H), 3.06–3.16 (m, 2H), 3.30–3.46 (m, 2H), 3.52–3.56 (m, 2H), 3.70–3.75 (m, 2H), 3.84–3.89 (m, 2H), 7.11 (t, <i>J</i> = 8.1 Hz, 1H), 7.47–7.51 (m, 1H), 7.73–7.80 (m, 1H), 8.06 (t, <i>J</i> = 1.9 Hz, 1H), 8.10 (s, 1H), 8.72 (s, 1H), 9.53 (s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 536 (M + H)<sup>+</sup>.</div></div><div id="sec6_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (3a<i>R</i>,6a<i>S</i>)-<i>tert</i>-Butyl 5-(6-(3-Isopropylphenylcarbamoyl)pyrazin-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2(1<i>H</i>)-carboxylate (<b>50</b>)</h3><div class="NLM_p last">Prepared from <b>45</b> and 3-isopropylaniline according to the procedures for <b>51</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 1.29 (d, <i>J</i> = 6.8 Hz, 6H), 1.47 (s, 9H), 2.90–2.99 (m, 1H), 3.06–3.16 (m, 2H), 3.31–3.56 (m, 4H), 3.72 (dd, <i>J</i> = 11.5, 7.5 Hz, 2H), 3.81–3.90 (m, 2H), 7.03–7.05 (m, 1H), 7.31 (t, <i>J</i> = 7.8 Hz, 1H), 7.52 (ddd, <i>J</i> = 7.9, 2.1, 0.9 Hz, 1H), 7.62 (t, <i>J</i> = 1.9 Hz, 1H), 8.09 (s, 1H), 8.75 (s, 1H), 9.52 (s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 452 (M + H)<sup>+</sup>.</div></div><div id="sec6_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Representitive Procedure for Amide Formation with EDCI. (3a<i>R</i>,6a<i>S</i>)-<i>tert</i>-Butyl 5-(6-(3,5-Dimethylphenylcarbamoyl)pyrazin-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2(1<i>H</i>)-carboxylate (<b>51</b>)</h3><div class="NLM_p last">Carboxylic acid <b>45</b> (101.9 mg, 0.30 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (3 mL), 3,5-dimethylaniline (110 μL, 0.88 mmol), HOBt (53.5 mg, 0.40 mmol), DMAP (10.4 mg, 0.085 mmol), and EDCI (94.3 mg, 0.49 mmol) were added to the reaction mixture. The reaction was stirred at ambient temperature for 5 h. The reaction mixture was concentrated and purified by preparative HPLC on a Waters Nova-Pak HR C18 6 μm 60 Å Prep-Pak cartridge column (40 mm ×100 mm) using a gradient of 10% to 100% acetonitrile in 10 mM aqueous ammonium acetate over 12 min at a flow rate of 70 mL/min to provide the title compound (109.0 mg, 83%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 1.47 (s, 9H), 2.35 (s, 6H), 3.05–3.15 (m, 2H), 3.30–3.55 (m, 4H), 3.72 (dd, <i>J</i> = 11.5, 7.5 Hz, 2H), 3.80–3.89 (m, 2H), 6.80 (s, 1H), 7.31 (s, 2H), 8.08 (s, 1H), 8.74 (s, 1H), 9.47 (s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 438 (M + H)<sup>+</sup>.</div></div><div id="sec6_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> (3a<i>R</i>,6a<i>S</i>)-<i>tert</i>-Butyl 5-(6-(3,5-Difluorophenylcarbamoyl)pyrazin-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2(1<i>H</i>)-carboxylate (<b>52</b>)</h3><div class="NLM_p last">Prepared from <b>45</b> and 3,5-difluoroaniline according to the procedures for <b>51</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 1.47 (s, 9H), 3.08–3.15 (m, 2H), 3.31–3.44 (m, 2H), 3.53 (dd, <i>J</i> = 11.0, 3.9 Hz, 2H), 3.69–3.76 (m, 2H), 3.82–3.88 (m, 2H), 6.61 (tt, <i>J</i> = 8.9, 2.3 Hz, 1H), 7.31–7.37 (m, 2H), 8.12 (s, 1H), 8.73 (s, 1H), 9.63 (s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 446 (M + H)<sup>+</sup>.</div></div><div id="sec6_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Representitive Procedure for Amide Formation from Methyl Esters with MgCl<sub>2</sub>. (3a<i>R</i>,6a<i>S</i>)-<i>tert</i>-Butyl 5-(6-(Benzylcarbamoyl)pyrazin-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2(1<i>H</i>)-carboxylate (<b>53</b>)</h3><div class="NLM_p last">Methyl ester <b>44</b> (201.4 mg, 0.58 mmol) and MgCl<sub>2</sub> (112.7 mg, 1.18 mmol) were suspended in THF (6 mL) and stirred at ambient temperature for 5 min. Benzylamine (150 μL, 1.37 mmol) was added, and the reaction was stirred at 40 °C for 18 h. The reaction mixture was then poured into water (50 mL) and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 35 mL). The organic extracts were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by preparative HPLC on a Waters Nova-Pak HR C18 Prep-Pak cartridge column (40 mm × 100 mm) using a gradient of 10–100% acetonitrile in 10 mM aqueous ammonium acetate over 12 min at a flow rate of 70 mL/min to provide the title compound (183.8 mg, 75%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 1.45 (s, 9H), 3.00–3.08 (m, 2H), 3.24–3.46 (m, 4H), 3.64–3.79 (m, 4H), 4.67 (d, <i>J</i> = 6.4 Hz, 2H), 7.31–7.37 (m, 5H), 7.96–8.03 (m, 2H), 8.69 (s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 424 (M + H)<sup>+</sup>.</div></div><div id="sec6_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> (3a<i>R</i>,6a<i>S</i>)-<i>tert</i>-Butyl 5-(6-(Benzyl(methyl)carbamoyl)pyrazin-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2(1<i>H</i>)-carboxylate (<b>54</b>)</h3><div class="NLM_p last">Prepared from <b>44</b> and <i>N</i>-benzylmethylamine according to the procedures for <b>53</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 1.45 (s, 9H), 2.90–3.76 (m, 13H), 4.64–4.76 (m, 2H), 7.28–7.37 (m, 5H), 7.86–7.89 (m, 1H), 8.14–8.19 (m, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 438 (M + H)<sup>+</sup>.</div></div><div id="sec6_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> (3a<i>R</i>,6a<i>S</i>)-<i>tert</i>-Butyl 5-(6-(1-Phenylethylcarbamoyl)pyrazin-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2(1<i>H</i>)-carboxylate (<b>55</b>)</h3><div class="NLM_p last">Prepared from <b>44</b> and α-methylbenzylamine according to the procedures for <b>53</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 1.46 (s, 9H), 1.60 (d, <i>J</i> = 7.8 Hz, 3H), 3.00–3.09 (m, 2H), 3.26–3.47 (m, 4H), 3.65–3.79 (m, 4H), 5.28–5.38 (m, 1H),7.28–7.30 (m, 1H), 7.33–7.41 (m, 4H), 7.91 (d, <i>J</i> = 8.1 Hz, 1H), 8.03 (s, 1H), 8.65 (s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 438 (M + H)<sup>+</sup>.</div></div><div id="sec6_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 6-Chloro-<i>N</i>-(2-methylbenzyl)pyrazine-2-carboxamide (<b>56</b>)</h3><div class="NLM_p last">Methyl ester <b>43</b> (1.00 g, 5.79 mmol) and MgCl<sub>2</sub> (1.11 g, 11.7 mmol) were suspended in THF (25 mL) and stirred at ambient temperature for 5 min. 2-Methylbenzylamine (1.8 mL, 14.5 mmol) was added, and the reaction was stirred at ambient temperature for 16 h. The reaction mixture was diluted with water (150 mL) and extracted with CH<sub>2</sub>Cl<sub>2</sub> (4 × 100 mL). The organic extracts were combined and washed with 0.25 M HCl (aq) (100 mL) and brine (100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by silica gel chromatography (5% EtOAc in CH<sub>2</sub>Cl<sub>2</sub>, <i>R</i><sub>f</sub> = 0.31) to afford the title compound as a white solid (1.35 g, 89%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz) δ 2.33 (s, 3H), 4.48 (d, <i>J</i> = 6.10 Hz, 2H), 7.12–7.26 (m, 4H), 9.02 (s, 1H), 9.15 (s, 1H) 9.33 (t, <i>J</i> = 5.76, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 262 (M + H)<sup>+</sup>.</div></div><div id="sec6_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> (3a<i>R</i>,6a<i>S</i>)-<i>tert</i>-Butyl 5-(6-(2-methylbenzylcarbamoyl)pyrazin-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2(1<i>H</i>)-carboxylate (<b>57</b>)</h3><div class="NLM_p last">Prepared from <b>56</b> and <b>38</b> according to the procedures for <b>40</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 1.45 (s, 9H), 2.38 (s, 3H), 3.00–3.07 (m, 2H), 3.25–3.45 (m, 4H), 3.63–3.76 (m, 4H), 4.66 (d, <i>J</i> = 5.8 Hz, 2H), 7.19–7.23 (m, 3H), 7.29–7.31 (m, 1H), 7.85 (t, <i>J</i> = 5.8 Hz, 1H), 8.04 (s, 1H), 8.68 (s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 438 (M + H)<sup>+</sup>.</div></div><div id="sec6_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> (3a<i>S</i>,6a<i>S</i>)-<i>tert</i>-Butyl 5-(6-(2-methylbenzylcarbamoyl)pyrazin-2-yl)hexahydropyrrolo[3,4-<i>b</i>]pyrrole-1(2<i>H</i>)-carboxylate (<b>58</b>)</h3><div class="NLM_p last">Prepared from <b>56</b> and <b>61</b> according to the procedures for <b>40</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 1.46 (s, 9H), 1.80–1.89 (m, 1H), 2.03–2.13 (m, 1H), 2.38 (s, 3H), 3.03–3.10 (m, 1H), 3.34–3.77 (m, 6H), 4.36–4.44 (m, 1H), 4.66 (d, <i>J</i> = 5.8 Hz, 2H), 7.15–7.20 (m, 3H), 7.28–7.31 (m, 1H), 7.86 (t, <i>J</i> = 5.8 Hz, 1H), 8.04 (s, 1H), 8.68 (s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 438 (M + H)<sup>+</sup>.</div></div><div id="sec6_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> (3a<i>R</i>,6a<i>R</i>)-<i>tert</i>-Butyl 1-(6-(2-Methylbenzylcarbamoyl)pyrazin-2-yl)hexahydropyrrolo[3,4-<i>b</i>]pyrrole-5(1<i>H</i>)-carboxylate (<b>59</b>)</h3><div class="NLM_p last">Prepared from <b>56</b> and <b>60</b> according to the procedures for <b>40</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 1.42 (s, 9H), 1.92–2.02 (m, 1H), 2.15–2.25 (m, 1H), 2.38 (s, 3H), 2.99–3.05 (m, 1H), 3.30–3.48 (m, 2H), 3.57–3.72 (m, 4H), 4.45 (td, <i>J</i> = 6.8,3.2 Hz, 2H), 4.59–4.73 (m, 2H), 7.16–7.22 (m, 3H), 7.28–7.31 (m, 1H), 7.80 (t, <i>J</i> = 5.6 Hz, 1H), 8.05 (s, 1H), 8.70 (s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 438 (M + H)<sup>+</sup>.</div></div><div id="sec6_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 6-Chloropyrazine-2-carboxylic Acid (<b>62</b>)</h3><div class="NLM_p last">Methyl ester <b>43</b> (1.78 g, 10.3 mmol) was dissolved in EtOH (25 mL), 1 M NaOH (25 mL) was added, and the reaction stirred at ambient temperature for 2 h. The reaction mixture was acidified to pH ≈ 3 with 1 M HCl (aq). The mixture was then diluted with water (150 mL) and extracted with EtOAc (4 × 100 mL). The organic extracts were combined, washed with brine (100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to provide the title compound as a white solid (1.54 g, 94%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz) δ 9.04 (s, 1H), 9.16 (s, 1H), 14.06 (br s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 176 (M + NH<sub>4</sub>)<sup>+</sup>.</div></div><div id="sec6_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 6-Chloropyrazine-2-carbonyl Chloride (<b>63</b>)</h3><div class="NLM_p last">Carboxylic acid <b>62</b> (1.47 g, 9.27 mmol) was suspended in CH<sub>2</sub>Cl<sub>2</sub> (50 mL). Oxalyl chloride (1.40 mL, 16.0 mmol) and DMF (35 μL, 0.45 mmol) were added, and the reaction stirred at ambient temperature for 3 h. The reaction mixture was concentrated and placed on a high vacuum line to provide the crude product (1.62 g, 99%) as a dark oil, which was used without additional purification.</div></div><div id="sec6_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 6-Chloro-<i>N</i>-<i>m</i>-tolylpyrazine-2-carboxamide (<b>64</b>)</h3><div class="NLM_p last">Acid chloride <b>63</b> (950 mg, 5.37 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (20 mL). Triethylamine (1.10 mL, 7.89 mmol) and <i>m</i>-toluidine (0.70 mL, 6.46 mmol) were added, and the reaction stirred at ambient temperature for 2 h. The reaction mixture was diluted with 0.1 M HCl (100 mL) and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 50 mL). The organic extracts were combined, washed with brine (50 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by silica gel chromatography (2.5% EtOAc in CH<sub>2</sub>Cl<sub>2</sub>, <i>R</i><sub>f</sub> = 0.39) to afford the title compound as a white solid (1.11 g, 83%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 2.40 (s, 3H), 7.02 (d, <i>J</i> = 7.5 Hz, 1H), 7.29 (t, <i>J</i> = 7.8 Hz, 1H), 7.56 (d, <i>J</i> = 8.1 Hz, 1H), 7.60 (s, 1H), 8.81 (s, 1H), 9.34 (br s, 1H), 9.41 (s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 248 (M + H)<sup>+</sup>.</div></div><div id="sec6_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 6-Chloro-<i>N</i>-(3-isopropoxyphenyl)pyrazine-2-carboxamide (<b>65</b>)</h3><div class="NLM_p last">Prepared from <b>63</b> and 3-isopropoxyaniline according to the procedures for <b>64</b>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz) δ 1.29 (d, <i>J</i> = 6.1 Hz, 6H), 4.54–4.62 (m, 1H), 6.70 (ddd, <i>J</i> = 8.2, 2.5, 0.9 Hz, 1H), 7.25 (t, <i>J</i> = 8.1 Hz, 1H), 7.44 (ddd, <i>J</i> = 8.1, 2.0, 0.9 Hz, 1H), 7.52 (t, <i>J</i> = 2.2 Hz, 1H), 9.07 (s, 1H), 9.23 (s, 1H), 10.56 (s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 309 (M + H)<sup>+</sup>.</div></div><div id="sec6_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> (3a<i>R</i>,6a<i>S</i>)-<i>tert</i>-Butyl 5-(6-(<i>m</i>-Tolylcarbamoyl)pyrazin-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2(1<i>H</i>)-carboxylate (<b>66</b>)</h3><div class="NLM_p last">Prepared from <b>64</b> and <b>38</b> according to the procedures for <b>40</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 1.47 (s, 9H), 2.39 (s, 3H), 3.06–3.14 (m, 2H), 3.29–3.56 (m, 4H), 3.69–3.75 (m, 2H), 3.81–3.90 (m, 2H), 6.98 (d, <i>J</i> = 7.5 Hz, 1H), 7.25–7.30 (m, 1H), 7.51–7.57 (m, 2H), 8.09 (s, 1H), 8.74 (s, 1H), 9.50 (s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 424 (M + H)<sup>+</sup>.</div></div><div id="sec6_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> (3a<i>S</i>,6a<i>S</i>)-<i>tert</i>-Butyl 5-(6-(<i>m</i>-Tolylcarbamoyl)pyrazin-2-yl)hexahydropyrrolo[3,4-<i>b</i>]pyrrole-1(2<i>H</i>)-carboxylate (<b>67</b>)</h3><div class="NLM_p last">Prepared from <b>64</b> and <b>61</b> according to the procedures for <b>40</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 1.48 (s, 9H), 1.84–1.93 (m, 1H), 2.09–2.21 (m, 1H), 2.39 (s, 3H), 3.10–3.20 (m, 1H), 3.47–3.86 (m, 6H), 4.44–4.50 (m, 1H), 6.96–6.99 (m, 1H), 7.24–7.29 (m, 1H), 7.52–7.57 (m, 2H), 8.09 (s, 1H), 8.73 (s, 1H), 9.51 (s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 424 (M + H)<sup>+</sup>.</div></div><div id="sec6_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> (3a<i>R</i>,6a<i>S</i>)-<i>tert</i>-Butyl 5-(6-(3-Isopropoxyphenylcarbamoyl)pyrazin-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2(1<i>H</i>)-carboxylate (<b>68</b>)</h3><div class="NLM_p last">Prepared from <b>65</b> and <b>38</b> according to the procedures for <b>40</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 1.36 (d, <i>J</i> = 6.1 Hz, 6H) 1.47 (s, 9H), 3.07–3.13 (m, 2H), 3.30–3.55 (m, 4H), 3.69–3.75 (m, 2H), 3.81–3.88 (m, 2H), 4.58–4.66 (m, 1H), 6.70 (ddd, <i>J</i> = 8.1, 2.4, 1.0 Hz, 1H), 7.17 (ddd, <i>J</i> = 8.1, 2.0, 1.0 Hz, 1H), 7.23–7.29 (m, 1H), 7.47 (t, <i>J</i> = 2.2 Hz, 1H), 8.09 (s, 1H), 8.74 (s, 1H), 9.54 (s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 468 (M + H)<sup>+</sup>.</div></div><div id="sec6_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 5-Bromo-<i>N</i>-(2-methylbenzyl)nicotinamide (<b>70</b>)</h3><div class="NLM_p last">Prepared from 5-bromonicotinic acid (<b>69)</b> and 2-methylbenzylamine according to the procedures for <b>51</b>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz) δ 2.32 (s, 3 H), 4.47 (d, <i>J</i> = 5.4 Hz, 2 H), 7.13–7.21 (m, 3 H), 7.24–7.33 (m, <i>J</i> = 3.9, 3.9 Hz, 1 H), 8.47 (t, <i>J</i> = 2.0 Hz, 1 H), 8.86 (d, <i>J</i> = 2.4 Hz, 1 H), 9.02 (d, <i>J</i> = 2.0 Hz, 1 H), 9.15 (t, <i>J</i> = 5.3 Hz, 1 H). MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 305, 307 (M + H)<sup>+</sup>.</div></div><div id="sec6_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> (3a<i>R</i>,6a<i>S</i>)-<i>tert</i>-Butyl 5-(5-(Ethoxycarbonyl)pyridin-3-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2(1<i>H</i>)-carboxylate (<b>72</b>)</h3><div class="NLM_p last">Ethyl 5-bromonicotinate (<b>71</b>) (2.80 g, 12.0 mmol), Boc-protected diazabicyclo[3.3.0]octane <b>38</b> (2.00 g, 9.42 mmol), tris(dibenzylideneacetone)dipalladium(0) (259 mg, 0.283 mmol), 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (491 mg, 0.848 mmol), and cesium carbonate (4.91 g, 15.1 mmol) in anhydrous dioxane (50 mL) were heated at 90 °C for 72 h. The reaction mixture was cooled and filtered through a glass frit. The filtrate was concentrated, and the residue was purified by silica gel chromatography (50% EtOAc in hexane, <i>R</i><sub>f</sub> = 0.15) to afford the title compound (3.2 g, 94%). <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 1.39 (t, <i>J</i> = 7.2 Hz, 3H), 1.45 (s, 9H), 3.10 (br s, 2H), 3.27–3.33 (m, 4H), 3.60 (dd, <i>J</i> = 9.9, 7.5 Hz, 2H), 3.63–3.70 (m, 2H), 4.39 (q, <i>J</i> = 7.2 Hz, 2H), 7.49 (dd, <i>J</i> = 3.1, 1.8 Hz, 1H), 8.07 (d, <i>J</i> = 2.7 Hz, 1H), 8.38 (d, <i>J</i> = 1.5 Hz, 1H). MS (APCI) <i>m</i>/<i>z</i> 362 (M + H)<sup>+</sup>.</div></div><div id="sec6_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 5-((3a<i>R</i>,6a<i>S</i>)-5-(<i>tert</i>-Butoxycarbonyl)hexahydropyrrolo[3,4-<i>c</i>]pyrrol-2(1<i>H</i>)-yl)nicotinic Acid (<b>73</b>)</h3><div class="NLM_p last">Ethyl ester <b>72</b> (3.20 g, 8.90 mmol) was dissolved in a solvent mixture of ethanol (40 mL) and water (20 mL). Sodium hydroxide (2.0 M, 13 mL) was added, and the reaction mixture was stirred at ambient temperature for 1 h. The mixture was then diluted with ethyl acetate (100 mL) and partitioned between ethyl acetate (250 mL) and water (30 mL). The aqueous layer was acidified to pH 4 and repartitioned between dichloromethane (200 mL) and water (250 mL). The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under vacuum to afford the title compound (3.0 g, 100%). <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ ppm 1.45 (s, 9H), 3.10 (br s, 2H), 3.27–3.34 (m, 4H), 3.61 (dd, <i>J</i> = 10.0, 7.5 Hz, 2H), 3.64–3.71 (m, 2H), 7.57 (dd, <i>J</i> = 2.8, 1.8 Hz, 1H), 8.04 (d, <i>J</i> = 1.5 Hz, 1H), 8.39 (s, 1H). MS (APCI) <i>m</i>/<i>z</i> 334 (M + H)<sup>+</sup>.</div></div><div id="sec6_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> (3a<i>R</i>,6a<i>S</i>)-<i>tert</i>-Butyl 5-(6-(Benzyloxy)pyrazin-2-yl)hexahydropyrrolo[3,4-<i>c</i>]pyrrole-2(1<i>H</i>)-carboxylate (<b>75</b>)</h3><div class="NLM_p last">Prepared from <b>38</b> and 2-(benzyloxy)-6-chloropyrazine, <b>74</b>, according to the procedures for <b>40</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 1.46 (s, 9H), 2.96–3.04 (m, 2H), 3.22–3.42 (m, 4H), 3.61–3.75 (m, 4H), 5.34 (s, 2H), 7.30–7.45 (m, 6H), 7.54 (s, 1H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 397 (M + H)<sup>+</sup>.</div></div><div id="sec6_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> (3a<i>R</i>,6a<i>S</i>)-2-(6-(Benzyloxy)pyrazin-2-yl)octahydropyrrolo[3,4-<i>c</i>]pyrrole (<b>76</b>)</h3><div class="NLM_p last">Prepared from <b>75</b> according to the procedures for <b>20</b>. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>, 300 MHz) δ 3.19–3.24 (m, 4H), 3.57–3.69 (m, 6H), 5.38 (s, 2H), 6.67 (s, 2H fumarate), 7.26–7.47 (m, 7H) ppm. MS (DCI/NH<sub>3</sub>) <i>m</i>/<i>z</i> 297 (M + H)<sup>+</sup>. Anal. (C<sub>17</sub>H<sub>20</sub>N<sub>4</sub>O·1.07C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>) C, H, N.</div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03440" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03440" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marc J. C. Scanio</span> - <span class="hlFld-Affiliation affiliation">Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6117, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2944485b4a075a4a4847404669484b4b465d5d074a4644"><span class="__cf_email__" data-cfemail="b0ddd1c2d39ec3d3d1ded9dff0d1d2d2dfc4c49ed3dfdd">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lei Shi</span> - <span class="hlFld-Affiliation affiliation">Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6117, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William H. Bunnelle</span> - <span class="hlFld-Affiliation affiliation">Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6117, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David J. Anderson</span> - <span class="hlFld-Affiliation affiliation">Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6117, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rosalind J. Helfrich</span> - <span class="hlFld-Affiliation affiliation">Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6117, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Malysz</span> - <span class="hlFld-Affiliation affiliation">Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6117, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kirsten K. Thorin-Hagene</span> - <span class="hlFld-Affiliation affiliation">Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6117, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ceclia E. Van Handel</span> - <span class="hlFld-Affiliation affiliation">Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6117, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kennan C. Marsh</span> - <span class="hlFld-Affiliation affiliation">Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6117, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chih-Hung Lee</span> - <span class="hlFld-Affiliation affiliation">Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6117, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Murali Gopalakrishnan</span> - <span class="hlFld-Affiliation affiliation">Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6117, United States</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm201045m" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i79" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i79"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i80" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i80"> Abbreviations Used</h2><tr><td class="NLM_term">nAChRs</td><td class="NLM_def"><p class="first last">nicotinic acetylcholine receptor</p></td></tr><tr><td class="NLM_term">ACh</td><td class="NLM_def"><p class="first last">acetylcholine</p></td></tr><tr><td class="NLM_term">mAChRs</td><td class="NLM_def"><p class="first last">muscarinic acetylcholine receptors</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">S<sub>N</sub>Ar</td><td class="NLM_def"><p class="first last">nucleophilic aromatic substitution</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyloxycarbonyl</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term"><i>m</i>CPBA</td><td class="NLM_def"><p class="first last"><i>meta</i>-chloroperoxybenzoic acid</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-dimethylamino pyridine</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">FLIPR</td><td class="NLM_def"><p class="first last">fluorescent imaging plate reader</p></td></tr><tr><td class="NLM_term">ip</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">per os (oral)</p></td></tr><tr><td class="NLM_term"><i>F</i></td><td class="NLM_def"><p class="first last">bioavailability</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">half-life</p></td></tr><tr><td class="NLM_term">b/p</td><td class="NLM_def"><p class="first last">brain-to-plasma</p></td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">DCI, direct chemical ionization</p></td></tr><tr><td class="NLM_term">ESI</td><td class="NLM_def"><p class="first last">electrospray ionization</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i81">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12111" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12111" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 72 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">D’Hoedt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, D.</span><span> </span><span class="NLM_article-title">Nicotinic acetylcholine receptors: an overview on drug discovery</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.1517%2F14728220902841045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=19335063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvVWgu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=395-411&author=D.+D%E2%80%99Hoedtauthor=D.+Bertrand&title=Nicotinic+acetylcholine+receptors%3A+an+overview+on+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic acetylcholine receptors: an overview on drug discovery</span></div><div class="casAuthors">D'hoedt, Dieter; Bertrand, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">395-411</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels that participate in many physiol. functions.  Receptors result from the assembly of five homologous or heterologous subunits that form the ligand-binding site and an ionic pore.  In vertebrates, 17 subunits have been identified, α (1-10), β (1-4), γ, δ, and ε.  Assembly of different subunit combinations allows a diversity of physiol. and pharmacol. properties.  To review the putative involvement of nAChRs in several diseases.  We discuss the expression pattern of the subunits, the pharmacol. tools for distinguishing them and their role in pathogenesis.  Long-standing efforts in this field should soon result in the finding of new mols. that might be applicable to situations ranging from neurol. diseases to immune treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNauxQ9KPdwbVg90H21EOLACvtfcHk0liCwUkvftUa0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvVWgu7c%253D&md5=e06b154c3c32685edf6778332e239bc6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1517%2F14728220902841045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728220902841045%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Hoedt%26aufirst%3DD.%26aulast%3DBertrand%26aufirst%3DD.%26atitle%3DNicotinic%2520acetylcholine%2520receptors%253A%2520an%2520overview%2520on%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2009%26volume%3D13%26spage%3D395%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Arneric, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holladay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span> </span><span class="NLM_article-title">Neuronal nicotinic receptors: A perspective on two decades of drug discovery research</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1092</span><span class="NLM_x">–</span> <span class="NLM_lpage">1101</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2007&pages=1092-1101&author=S.+P.+Arnericauthor=M.+Holladayauthor=M.+Williams&title=Neuronal+nicotinic+receptors%3A+A+perspective+on+two+decades+of+drug+discovery+research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArneric%26aufirst%3DS.%2BP.%26aulast%3DHolladay%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DM.%26atitle%3DNeuronal%2520nicotinic%2520receptors%253A%2520A%2520perspective%2520on%2520two%2520decades%2520of%2520drug%2520discovery%2520research%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2007%26volume%3D74%26spage%3D1092%26epage%3D1101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Langmead, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reavill, C.</span><span> </span><span class="NLM_article-title">Muscarinic acetylcholine receptors as CNS drug targets</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">232</span><span class="NLM_x">–</span> <span class="NLM_lpage">243</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.1016%2Fj.pharmthera.2007.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=18082893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtV2itrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2008&pages=232-243&author=C.+J.+Langmeadauthor=J.+Watsonauthor=C.+Reavill&title=Muscarinic+acetylcholine+receptors+as+CNS+drug+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Muscarinic acetylcholine receptors as CNS drug targets</span></div><div class="casAuthors">Langmead, Christopher J.; Watson, Jeannette; Reavill, Charlie</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">232-243</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Muscarinic acetylcholine receptors (mAChRs) are widely expressed in the CNS where they control a variety of neuronal functions.  Due to their roles in a no. of CNS processes, mAChRs have long been a target of the drug discovery industry; however, the only mAChR ligands approved for use in the clinic are non-selective antagonists for the treatment of Parkinson's disease.  This article briefly reviews recent progress made in mAChR drug discovery for Alzheimer's disease (AD), schizophrenia and Parkinson's disease, with particular emphasis on novel target validation, as well as highlighting novel indications such as drug addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosxKbNG-yy87Vg90H21EOLACvtfcHk0liCwUkvftUa0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtV2itrc%253D&md5=a65c212d434f0172b4e6800cc19df427</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2007.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2007.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DWatson%26aufirst%3DJ.%26aulast%3DReavill%26aufirst%3DC.%26atitle%3DMuscarinic%2520acetylcholine%2520receptors%2520as%2520CNS%2520drug%2520targets%26jtitle%3DPharmacol.%2520Ther.%26date%3D2008%26volume%3D117%26spage%3D232%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Gregory, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span> </span><span class="NLM_article-title">Allosteric modulation of muscarinic acetylcholine receptors</span> <span class="citation_source-journal">Curr. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.2174%2F157015907781695946" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=19305798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKqsLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=157-167&author=K.+J.+Gregoryauthor=P.+M.+Sextonauthor=A.+Christopoulos&title=Allosteric+modulation+of+muscarinic+acetylcholine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulation of muscarinic acetylcholine receptors</span></div><div class="casAuthors">Gregory, Karen J.; Sexton, Patrick M.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">157-167</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1570-159X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Muscarinic acetylcholine receptors (mAChRs) are prototypical Family A G protein coupled-receptors.  The five mAChR subtypes are widespread throughout the periphery and the central nervous system and, accordingly, are widely involved in a variety of both physiol. and pathophysiol. processes.  There currently remains an unmet need for better therapeutic agents that can selectively target a given mAChR subtype to the relative exclusion of others.  The main reason for the lack of such selective mAChR ligands is the high sequence homol. within the acetylcholine-binding site (orthosteric site) across all mAChRs.  However, the mAChRs possess at least one, and likely two, extracellular allosteric binding sites that can recognize small mol. allosteric modulators to regulate the binding and function of orthosteric ligands.  Extensive studies of prototypical mAChR modulators, such as gallamine and alcuronium, have provided strong pharmacol. evidence, and assocd. structure-activity relationships (SAR), for a "common" allosteric site on all five mAChRs.  These studies are also supported by mutagenesis expts. implicating the second extracellular loop and the interface between the third extracellular loop and the top of transmembrane domain 7 as contributing to the common allosteric site.  Other studies are also delineating the pharmacol. of a second allosteric site, recognized by compds. such as staurosporine.  In addn., allosteric agonists, such as McN-A-343, AC-42 and N-desmethylclozapine, have also been identified.  Current challenges to the field include the ability to effectively detect and validate allosteric mechanisms, and to quantify allosteric effects on binding affinity and signaling efficacy to inform allosteric modulator SAR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMjqjcw6KlILVg90H21EOLACvtfcHk0lgndmMgwWt3jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKqsLnP&md5=a30c0102440ffbdc1fc6efe9da084521</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F157015907781695946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157015907781695946%26sid%3Dliteratum%253Aachs%26aulast%3DGregory%26aufirst%3DK.%2BJ.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DAllosteric%2520modulation%2520of%2520muscarinic%2520acetylcholine%2520receptors%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2007%26volume%3D5%26spage%3D157%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Wess, J.</span><span> </span><span class="NLM_article-title">Muscarinic acetylcholine receptors</span> <span class="citation_source-journal">Handb. Contemp. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsVegtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2007&pages=147-192&author=J.+Wess&title=Muscarinic+acetylcholine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Muscarinic acetylcholine receptors</span></div><div class="casAuthors">Wess, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Contemporary Neuropharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">147-192</span>CODEN:
                <span class="NLM_cas:coden">69JRSF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  A review on mol. cloning studies which have shown that the muscarinic effects of acetylcholine (ACh) are mediated by a family of cell surface receptors referred to as muscarinic ACh receptors (M1-M5 mAChRs).  Studies with M1-M5 mAChR single-KO and various mAChR double-KO strains have led to a wealth of novel information about the physiol. and pathophysiol. roles of the individual mAChR subtypes.  The development of a new generation of mAChR mutant mice in which specific receptor subtypes can be inactivated in a tissue-specific and/or time-dependent fashion should provide even more powerful research tools.  These studies should pave the way towards the development of novel strategies for the treatment of a variety of important pathophysiol. conditions including pain, obesity, diabetes, and various disorders of the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_KAdC4eV1sLVg90H21EOLACvtfcHk0lgndmMgwWt3jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsVegtLg%253D&md5=797807a37a788a12cf2f5b72832b839c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWess%26aufirst%3DJ.%26atitle%3DMuscarinic%2520acetylcholine%2520receptors%26jtitle%3DHandb.%2520Contemp.%2520Neuropharmacol.%26date%3D2007%26volume%3D1%26spage%3D147%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Ishii, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurachi, Y.</span><span> </span><span class="NLM_article-title">Muscarinic acetylcholine receptors</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3573</span><span class="NLM_x">–</span> <span class="NLM_lpage">3581</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.2174%2F138161206778522056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=17073660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFalsL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=3573-3581&author=M.+Ishiiauthor=Y.+Kurachi&title=Muscarinic+acetylcholine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Muscarinic acetylcholine receptors</span></div><div class="casAuthors">Ishii, Masaru; Kurachi, Yoshihisa</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">3573-3581</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Muscarinic acetylcholine receptors mediate diverse physiol. functions.  At present, five receptor subtypes (M1-M5) have been identified.  The odd-numbered receptors (M1, M3, and M5) are preferentially coupled to Gq/11 and activate phospholipase C, which initiates the phosphatidylinositol trisphosphate cascade leading to intracellular Ca2+ mobilization and activation of protein kinase C.  On the other hand, the even-numbered receptors (M2 and M4) are coupled to Gi/o, and inhibit adenylyl cyclase activity.  They also activate G protein-gated potassium channels, which leads to hyperpolarization of the plasma membrane in different excitable cells.  Individual members of the family are expressed in an overlapping fashion in various tissues and cell types.  Recent gene targeting approaches have unraveled the specific function of these muscarinic receptor subtypes, which were not able to be fully elucidated with pharmacol. approaches because of the non-selective effects of the available ligands.  Based on these findings, muscarinic receptors have been emerging as an important therapeutic target for various diseases, including dry mouth, incontinence and chronic obstructive pulmonary disease.  Here we review the latest advances in the structural and functional characterization of muscarinic acetylcholine receptors and the pharmaceutical development of muscarinic receptor ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5caUvtB5RB7Vg90H21EOLACvtfcHk0lgndmMgwWt3jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFalsL7E&md5=a03f69bb2bdeca1003f5fd96eeea8c45</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F138161206778522056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206778522056%26sid%3Dliteratum%253Aachs%26aulast%3DIshii%26aufirst%3DM.%26aulast%3DKurachi%26aufirst%3DY.%26atitle%3DMuscarinic%2520acetylcholine%2520receptors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D3573%26epage%3D3581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Lloyd, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span> </span><span class="NLM_article-title">Neuronal nicotinic acetylcholine receptors as novel drug targets</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">292</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=10640281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotFegsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2000&pages=461-467&author=G.+K.+Lloydauthor=M.+Williams&title=Neuronal+nicotinic+acetylcholine+receptors+as+novel+drug+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal nicotinic acetylcholine receptors as novel drug targets</span></div><div class="casAuthors">Lloyd, G. Kenneth; Williams, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">461-467</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review with ∼45 refs.  Nicotinic acetylcholine receptors (nAChRs)are discussed in relation to nicotinic acetylcholine receptor agonists and antagonists, functional responses to nAChRs activation, therapeutic opportunities and future prospects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnGGNvhT5cv7Vg90H21EOLACvtfcHk0lgndmMgwWt3jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotFegsA%253D%253D&md5=d39d43ba975325f8c16cefd0446efce1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLloyd%26aufirst%3DG.%2BK.%26aulast%3DWilliams%26aufirst%3DM.%26atitle%3DNeuronal%2520nicotinic%2520acetylcholine%2520receptors%2520as%2520novel%2520drug%2520targets%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D292%26spage%3D461%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Newhouse, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corwin, J.</span><span> </span><span class="NLM_article-title">Nicotinic treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">278</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.1016%2FS0006-3223%2800%2901069-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=11230878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsFSjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2001&pages=268-278&author=P.+A.+Newhouseauthor=A.+Potterauthor=M.+Keltonauthor=J.+Corwin&title=Nicotinic+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic treatment of Alzheimer's disease</span></div><div class="casAuthors">Newhouse, P. A.; Potter, A.; Kelton, M.; Corwin, J.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">268-278</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 67 refs.  Ongoing investigations of the mol. substructure of central nervous system nicotinic receptors, their accompanying pharmacol., and the effects of nicotinic agents on cognitive function have suggested the possibility that nicotinic stimulation may have beneficial effects in Alzheimer's disease and other neuropsychiatric disorders.  Studies have explored the role of central nervous system nicotinic mechanisms in normal human cognitive and behavioral functioning as well as their role in Alzheimer's disease.  Results from acute therapeutic trials with nicotine and novel nicotinic agents suggest that nicotinic stimulation in Alzheimer's disease patients can improve the acquisition and retention of verbal and visual information and decrease errors in cognitive tasks, as well as improve accuracy and response time.  Whether such results will translate into improved clin. functioning remains to be fully tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsJkcLd03N0bVg90H21EOLACvtfcHk0lhJjre79xUAKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsFSjtbc%253D&md5=7678c16f6ebc960860f56898347bdd50</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2800%2901069-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252800%252901069-6%26sid%3Dliteratum%253Aachs%26aulast%3DNewhouse%26aufirst%3DP.%2BA.%26aulast%3DPotter%26aufirst%3DA.%26aulast%3DKelton%26aufirst%3DM.%26aulast%3DCorwin%26aufirst%3DJ.%26atitle%3DNicotinic%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBiol.%2520Psychiatry%26date%3D2001%26volume%3D49%26spage%3D268%26epage%3D278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daanen, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryther, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrimpf, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dart, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curzon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Y.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puttfarcken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Searle, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Putman, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surowy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlocco, D.</span><span> </span><span class="NLM_article-title">Structure–Activity Studies and Analgesic Efficacy of <i>N</i>-(3-Pyridinyl)-Bridged Bicyclic Diamines, Exceptionally Potent Agonists at Nicotinic Acetylcholine Receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3627</span><span class="NLM_x">–</span> <span class="NLM_lpage">3644</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070018l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3627-3644&author=W.+H.+Bunnelleauthor=J.+F.+Daanenauthor=K.+B.+Rytherauthor=M.+R.+Schrimpfauthor=M.+J.+Dartauthor=A.+Gelainauthor=M.+D.+Meyerauthor=J.+M.+Frostauthor=D.+J.+Andersonauthor=M.+Buckleyauthor=P.+Curzonauthor=Y.-J.+Caoauthor=P.+Puttfarckenauthor=X.+Searleauthor=J.+Jiauthor=C.+B.+Putmanauthor=C.+Surowyauthor=L.+Tomaauthor=D.+Barlocco&title=Structure%E2%80%93Activity+Studies+and+Analgesic+Efficacy+of+N-%283-Pyridinyl%29-Bridged+Bicyclic+Diamines%2C+Exceptionally+Potent+Agonists+at+Nicotinic+Acetylcholine+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm070018l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070018l%26sid%3Dliteratum%253Aachs%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26aulast%3DDaanen%26aufirst%3DJ.%2BF.%26aulast%3DRyther%26aufirst%3DK.%2BB.%26aulast%3DSchrimpf%26aufirst%3DM.%2BR.%26aulast%3DDart%26aufirst%3DM.%2BJ.%26aulast%3DGelain%26aufirst%3DA.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26aulast%3DFrost%26aufirst%3DJ.%2BM.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DBuckley%26aufirst%3DM.%26aulast%3DCurzon%26aufirst%3DP.%26aulast%3DCao%26aufirst%3DY.-J.%26aulast%3DPuttfarcken%26aufirst%3DP.%26aulast%3DSearle%26aufirst%3DX.%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DPutman%26aufirst%3DC.%2BB.%26aulast%3DSurowy%26aufirst%3DC.%26aulast%3DToma%26aufirst%3DL.%26aulast%3DBarlocco%26aufirst%3DD.%26atitle%3DStructure%25E2%2580%2593Activity%2520Studies%2520and%2520Analgesic%2520Efficacy%2520of%2520N-%25283-Pyridinyl%2529-Bridged%2520Bicyclic%2520Diamines%252C%2520Exceptionally%2520Potent%2520Agonists%2520at%2520Nicotinic%2520Acetylcholine%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3627%26epage%3D3644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Adler, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olincy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flach, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickford, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, R.</span><span> </span><span class="NLM_article-title">Schizophrenia, sensory gating, and nicotinic receptors</span> <span class="citation_source-journal">Schizophrenia Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.1093%2Foxfordjournals.schbul.a033320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=9613620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A280%3ADyaK1c3ntlKktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1998&pages=189-202&author=L.+E.+Adlerauthor=A.+Olincyauthor=M.+Waldoauthor=J.+G.+Harrisauthor=J.+Griffithauthor=K.+Stevensauthor=K.+Flachauthor=H.+Nagamotoauthor=P.+Bickfordauthor=S.+Leonardauthor=R.+Freedman&title=Schizophrenia%2C+sensory+gating%2C+and+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Schizophrenia, sensory gating, and nicotinic receptors</span></div><div class="casAuthors">Adler L E; Olincy A; Waldo M; Harris J G; Griffith J; Stevens K; Flach K; Nagamoto H; Bickford P; Leonard S; Freedman R</div><div class="citationInfo"><span class="NLM_cas:title">Schizophrenia bulletin</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">189-202</span>
        ISSN:<span class="NLM_cas:issn">0586-7614</span>.
    </div><div class="casAbstract">A series of human and animal investigations has suggested that altered expression and function of the alpha7-nicotinic cholinergic receptor may be responsible for the auditory sensory gating deficit characterized in schizophrenia patients and their relatives as diminished suppression of an auditory-evoked response (P50) to repeated stimuli.  This finding, in conjunction with evidence for familial transmission of this sensory gating deficit, suggests a pathogenic role of the gene for the alpha7-nicotinic receptor in schizophrenia.  This article considers the possible effects of this dysfunction in a broader context.  Not only is this dysfunction consistent with difficulties in sensory gating, but it might also predispose patients to problems with learning efficiency and accuracy.  Such learning problems could underlie schizophrenia patients' delusional thinking, hallucinations, and social dysfunction.  In addition, heavy smoking in many schizophrenia patients is consistent with the high concentration of nicotine necessary to activate the receptor and with the receptor's extremely rapid desensitization.  Finally, the receptor's possible role in cell growth and differentiation should be considered in connection with developmental deficits and other cellular abnormalities in schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRztFXXY9w4_eqrn-c4Of3KfW6udTcc2eZIBginDFPzDbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1c3ntlKktA%253D%253D&md5=e2c098d4c96aa258dfeda282c393a34b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1093%2Foxfordjournals.schbul.a033320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Foxfordjournals.schbul.a033320%26sid%3Dliteratum%253Aachs%26aulast%3DAdler%26aufirst%3DL.%2BE.%26aulast%3DOlincy%26aufirst%3DA.%26aulast%3DWaldo%26aufirst%3DM.%26aulast%3DHarris%26aufirst%3DJ.%2BG.%26aulast%3DGriffith%26aufirst%3DJ.%26aulast%3DStevens%26aufirst%3DK.%26aulast%3DFlach%26aufirst%3DK.%26aulast%3DNagamoto%26aufirst%3DH.%26aulast%3DBickford%26aufirst%3DP.%26aulast%3DLeonard%26aufirst%3DS.%26aulast%3DFreedman%26aufirst%3DR.%26atitle%3DSchizophrenia%252C%2520sensory%2520gating%252C%2520and%2520nicotinic%2520receptors%26jtitle%3DSchizophrenia%2520Bull.%26date%3D1998%26volume%3D24%26spage%3D189%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Potter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corwin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piasecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenox, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newhouse, P. A.</span><span> </span><span class="NLM_article-title">Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer’s disease</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">334</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=1999&pages=334-342&author=A.+Potterauthor=J.+Corwinauthor=J.+Langauthor=M.+Piaseckiauthor=R.+Lenoxauthor=P.+A.+Newhouse&title=Acute+effects+of+the+selective+cholinergic+channel+activator+%28nicotinic+agonist%29+ABT-418+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPotter%26aufirst%3DA.%26aulast%3DCorwin%26aufirst%3DJ.%26aulast%3DLang%26aufirst%3DJ.%26aulast%3DPiasecki%26aufirst%3DM.%26aulast%3DLenox%26aufirst%3DR.%26aulast%3DNewhouse%26aufirst%3DP.%2BA.%26atitle%3DAcute%2520effects%2520of%2520the%2520selective%2520cholinergic%2520channel%2520activator%2520%2528nicotinic%2520agonist%2529%2520ABT-418%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPsychopharmacology%26date%3D1999%26volume%3D142%26spage%3D334%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Ross, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrovitch, H.</span><span> </span><span class="NLM_article-title">Current evidence for neuroprotective effects of nicotine and caffeine against Parkinson’s disease</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">797</span><span class="NLM_x">–</span> <span class="NLM_lpage">806</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.2165%2F00002512-200118110-00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=11772120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVSjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2001&pages=797-806&author=G.+W.+Rossauthor=H.+Petrovitch&title=Current+evidence+for+neuroprotective+effects+of+nicotine+and+caffeine+against+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Current evidence for neuroprotective effects of nicotine and caffeine against Parkinson's disease</span></div><div class="casAuthors">Ross, G. Webster; Petrovitch, Helen</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">797-806</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is the second most common neurodegenerative disorder affecting 1-3% of individuals over the age of 65 yr.  While effective therapy exists for treating the bradykinesia, rigidity, and tremor assocd. with the disease, the cause is unknown.  There is no treatment available to prevent or slow the progressive neuronal loss in the substantia nigra and assocd. decreased levels of dopamine in the striatum that underlie the cardinal features of the disease.  Both retrospective and prospective epidemiol. studies have consistently demonstrated an inverse assocn. between cigarette smoking and PD, leading to theories that smoking in general and nicotine in particular might be neuroprotective.  Nicotine has been shown in animals to stimulate the release of dopamine in the striatum, and to preserve nigral neurons and striatal dopamine levels in lab. animals with lesioned nigrostriatal pathways.  Coffee and caffeine consumption have also been shown in epidemiol. studies to be inversely related to PD risk.  Caffeine is an adenosine A2A receptor antagonist that enhances locomotor activity in animal models of parkinsonism.  Theophylline, a related compd. that has A2A receptor blocking properties, has been shown in one small trial to improve motor function in patients with PD.  Recently, potent and highly selective A2A receptor antagonists have been developed that have demonstrated improvement in motor function in animal models of parkinsonism.  Exciting findings are emerging that demonstrate attenuation of dopaminergic neurotoxicity with caffeine and other adenosine receptor antagonists in mice given the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), suggesting that these compds. may be neuroprotective.  Evidence for the neuroprotective potential of nicotine and caffeine is compelling, but further work is needed before testing these and related compds. in clin. trials for both individuals at high risk of developing PD and those with early, untreated disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHnRfJLnSyQ7Vg90H21EOLACvtfcHk0lhvQZhgCDzlKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVSjtQ%253D%253D&md5=bb8a6fe64576e359efa3874df57ef98c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2165%2F00002512-200118110-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002512-200118110-00001%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DG.%2BW.%26aulast%3DPetrovitch%26aufirst%3DH.%26atitle%3DCurrent%2520evidence%2520for%2520neuroprotective%2520effects%2520of%2520nicotine%2520and%2520caffeine%2520against%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DDrugs%2520Aging%26date%3D2001%26volume%3D18%26spage%3D797%26epage%3D806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Jorenby, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hays, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigotti, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azoulay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watsky, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billing, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christen, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilderman, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Make, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merideth, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachs, D. P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swartz, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weerasinghe, M. U.</span><span> </span><span class="NLM_article-title">Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs. placebo or sustained-release bupropion for smoking cessation. A randomized controlled trial</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2006&pages=56-63&author=D.+E.+Jorenbyauthor=J.+T.+Haysauthor=N.+A.+Rigottiauthor=S.+Azoulayauthor=E.+J.+Watskyauthor=K.+E.+Williamsauthor=C.+B.+Billingauthor=J.+Gongauthor=K.+R.+Reevesauthor=B.+Bockauthor=A.+G.+Christenauthor=L.+I.+Gildermanauthor=S.+K.+Goldsteinauthor=T.+C.+Jacksonauthor=B.+J.+Makeauthor=C.+H.+Meridethauthor=D.+P.+L.+Sachsauthor=S.+C.+Sharpauthor=S.+H.+Swartzauthor=M.+U.+Weerasinghe&title=Efficacy+of+varenicline%2C+an+%CE%B14%CE%B22+nicotinic+acetylcholine+receptor+partial+agonist%2C+vs.+placebo+or+sustained-release+bupropion+for+smoking+cessation.+A+randomized+controlled+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJorenby%26aufirst%3DD.%2BE.%26aulast%3DHays%26aufirst%3DJ.%2BT.%26aulast%3DRigotti%26aufirst%3DN.%2BA.%26aulast%3DAzoulay%26aufirst%3DS.%26aulast%3DWatsky%26aufirst%3DE.%2BJ.%26aulast%3DWilliams%26aufirst%3DK.%2BE.%26aulast%3DBilling%26aufirst%3DC.%2BB.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DReeves%26aufirst%3DK.%2BR.%26aulast%3DBock%26aufirst%3DB.%26aulast%3DChristen%26aufirst%3DA.%2BG.%26aulast%3DGilderman%26aufirst%3DL.%2BI.%26aulast%3DGoldstein%26aufirst%3DS.%2BK.%26aulast%3DJackson%26aufirst%3DT.%2BC.%26aulast%3DMake%26aufirst%3DB.%2BJ.%26aulast%3DMerideth%26aufirst%3DC.%2BH.%26aulast%3DSachs%26aufirst%3DD.%2BP.%2BL.%26aulast%3DSharp%26aufirst%3DS.%2BC.%26aulast%3DSwartz%26aufirst%3DS.%2BH.%26aulast%3DWeerasinghe%26aufirst%3DM.%2BU.%26atitle%3DEfficacy%2520of%2520varenicline%252C%2520an%2520%25CE%25B14%25CE%25B22%2520nicotinic%2520acetylcholine%2520receptor%2520partial%2520agonist%252C%2520vs.%2520placebo%2520or%2520sustained-release%2520bupropion%2520for%2520smoking%2520cessation.%2520A%2520randomized%2520controlled%2520trial%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2006%26volume%3D296%26spage%3D56%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Paleari, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesario, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, P.</span><span> </span><span class="NLM_article-title">α7-Nicotinic receptor antagonists at the beginning of a clinical era for NSCLC and mesothelioma?</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">822</span><span class="NLM_x">–</span> <span class="NLM_lpage">836</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=822-836&author=L.+Paleariauthor=A.+Cesarioauthor=M.+Finiauthor=P.+Russo&title=%CE%B17-Nicotinic+receptor+antagonists+at+the+beginning+of+a+clinical+era+for+NSCLC+and+mesothelioma%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaleari%26aufirst%3DL.%26aulast%3DCesario%26aufirst%3DA.%26aulast%3DFini%26aufirst%3DM.%26aulast%3DRusso%26aufirst%3DP.%26atitle%3D%25CE%25B17-Nicotinic%2520receptor%2520antagonists%2520at%2520the%2520beginning%2520of%2520a%2520clinical%2520era%2520for%2520NSCLC%2520and%2520mesothelioma%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26spage%3D822%26epage%3D836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Meyer, M. D.</span><span> </span><span class="NLM_article-title">Neuronal nicotinic acetylcholine receptors as a target for the treatment of neuropathic pain</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=355-359&author=M.+D.+Meyer&title=Neuronal+nicotinic+acetylcholine+receptors+as+a+target+for+the+treatment+of+neuropathic+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26atitle%3DNeuronal%2520nicotinic%2520acetylcholine%2520receptors%2520as%2520a%2520target%2520for%2520the%2520treatment%2520of%2520neuropathic%2520pain%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2006%26volume%3D67%26spage%3D355%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Sarter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parikh, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, W. M.</span><span> </span><span class="NLM_article-title">nAChR agonist-induced cognition enhancement: Integration of cognitive and neuronal mechanisms</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">667</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=658-667&author=M.+Sarterauthor=V.+Parikhauthor=W.+M.+Howe&title=nAChR+agonist-induced+cognition+enhancement%3A+Integration+of+cognitive+and+neuronal+mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarter%26aufirst%3DM.%26aulast%3DParikh%26aufirst%3DV.%26aulast%3DHowe%26aufirst%3DW.%2BM.%26atitle%3DnAChR%2520agonist-induced%2520cognition%2520enhancement%253A%2520Integration%2520of%2520cognitive%2520and%2520neuronal%2520mechanisms%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D658%26epage%3D667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Dwoskin, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wooters, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crooks, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardo, M. T.</span><span> </span><span class="NLM_article-title">Nicotinic receptor-based therapeutics and candidates for smoking cessation</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">732</span><span class="NLM_x">–</span> <span class="NLM_lpage">743</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=732-743&author=L.+P.+Dwoskinauthor=A.+M.+Smithauthor=T.+E.+Wootersauthor=Z.+Zhangauthor=P.+A.+Crooksauthor=M.+T.+Bardo&title=Nicotinic+receptor-based+therapeutics+and+candidates+for+smoking+cessation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDwoskin%26aufirst%3DL.%2BP.%26aulast%3DSmith%26aufirst%3DA.%2BM.%26aulast%3DWooters%26aufirst%3DT.%2BE.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26aulast%3DBardo%26aufirst%3DM.%2BT.%26atitle%3DNicotinic%2520receptor-based%2520therapeutics%2520and%2520candidates%2520for%2520smoking%2520cessation%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D732%26epage%3D743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Holladay, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasicak, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryther, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannon, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D. J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntzweiler, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnelly-Roberts, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piattoni-Kaplan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arneric, S. P.</span><span> </span><span class="NLM_article-title">Identification and Structure–Activity Relationships of (<i>R</i>)-5-(2-Azetidinylmethoxy)-2-chloropyridine (ABT-594), a Potent, Orally Active, Non-Opiate Analgesic Agent Acting via Neuronal Nicotinic Acetylcholine Receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9706224" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=407-412&author=M.+W.+Holladayauthor=J.+T.+Wasicakauthor=N.-H.+Linauthor=Y.+Heauthor=K.+B.+Rytherauthor=A.+W.+Bannonauthor=M.+J.+Buckleyauthor=D.+J.+B.+Kimauthor=M.+W.+Deckerauthor=D.+J.+Andersonauthor=J.+E.+Campbellauthor=T.+A.+Kuntzweilerauthor=D.+L.+Donnelly-Robertsauthor=M.+Piattoni-Kaplanauthor=C.+A.+Briggsauthor=M.+Williamsauthor=S.+P.+Arneric&title=Identification+and+Structure%E2%80%93Activity+Relationships+of+%28R%29-5-%282-Azetidinylmethoxy%29-2-chloropyridine+%28ABT-594%29%2C+a+Potent%2C+Orally+Active%2C+Non-Opiate+Analgesic+Agent+Acting+via+Neuronal+Nicotinic+Acetylcholine+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm9706224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9706224%26sid%3Dliteratum%253Aachs%26aulast%3DHolladay%26aufirst%3DM.%2BW.%26aulast%3DWasicak%26aufirst%3DJ.%2BT.%26aulast%3DLin%26aufirst%3DN.-H.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DRyther%26aufirst%3DK.%2BB.%26aulast%3DBannon%26aufirst%3DA.%2BW.%26aulast%3DBuckley%26aufirst%3DM.%2BJ.%26aulast%3DKim%26aufirst%3DD.%2BJ.%2BB.%26aulast%3DDecker%26aufirst%3DM.%2BW.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DCampbell%26aufirst%3DJ.%2BE.%26aulast%3DKuntzweiler%26aufirst%3DT.%2BA.%26aulast%3DDonnelly-Roberts%26aufirst%3DD.%2BL.%26aulast%3DPiattoni-Kaplan%26aufirst%3DM.%26aulast%3DBriggs%26aufirst%3DC.%2BA.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DArneric%26aufirst%3DS.%2BP.%26atitle%3DIdentification%2520and%2520Structure%25E2%2580%2593Activity%2520Relationships%2520of%2520%2528R%2529-5-%25282-Azetidinylmethoxy%2529-2-chloropyridine%2520%2528ABT-594%2529%252C%2520a%2520Potent%252C%2520Orally%2520Active%252C%2520Non-Opiate%2520Analgesic%2520Agent%2520Acting%2520via%2520Neuronal%2520Nicotinic%2520Acetylcholine%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D407%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Coe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rollema, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span> </span><span class="NLM_article-title">Case history: Chantix/Champix (varenicline tartrate), a nicotinic acetylcholine receptor partial agonist as a smoking cessation aid</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=71-101&author=J.+W.+Coeauthor=H.+Rollemaauthor=B.+T.+O%E2%80%99Neill&title=Case+history%3A+Chantix%2FChampix+%28varenicline+tartrate%29%2C+a+nicotinic+acetylcholine+receptor+partial+agonist+as+a+smoking+cessation+aid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoe%26aufirst%3DJ.%2BW.%26aulast%3DRollema%26aufirst%3DH.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DCase%2520history%253A%2520Chantix%252FChampix%2520%2528varenicline%2520tartrate%2529%252C%2520a%2520nicotinic%2520acetylcholine%2520receptor%2520partial%2520agonist%2520as%2520a%2520smoking%2520cessation%2520aid%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D71%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Taly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corringer, P.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guedin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lestage, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changeux, J.-P.</span><span> </span><span class="NLM_article-title">Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">733</span><span class="NLM_x">–</span> <span class="NLM_lpage">750</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=733-750&author=A.+Talyauthor=P.-J.+Corringerauthor=D.+Guedinauthor=P.+Lestageauthor=J.-P.+Changeux&title=Nicotinic+receptors%3A+allosteric+transitions+and+therapeutic+targets+in+the+nervous+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaly%26aufirst%3DA.%26aulast%3DCorringer%26aufirst%3DP.-J.%26aulast%3DGuedin%26aufirst%3DD.%26aulast%3DLestage%26aufirst%3DP.%26aulast%3DChangeux%26aufirst%3DJ.-P.%26atitle%3DNicotinic%2520receptors%253A%2520allosteric%2520transitions%2520and%2520therapeutic%2520targets%2520in%2520the%2520nervous%2520system%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D733%26epage%3D750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Dani, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, D.</span><span> </span><span class="NLM_article-title">Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">699</span><span class="NLM_x">–</span> <span class="NLM_lpage">729</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.1146%2Fannurev.pharmtox.47.120505.105214" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=17009926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1alurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=699-729&author=J.+A.+Daniauthor=D.+Bertrand&title=Nicotinic+acetylcholine+receptors+and+nicotinic+cholinergic+mechanisms+of+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system</span></div><div class="casAuthors">Dani, John A.; Bertrand, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">699-729</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Subtypes of neuronal nicotinic acetylcholine receptors (nAChRs) are constructed from numerous subunit combinations that compose channel-receptor complexes with varied functional and pharmacol. characteristics.  Structural and functional diversity and the broad presynaptic, postsynaptic, and nonsynaptic locations of nAChRs underlie their mainly modulatory roles throughout the mammalian brain.  Presynaptic and preterminal nicotinic receptors enhance neurotransmitter release, postsynaptic nAChRs contribute a small minority of fast excitatory transmission, and nonsynaptic nAChRs modulate many neurotransmitter systems by influencing neuronal excitability.  Nicotinic receptors have roles in development and synaptic plasticity, and nicotinic mechanisms participate in learning, memory, and attention.  Decline, disruption, or alterations of nicotinic cholinergic mechanisms contribute to dysfunctions such as epilepsy, schizophrenia, Parkinson's disease, autism, dementia with Lewy bodies, Alzheimer's disease, and addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp70HAk5CzKZbVg90H21EOLACvtfcHk0lhFH3ZKsWr5FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1alurk%253D&md5=72cacc238ec2a67f7ebae0b74582682f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.47.120505.105214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.47.120505.105214%26sid%3Dliteratum%253Aachs%26aulast%3DDani%26aufirst%3DJ.%2BA.%26aulast%3DBertrand%26aufirst%3DD.%26atitle%3DNicotinic%2520acetylcholine%2520receptors%2520and%2520nicotinic%2520cholinergic%2520mechanisms%2520of%2520the%2520central%2520nervous%2520system%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2007%26volume%3D47%26spage%3D699%26epage%3D729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Sargent, P. B.</span><span> </span><span class="NLM_article-title">The diversity of neuronal nicotinic acetylcoline receptors</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">443</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.1146%2Fannurev.ne.16.030193.002155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=7681637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADyaK3sXitVGgs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1993&pages=403-443&author=P.+B.+Sargent&title=The+diversity+of+neuronal+nicotinic+acetylcoline+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The diversity of neuronal nicotinic acetylcoline receptors</span></div><div class="casAuthors">Sargent, Peter B.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">403-43</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    </div><div class="casAbstract">A review, with ∼225 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplKEuljNK4m7Vg90H21EOLACvtfcHk0lhFH3ZKsWr5FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXitVGgs7k%253D&md5=fc0aa05d52fdecf3cb50fe0376a29bf5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1146%2Fannurev.ne.16.030193.002155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.ne.16.030193.002155%26sid%3Dliteratum%253Aachs%26aulast%3DSargent%26aufirst%3DP.%2BB.%26atitle%3DThe%2520diversity%2520of%2520neuronal%2520nicotinic%2520acetylcoline%2520receptors%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D1993%26volume%3D16%26spage%3D403%26epage%3D443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Lukas, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changeux, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Novere, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albuquerque, E. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balfour, D. J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiappinelli, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dani, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grady, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wonnacott, S.</span><span> </span><span class="NLM_article-title">International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1999&pages=397-401&author=R.+J.+Lukasauthor=J.-P.+Changeuxauthor=N.+Le+Novereauthor=E.+X.+Albuquerqueauthor=D.+J.+K.+Balfourauthor=D.+K.+Bergauthor=D.+Bertrandauthor=V.+A.+Chiappinelliauthor=P.+B.+S.+Clarkeauthor=A.+C.+Collinsauthor=J.+A.+Daniauthor=S.+R.+Gradyauthor=K.+J.+Kellarauthor=J.+M.+Lindstromauthor=M.+J.+Marksauthor=M.+Quikauthor=P.+W.+Taylorauthor=S.+Wonnacott&title=International+Union+of+Pharmacology.+XX.+Current+status+of+the+nomenclature+for+nicotinic+acetylcholine+receptors+and+their+subunits"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26aulast%3DChangeux%26aufirst%3DJ.-P.%26aulast%3DLe%2BNovere%26aufirst%3DN.%26aulast%3DAlbuquerque%26aufirst%3DE.%2BX.%26aulast%3DBalfour%26aufirst%3DD.%2BJ.%2BK.%26aulast%3DBerg%26aufirst%3DD.%2BK.%26aulast%3DBertrand%26aufirst%3DD.%26aulast%3DChiappinelli%26aufirst%3DV.%2BA.%26aulast%3DClarke%26aufirst%3DP.%2BB.%2BS.%26aulast%3DCollins%26aufirst%3DA.%2BC.%26aulast%3DDani%26aufirst%3DJ.%2BA.%26aulast%3DGrady%26aufirst%3DS.%2BR.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26aulast%3DLindstrom%26aufirst%3DJ.%2BM.%26aulast%3DMarks%26aufirst%3DM.%2BJ.%26aulast%3DQuik%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DP.%2BW.%26aulast%3DWonnacott%26aufirst%3DS.%26atitle%3DInternational%2520Union%2520of%2520Pharmacology.%2520XX.%2520Current%2520status%2520of%2520the%2520nomenclature%2520for%2520nicotinic%2520acetylcholine%2520receptors%2520and%2520their%2520subunits%26jtitle%3DPharmacol.%2520Rev.%26date%3D1999%26volume%3D51%26spage%3D397%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malysz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gronlien Jens, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Kouhen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakerud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetterstrand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs Clark, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span> </span><span class="NLM_article-title">Stimulation of dopamine release by nicotinic acetylcholine receptor ligands in rat brain slices correlates with the profile of high, but not low, sensitivity α4β2 subunit combination</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">844</span><span class="NLM_x">–</span> <span class="NLM_lpage">851</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=844-851&author=D.+J.+Andersonauthor=J.+Malyszauthor=H.+Gronlien+Jensauthor=R.+El+Kouhenauthor=M.+Hakerudauthor=C.+Wetterstrandauthor=A.+Briggs+Clarkauthor=M.+Gopalakrishnan&title=Stimulation+of+dopamine+release+by+nicotinic+acetylcholine+receptor+ligands+in+rat+brain+slices+correlates+with+the+profile+of+high%2C+but+not+low%2C+sensitivity+%CE%B14%CE%B22+subunit+combination"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DMalysz%26aufirst%3DJ.%26aulast%3DGronlien%2BJens%26aufirst%3DH.%26aulast%3DEl%2BKouhen%26aufirst%3DR.%26aulast%3DHakerud%26aufirst%3DM.%26aulast%3DWetterstrand%26aufirst%3DC.%26aulast%3DBriggs%2BClark%26aufirst%3DA.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26atitle%3DStimulation%2520of%2520dopamine%2520release%2520by%2520nicotinic%2520acetylcholine%2520receptor%2520ligands%2520in%2520rat%2520brain%2520slices%2520correlates%2520with%2520the%2520profile%2520of%2520high%252C%2520but%2520not%2520low%252C%2520sensitivity%2520%25CE%25B14%25CE%25B22%2520subunit%2520combination%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D844%26epage%3D851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Gotti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clementi, F.</span><span> </span><span class="NLM_article-title">Brain nicotinic acetylcholine receptors: native subtypes and their relevance</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">482</span><span class="NLM_x">–</span> <span class="NLM_lpage">491</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.1016%2Fj.tips.2006.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=16876883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD28XotlGktrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=482-491&author=C.+Gottiauthor=M.+Zoliauthor=F.+Clementi&title=Brain+nicotinic+acetylcholine+receptors%3A+native+subtypes+and+their+relevance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Brain nicotinic acetylcholine receptors: native subtypes and their relevance</span></div><div class="casAuthors">Gotti, Cecilia; Zoli, Michele; Clementi, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">482-491</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Neuronal nicotinic acetylcholine receptors comprise a heterogeneous class of cationic channels that is present throughout the nervous system.  These channels are involved both in physiol. functions (including cognition, reward, motor activity and analgesia) and in pathol. conditions such as Alzheimer's disease, Parkinson's disease, some forms of epilepsy, depression, autism and schizophrenia.  They are also the targets of tobacco-smoking effects and addiction.  Neuronal nicotinic acetylcholine receptors are pentamers of homomeric or heteromeric combinations of α (α2-α10) and β (β2-β4) subunits, which have different pharmacol. and biophys. properties and locations in the brain.  The lack of subtype-specific ligands and the fact that many neuronal cells express multiple subtypes initially hampered the identification of the different native nicotinic acetylcholine receptor subtypes, but the increasing knowledge of subtype compn. and roles will be of considerable interest for the development of new and clin. useful nicotinic acetylcholine receptor ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEGpOWmD0nkrVg90H21EOLACvtfcHk0livB3eTRViV2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotlGktrw%253D&md5=3c913a4e614585b2f3f52fdfb523d28f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2006.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2006.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DGotti%26aufirst%3DC.%26aulast%3DZoli%26aufirst%3DM.%26aulast%3DClementi%26aufirst%3DF.%26atitle%3DBrain%2520nicotinic%2520acetylcholine%2520receptors%253A%2520native%2520subtypes%2520and%2520their%2520relevance%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2006%26volume%3D27%26spage%3D482%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Gotti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaimarri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanardi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clementi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoli, M.</span><span> </span><span class="NLM_article-title">Heterogeneity and complexity of native brain nicotinic receptors</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1102</span><span class="NLM_x">–</span> <span class="NLM_lpage">1111</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2007&pages=1102-1111&author=C.+Gottiauthor=M.+Morettiauthor=A.+Gaimarriauthor=A.+Zanardiauthor=F.+Clementiauthor=M.+Zoli&title=Heterogeneity+and+complexity+of+native+brain+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGotti%26aufirst%3DC.%26aulast%3DMoretti%26aufirst%3DM.%26aulast%3DGaimarri%26aufirst%3DA.%26aulast%3DZanardi%26aufirst%3DA.%26aulast%3DClementi%26aufirst%3DF.%26aulast%3DZoli%26aufirst%3DM.%26atitle%3DHeterogeneity%2520and%2520complexity%2520of%2520native%2520brain%2520nicotinic%2520receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2007%26volume%3D74%26spage%3D1102%26epage%3D1111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Gotti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clementi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fornari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaimarri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiducci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manfredi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedrazzi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pucci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoli, M.</span><span> </span><span class="NLM_article-title">Structural and functional diversity of native brain neuronal nicotinic receptors</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">–</span> <span class="NLM_lpage">711</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=703-711&author=C.+Gottiauthor=F.+Clementiauthor=A.+Fornariauthor=A.+Gaimarriauthor=S.+Guiducciauthor=I.+Manfrediauthor=M.+Morettiauthor=P.+Pedrazziauthor=L.+Pucciauthor=M.+Zoli&title=Structural+and+functional+diversity+of+native+brain+neuronal+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGotti%26aufirst%3DC.%26aulast%3DClementi%26aufirst%3DF.%26aulast%3DFornari%26aufirst%3DA.%26aulast%3DGaimarri%26aufirst%3DA.%26aulast%3DGuiducci%26aufirst%3DS.%26aulast%3DManfredi%26aufirst%3DI.%26aulast%3DMoretti%26aufirst%3DM.%26aulast%3DPedrazzi%26aufirst%3DP.%26aulast%3DPucci%26aufirst%3DL.%26aulast%3DZoli%26aufirst%3DM.%26atitle%3DStructural%2520and%2520functional%2520diversity%2520of%2520native%2520brain%2520neuronal%2520nicotinic%2520receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D703%26epage%3D711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Decker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M. D.</span><span> </span><span class="NLM_article-title">The potential of neuronal nicotinic acetylcholine receptor agonists for treating CNS conditions</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1027</span><span class="NLM_x">–</span> <span class="NLM_lpage">1040</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1027-1040&author=M.+W.+Deckerauthor=M.+Gopalakrishnanauthor=M.+D.+Meyer&title=The+potential+of+neuronal+nicotinic+acetylcholine+receptor+agonists+for+treating+CNS+conditions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDecker%26aufirst%3DM.%2BW.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26atitle%3DThe%2520potential%2520of%2520neuronal%2520nicotinic%2520acetylcholine%2520receptor%2520agonists%2520for%2520treating%2520CNS%2520conditions%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2008%26volume%3D3%26spage%3D1027%26epage%3D1040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Poorthuis, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goriounova, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couey, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansvelder, H. D.</span><span> </span><span class="NLM_article-title">Nicotinic actions on neuronal networks for cognition: General principles and long-term consequences</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">668</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=668-676&author=R.+B.+Poorthuisauthor=N.+A.+Goriounovaauthor=J.+J.+Coueyauthor=H.+D.+Mansvelder&title=Nicotinic+actions+on+neuronal+networks+for+cognition%3A+General+principles+and+long-term+consequences"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPoorthuis%26aufirst%3DR.%2BB.%26aulast%3DGoriounova%26aufirst%3DN.%2BA.%26aulast%3DCouey%26aufirst%3DJ.%2BJ.%26aulast%3DMansvelder%26aufirst%3DH.%2BD.%26atitle%3DNicotinic%2520actions%2520on%2520neuronal%2520networks%2520for%2520cognition%253A%2520General%2520principles%2520and%2520long-term%2520consequences%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D668%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Marks, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wageman, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grady, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, C. A.</span><span> </span><span class="NLM_article-title">Selectivity of ABT-089 for α4β2* and α6β2* nicotinic acetylcholine receptors in brain</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">910</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=910&author=M.+J.+Marksauthor=C.+R.+Wagemanauthor=S.+R.+Gradyauthor=M.+Gopalakrishnanauthor=C.+A.+Briggs&title=Selectivity+of+ABT-089+for+%CE%B14%CE%B22*+and+%CE%B16%CE%B22*+nicotinic+acetylcholine+receptors+in+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DM.%2BJ.%26aulast%3DWageman%26aufirst%3DC.%2BR.%26aulast%3DGrady%26aufirst%3DS.%2BR.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26aulast%3DBriggs%26aufirst%3DC.%2BA.%26atitle%3DSelectivity%2520of%2520ABT-089%2520for%2520%25CE%25B14%25CE%25B22%252A%2520and%2520%25CE%25B16%25CE%25B22%252A%2520nicotinic%2520acetylcholine%2520receptors%2520in%2520brain%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Sullivan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannon, A. W.</span><span> </span><span class="NLM_article-title">Epibatidine: pharmacological properties of a novel nicotinic acetylcholine receptor agonist and analgesic agent</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1996&pages=21-39&author=J.+P.+Sullivanauthor=A.+W.+Bannon&title=Epibatidine%3A+pharmacological+properties+of+a+novel+nicotinic+acetylcholine+receptor+agonist+and+analgesic+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26aulast%3DBannon%26aufirst%3DA.%2BW.%26atitle%3DEpibatidine%253A%2520pharmacological%2520properties%2520of%2520a%2520novel%2520nicotinic%2520acetylcholine%2520receptor%2520agonist%2520and%2520analgesic%2520agent%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D1996%26volume%3D2%26spage%3D21%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Lin, N.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryther, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvey, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnelly-Roberts, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brioni, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccafusco, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prendergast, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arneric, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holladay, M. W.</span><span> </span><span class="NLM_article-title">Structure–Activity Studies on 2-Methyl-3-(2(<i>S</i>)-pyrrolidinylmethoxy)pyridine (ABT-089): An Orally Bioavailable 3-Pyridyl Ether Nicotinic Acetylcholine Receptor Ligand with Cognition-Enhancing Properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm960233u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=385-390&author=N.-H.+Linauthor=D.+E.+Gunnauthor=K.+B.+Rytherauthor=D.+S.+Garveyauthor=D.+L.+Donnelly-Robertsauthor=M.+W.+Deckerauthor=J.+D.+Brioniauthor=M.+J.+Buckleyauthor=A.+D.+Rodriguesauthor=K+G.+Marshauthor=D.+J.+Andersonauthor=J.+J.+Buccafuscoauthor=M.+A.+Prendergastauthor=J.+P.+Sullivanauthor=M.+Williamsauthor=S.+P.+Arnericauthor=M.+W.+Holladay&title=Structure%E2%80%93Activity+Studies+on+2-Methyl-3-%282%28S%29-pyrrolidinylmethoxy%29pyridine+%28ABT-089%29%3A+An+Orally+Bioavailable+3-Pyridyl+Ether+Nicotinic+Acetylcholine+Receptor+Ligand+with+Cognition-Enhancing+Properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm960233u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960233u%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DN.-H.%26aulast%3DGunn%26aufirst%3DD.%2BE.%26aulast%3DRyther%26aufirst%3DK.%2BB.%26aulast%3DGarvey%26aufirst%3DD.%2BS.%26aulast%3DDonnelly-Roberts%26aufirst%3DD.%2BL.%26aulast%3DDecker%26aufirst%3DM.%2BW.%26aulast%3DBrioni%26aufirst%3DJ.%2BD.%26aulast%3DBuckley%26aufirst%3DM.%2BJ.%26aulast%3DRodrigues%26aufirst%3DA.%2BD.%26aulast%3DMarsh%26aufirst%3DK%2BG.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DBuccafusco%26aufirst%3DJ.%2BJ.%26aulast%3DPrendergast%26aufirst%3DM.%2BA.%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DArneric%26aufirst%3DS.%2BP.%26aulast%3DHolladay%26aufirst%3DM.%2BW.%26atitle%3DStructure%25E2%2580%2593Activity%2520Studies%2520on%25202-Methyl-3-%25282%2528S%2529-pyrrolidinylmethoxy%2529pyridine%2520%2528ABT-089%2529%253A%2520An%2520Orally%2520Bioavailable%25203-Pyridyl%2520Ether%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Ligand%2520with%2520Cognition-Enhancing%2520Properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D385%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Sullivan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnelly-Roberts, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piattoni-Kaplan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenna, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryther, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holladay, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wonnacott, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arneric, S. P.</span><span> </span><span class="NLM_article-title">ABT-089 [2-methyl-3-(2-(<i>S</i>)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective properties</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=9336329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADyaK2sXmslCltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=235-246&author=J.+P.+Sullivanauthor=D.+Donnelly-Robertsauthor=C.+A.+Briggsauthor=D.+J.+Andersonauthor=M.+Gopalakrishnanauthor=I.+C.+Xueauthor=M.+Piattoni-Kaplanauthor=E.+Molinariauthor=J.+E.+Campbellauthor=D.+G.+McKennaauthor=D.+E.+Gunnauthor=N.-H.+Linauthor=K.+B.+Rytherauthor=Y.+Heauthor=M.+W.+Holladayauthor=S.+Wonnacottauthor=M.+Williamsauthor=S.+P.+Arneric&title=ABT-089+%5B2-methyl-3-%282-%28S%29-pyrrolidinylmethoxy%29pyridine%5D%3A+I.+A+potent+and+selective+cholinergic+channel+modulator+with+neuroprotective+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective properties</span></div><div class="casAuthors">Sullivan, James P.; Donnelly-Roberts, Diana; Briggs, Clark A.; Anderson, David J.; Gopalakrishnan, Murali; Xue, Iris C.; Piattoni-Kaplan, Marietta; Molinari, Eduardo; Campbell, Jeffrey E.; Mckenna, David G.; Gunn, David E.; Lin, Nan-Horng; Ryther, Keith B.; He, Yun; Holladay, Mark W.; Wonnacott, Susan; Williams, Michael; Arneric, Stephen P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-246</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">Accumulating preclin. and clin. evidence data suggests that compds. that selectively activate neuronal nicotinic acetylcholine receptor (nAChR) subtypes may have therapeutic utility for the treatment of several neurol. disorders.  In the present study, the in vitro pharmacol. properties of the novel cholinergic channel modulator ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine], are described.  In radioligand binding studies, ABT-089 was shown to display selectivity toward the high-affinity (-)-cytisine binding site present on the α4β2 nAChR subtype (Ki = 16 nM) relative to the [125I]α-bungarotoxin binding site present on the α7 (Ki ≥ 10,000 nM) and α1β1δγ(Ki > 1000 nM) nAChR subtypes.  In cation flux and channel current studies, ABT-089 displayed a more complex profile than (-)-nicotine having agonist, partial agonist and inhibitory activities depending on the nAChR subtype with which it interacts.  ABT-089 differentially stimulated neurotransmitter release.  The compd. displayed a similar potency and efficacy to (-)-nicotine to facilitate ACh release (ABT-089, EC50 = 3 μM; (-)-nicotine, EC50 = 1 μM), but was markedly less potent and less efficacious than (-)-nicotine to stimulate dopamine release (ABT-089, EC50 = 1.1 μM; (-)-nicotine, EC50 = 0.04 μM).  Addnl., ABT-089 was neuroprotective against the excitotoxic insults elicited by exposure to glutamate in both rat cortical cell cultures (EC50 = 10 ± 3 μM) and differentiated human IMR32 cells (EC50 = 3 ± 2 μM).  The differential full agonist/partial agonist profile of ABT-089, as compared with (-)-nicotine and ABT-418, illustrates the complexity of nAChR activation and the potential to target responses at subclasses of the neuronal and peripheral receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqLb9I4NYSt7Vg90H21EOLACvtfcHk0lgl4p5GI6ZJlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslCltLs%253D&md5=1e8c857bc451d094a273cc07d590b9fd</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26aulast%3DDonnelly-Roberts%26aufirst%3DD.%26aulast%3DBriggs%26aufirst%3DC.%2BA.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26aulast%3DXue%26aufirst%3DI.%2BC.%26aulast%3DPiattoni-Kaplan%26aufirst%3DM.%26aulast%3DMolinari%26aufirst%3DE.%26aulast%3DCampbell%26aufirst%3DJ.%2BE.%26aulast%3DMcKenna%26aufirst%3DD.%2BG.%26aulast%3DGunn%26aufirst%3DD.%2BE.%26aulast%3DLin%26aufirst%3DN.-H.%26aulast%3DRyther%26aufirst%3DK.%2BB.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DHolladay%26aufirst%3DM.%2BW.%26aulast%3DWonnacott%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DArneric%26aufirst%3DS.%2BP.%26atitle%3DABT-089%2520%255B2-methyl-3-%25282-%2528S%2529-pyrrolidinylmethoxy%2529pyridine%255D%253A%2520I.%2520A%2520potent%2520and%2520selective%2520cholinergic%2520channel%2520modulator%2520with%2520neuroprotective%2520properties%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D235%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Decker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannon, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curzon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunther, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brioni, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holladay, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daanen, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccafusco, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prendergast, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arneric, S. P.</span><span> </span><span class="NLM_article-title">ABT-089 [2-methyl-3-(2-(<i>S</i>)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=9336330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADyaK2sXmslCltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=247-258&author=M.+W.+Deckerauthor=A.+W.+Bannonauthor=P.+Curzonauthor=K.+L.+Guntherauthor=J.+D.+Brioniauthor=M.+W.+Holladayauthor=N.-H.+Linauthor=Y.+Liauthor=J.+F.+Daanenauthor=J.+J.+Buccafuscoauthor=M.+A.+Prendergastauthor=W.+J.+Jacksonauthor=S.+P.+Arneric&title=ABT-089+%5B2-methyl-3-%282-%28S%29-pyrrolidinylmethoxy%29pyridine+dihydrochloride%5D%3A+II.+A+novel+cholinergic+channel+modulator+with+effects+on+cognitive+performance+in+rats+and+monkeys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys</span></div><div class="casAuthors">Decker, Michael W.; Bannon, Anthony W.; Curzon, Peter; Gunther, Karen L.; Brioni, Jorge D.; Holladay, Mark W.; Lin, Nan-Horng; Li, Yihong; Daanen, Jerome F.; Buccafusco, Jerry J.; Prendergast, Mark A.; Jackson, William J.; Arneric, Stephen P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">247-258</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride], a novel ligand at neuronal nicotinic acetylcholine receptors with reduced adverse effects and improved oral bio-availability relative to (-)-nicotine, was tested in a variety of cognitive tests in rats and monkeys.  Administered acutely, ABT-089 only marginally improved the spatial discrimination water maze performance of septal-lesioned rats.  However, more robust improvement (45% error redn. on the last training day) was obsd. when ABT-089 was administered continuously via s.c. osmotic pumps (min. ED: 1.3 μmol/kg/day).  Continuous infusion of (-)-nicotine produced comparable improvement in the spatial discrimination water maze performance of septal-lesioned rats, but a 40-fold higher dose of (-)-nicotine was required (62 μmol/kg/day).  Continuous infusion of ABT-089 to aged rats enhanced spatial learning in a std. Morris water maze, as indexed by spatial bias exhibited during a probe trial conducted after 4 days of training, but not when they were subsequently trained in a two-platform spatial discrimination water maze.  The compd. induced a small impairment in young rats on the std. water maze, but not on the two-platform task.  A probe trial conducted after addnl. training in the std. water maze revealed no age or drug effects.  ABT-089 did not affect performance of either the aged or young rats during inhibitory (passive) avoidance training.  Also, continuous infusion of ABT-089 did not affect responses to acoustic startle or prepulse inhibition of acoustic startle in young, aged or septal-lesioned rats and did not affect locomotor activity in either sham-lesioned or septal-lesioned rats.  In monkeys, acute administration of ABT-089 modestly improved the delayed matching-to-sample performance of mature, adult monkeys and more robustly improved performance in aged monkeys.  Improved performance in the aged monkeys was restricted to the longest delay intervals and was not accompanied by changes in response latencies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4aVDc0gQwlbVg90H21EOLACvtfcHk0liEvhaejwiwuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslCltLg%253D&md5=a86796c0f9d8a4ef0eeba49dbf2f23a0</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDecker%26aufirst%3DM.%2BW.%26aulast%3DBannon%26aufirst%3DA.%2BW.%26aulast%3DCurzon%26aufirst%3DP.%26aulast%3DGunther%26aufirst%3DK.%2BL.%26aulast%3DBrioni%26aufirst%3DJ.%2BD.%26aulast%3DHolladay%26aufirst%3DM.%2BW.%26aulast%3DLin%26aufirst%3DN.-H.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DDaanen%26aufirst%3DJ.%2BF.%26aulast%3DBuccafusco%26aufirst%3DJ.%2BJ.%26aulast%3DPrendergast%26aufirst%3DM.%2BA.%26aulast%3DJackson%26aufirst%3DW.%2BJ.%26aulast%3DArneric%26aufirst%3DS.%2BP.%26atitle%3DABT-089%2520%255B2-methyl-3-%25282-%2528S%2529-pyrrolidinylmethoxy%2529pyridine%2520dihydrochloride%255D%253A%2520II.%2520A%2520novel%2520cholinergic%2520channel%2520modulator%2520with%2520effects%2520on%2520cognitive%2520performance%2520in%2520rats%2520and%2520monkeys%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D247%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Rueter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnelly-Roberts, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gintant, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osinski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhart, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preusser, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seifert, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, J. P.</span><span> </span><span class="NLM_article-title">ABT-089: Pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disorders</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=167-182&author=L.+E.+Rueterauthor=D.+J.+Andersonauthor=C.+A.+Briggsauthor=D.+L.+Donnelly-Robertsauthor=G.+A.+Gintantauthor=M.+Gopalakrishnanauthor=N.-H.+Linauthor=M.+A.+Osinskiauthor=G.+A.+Reinhartauthor=M.+J.+Buckleyauthor=R.+L.+Martinauthor=J.+S.+McDermottauthor=L.+C.+Preusserauthor=T.+R.+Seifertauthor=Z.+Suauthor=B.+F.+Coxauthor=M.+W.+Deckerauthor=J.+P.+Sullivan&title=ABT-089%3A+Pharmacological+properties+of+a+neuronal+nicotinic+acetylcholine+receptor+agonist+for+the+potential+treatment+of+cognitive+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRueter%26aufirst%3DL.%2BE.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DBriggs%26aufirst%3DC.%2BA.%26aulast%3DDonnelly-Roberts%26aufirst%3DD.%2BL.%26aulast%3DGintant%26aufirst%3DG.%2BA.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DN.-H.%26aulast%3DOsinski%26aufirst%3DM.%2BA.%26aulast%3DReinhart%26aufirst%3DG.%2BA.%26aulast%3DBuckley%26aufirst%3DM.%2BJ.%26aulast%3DMartin%26aufirst%3DR.%2BL.%26aulast%3DMcDermott%26aufirst%3DJ.%2BS.%26aulast%3DPreusser%26aufirst%3DL.%2BC.%26aulast%3DSeifert%26aufirst%3DT.%2BR.%26aulast%3DSu%26aufirst%3DZ.%26aulast%3DCox%26aufirst%3DB.%2BF.%26aulast%3DDecker%26aufirst%3DM.%2BW.%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26atitle%3DABT-089%253A%2520Pharmacological%2520properties%2520of%2520a%2520neuronal%2520nicotinic%2520acetylcholine%2520receptor%2520agonist%2520for%2520the%2520potential%2520treatment%2520of%2520cognitive%2520disorders%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2004%26volume%3D10%26spage%3D167%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Prendergast, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terry, A. V.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arneric, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccafusco, J. J.</span><span> </span><span class="NLM_article-title">Central nicotinic receptor agonists ABT-418, ABT-089, and (−)-nicotine reduce distractibility in adult monkeys</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=1998&pages=50-58&author=M.+A.+Prendergastauthor=W.+J.+Jacksonauthor=A.+V.+Terryauthor=M.+W.+Deckerauthor=S.+P.+Arnericauthor=J.+J.+Buccafusco&title=Central+nicotinic+receptor+agonists+ABT-418%2C+ABT-089%2C+and+%28%E2%88%92%29-nicotine+reduce+distractibility+in+adult+monkeys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrendergast%26aufirst%3DM.%2BA.%26aulast%3DJackson%26aufirst%3DW.%2BJ.%26aulast%3DTerry%26aufirst%3DA.%2BV.%26aulast%3DDecker%26aufirst%3DM.%2BW.%26aulast%3DArneric%26aufirst%3DS.%2BP.%26aulast%3DBuccafusco%26aufirst%3DJ.%2BJ.%26atitle%3DCentral%2520nicotinic%2520receptor%2520agonists%2520ABT-418%252C%2520ABT-089%252C%2520and%2520%2528%25E2%2588%2592%2529-nicotine%2520reduce%2520distractibility%2520in%2520adult%2520monkeys%26jtitle%3DPsychopharmacology%26date%3D1998%26volume%3D136%26spage%3D50%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Wilens, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verlinden, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adler, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wozniak, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S. A.</span><span> </span><span class="NLM_article-title">ABT-089, A Neuronal Nicotinic Receptor Partial Agonist, for the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Pilot Study</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1065</span><span class="NLM_x">–</span> <span class="NLM_lpage">1070</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.1016%2Fj.biopsych.2005.10.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=16499880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD28Xls1eju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2006&pages=1065-1070&author=T.+E.+Wilensauthor=M.+H.+Verlindenauthor=L.+A.+Adlerauthor=P.+J.+Wozniakauthor=S.+A.+West&title=ABT-089%2C+A+Neuronal+Nicotinic+Receptor+Partial+Agonist%2C+for+the+Treatment+of+Attention-Deficit%2FHyperactivity+Disorder+in+Adults%3A+Results+of+a+Pilot+Study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">ABT-089, A Neuronal Nicotinic Receptor Partial Agonist, for the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Pilot Study</span></div><div class="casAuthors">Wilens, Timothy E.; Verlinden, Marleen H.; Adler, Lenard A.; Wozniak, Patricia J.; West, Scott A.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1065-1070</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">This pilot study was designed to evaluate ABT-089, a neuronal nicotinic receptor partial agonist, as treatment for adult attention-deficit/hyperactivity disorder (ADHD).  Adults with ADHD received placebo, 2 mg, 4 mg, or 20 mg of ABT-089 for 2 wk each in a randomized, double-blind, placebo-controlled, 4 × 4 Latin square design for a total of 8 wk.  In addn. to the primary outcome, the Conner's Adult ADHD Rating Scale (CAARS), secondary rating scales, and neuropsychol. and safety assessments were completed.  A total of 11 adults with well-characterized ADHD completed this crossover study.  ABT-089 b.i.d. was superior to placebo for the CAARS Total Symptom Score, which was the primary endpoint (placebo: 38.0 ± 1.9; 2 mg b.i.d.: 32.2 ± 1.9, one-tail p = .021; 4 mg b.i.d.: 33.2 ± 1.9, p = .047; 20 mg b.i.d.: 33.5 ± 1.9, p = .056).  ABT-089 was also superior to placebo for the CAARS ADHD Index and Hyperactive/Impulsive scores and the Clin. Global Impression-ADHD Severity score.  On the clin. efficacy endpoints, CAARS Total Symptom Score and CAARS Hyperactive/Impulsive score, a shallow inverted U-shaped dose-response curve was obsd.; however, the dose-response curve for attention and memory effects as measured by computerized cognitive testing seemed dose-linear.  No clin. meaningful findings in safety assessments or side effect profile were obsd.  Data from this pilot study suggest that ABT-089 might be effective in treating adult ADHD and that it is well tolerated.  On the basis of these promising results, larger, parallel-group ABT-089 studies of longer duration are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf9cpJKRq47LVg90H21EOLACvtfcHk0liEvhaejwiwuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xls1eju7c%253D&md5=2fb0da77ee46952d8fa05e33204707e5</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2005.10.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2005.10.029%26sid%3Dliteratum%253Aachs%26aulast%3DWilens%26aufirst%3DT.%2BE.%26aulast%3DVerlinden%26aufirst%3DM.%2BH.%26aulast%3DAdler%26aufirst%3DL.%2BA.%26aulast%3DWozniak%26aufirst%3DP.%2BJ.%26aulast%3DWest%26aufirst%3DS.%2BA.%26atitle%3DABT-089%252C%2520A%2520Neuronal%2520Nicotinic%2520Receptor%2520Partial%2520Agonist%252C%2520for%2520the%2520Treatment%2520of%2520Attention-Deficit%252FHyperactivity%2520Disorder%2520in%2520Adults%253A%2520Results%2520of%2520a%2520Pilot%2520Study%26jtitle%3DBiol.%2520Psychiatry%26date%3D2006%26volume%3D59%26spage%3D1065%26epage%3D1070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Wilens, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M. W.</span><span> </span><span class="NLM_article-title">Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1212</span><span class="NLM_x">–</span> <span class="NLM_lpage">1223</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2007&pages=1212-1223&author=T.+E.+Wilensauthor=M.+W.+Decker&title=Neuronal+nicotinic+receptor+agonists+for+the+treatment+of+attention-deficit%2Fhyperactivity+disorder%3A+focus+on+cognition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilens%26aufirst%3DT.%2BE.%26aulast%3DDecker%26aufirst%3DM.%2BW.%26atitle%3DNeuronal%2520nicotinic%2520receptor%2520agonists%2520for%2520the%2520treatment%2520of%2520attention-deficit%252Fhyperactivity%2520disorder%253A%2520focus%2520on%2520cognition%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2007%26volume%3D74%26spage%3D1212%26epage%3D1223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musachio, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Z.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chellappan, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">Sazetidine-A, a novel ligand that desensitizes α4β2 nicotinic acetylcholine receptors without activating them</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1454</span><span class="NLM_x">–</span> <span class="NLM_lpage">1460</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=1454-1460&author=Y.+Xiaoauthor=H.+Fanauthor=J.+L.+Musachioauthor=Z.-L.+Weiauthor=S.+K.+Chellappanauthor=A.+P.+Kozikowskiauthor=K.+J.+Kellar&title=Sazetidine-A%2C+a+novel+ligand+that+desensitizes+%CE%B14%CE%B22+nicotinic+acetylcholine+receptors+without+activating+them"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DMusachio%26aufirst%3DJ.%2BL.%26aulast%3DWei%26aufirst%3DZ.-L.%26aulast%3DChellappan%26aufirst%3DS.%2BK.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DSazetidine-A%252C%2520a%2520novel%2520ligand%2520that%2520desensitizes%2520%25CE%25B14%25CE%25B22%2520nicotinic%2520acetylcholine%2520receptors%2520without%2520activating%2520them%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D1454%26epage%3D1460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarone, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Chemistry and Pharmacological Characterization of Novel Nitrogen Analogues of AMOP-H-OH (Sazetidine-A, 6-[5-(Azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol) as α4β2-Nicotinic Acetylcholine Receptor-Selective Partial Agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">6973</span><span class="NLM_x">–</span> <span class="NLM_lpage">6985</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100765u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6973-6985&author=J.+Liuauthor=J.+B.+Eatonauthor=B.+Caldaroneauthor=R.+J.+Lukasauthor=A.+P.+Kozikowski&title=Chemistry+and+Pharmacological+Characterization+of+Novel+Nitrogen+Analogues+of+AMOP-H-OH+%28Sazetidine-A%2C+6-%5B5-%28Azetidin-2-ylmethoxy%29pyridin-3-yl%5Dhex-5-yn-1-ol%29+as+%CE%B14%CE%B22-Nicotinic+Acetylcholine+Receptor-Selective+Partial+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm100765u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100765u%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DEaton%26aufirst%3DJ.%2BB.%26aulast%3DCaldarone%26aufirst%3DB.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DChemistry%2520and%2520Pharmacological%2520Characterization%2520of%2520Novel%2520Nitrogen%2520Analogues%2520of%2520AMOP-H-OH%2520%2528Sazetidine-A%252C%25206-%255B5-%2528Azetidin-2-ylmethoxy%2529pyridin-3-yl%255Dhex-5-yn-1-ol%2529%2520as%2520%25CE%25B14%25CE%25B22-Nicotinic%2520Acetylcholine%2520Receptor-Selective%2520Partial%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6973%26epage%3D6985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tietje, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scanio, M. J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyhring, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gronlien, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ween, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorin-Hagene, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M. D.</span><span> </span><span class="NLM_article-title">Octahydropyrrolo[3,4-<i>c</i>]pyrrole: a diamine scaffold for construction of either α4β2 or α7-selective nicotinic acetylcholine receptor (nAChR) ligands. substitutions that switch subtype selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4126</span><span class="NLM_x">–</span> <span class="NLM_lpage">4141</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900249k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4126-4141&author=W.+H.+Bunnelleauthor=K.+R.+Tietjeauthor=J.+M.+Frostauthor=D.+Petersauthor=J.+Jiauthor=T.+Liauthor=M.+J.+C.+Scanioauthor=L.+Shiauthor=D.+J.+Andersonauthor=T.+Dyhringauthor=J.+H.+Gronlienauthor=H.+Weenauthor=K.+Thorin-Hageneauthor=M.+D.+Meyer&title=Octahydropyrrolo%5B3%2C4-c%5Dpyrrole%3A+a+diamine+scaffold+for+construction+of+either+%CE%B14%CE%B22+or+%CE%B17-selective+nicotinic+acetylcholine+receptor+%28nAChR%29+ligands.+substitutions+that+switch+subtype+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm900249k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900249k%26sid%3Dliteratum%253Aachs%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26aulast%3DTietje%26aufirst%3DK.%2BR.%26aulast%3DFrost%26aufirst%3DJ.%2BM.%26aulast%3DPeters%26aufirst%3DD.%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DScanio%26aufirst%3DM.%2BJ.%2BC.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DDyhring%26aufirst%3DT.%26aulast%3DGronlien%26aufirst%3DJ.%2BH.%26aulast%3DWeen%26aufirst%3DH.%26aulast%3DThorin-Hagene%26aufirst%3DK.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26atitle%3DOctahydropyrrolo%255B3%252C4-c%255Dpyrrole%253A%2520a%2520diamine%2520scaffold%2520for%2520construction%2520of%2520either%2520%25CE%25B14%25CE%25B22%2520or%2520%25CE%25B17-selective%2520nicotinic%2520acetylcholine%2520receptor%2520%2528nAChR%2529%2520ligands.%2520substitutions%2520that%2520switch%2520subtype%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4126%26epage%3D4141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Schrimpf, M. R.; Tietje, K. R.; Toupence, R. B.; Ji, J.; Basha, A.; Bunnelle, W. H.; Daanen, J. F.; Pace, J. M.; Sippy, K. B.</span><span> </span><span class="NLM_article-title">Diazabicyclic central nervous system active agents</span>. Patent WO0181347, <span class="NLM_month">Nov</span><span class="NLM_day">1</span>,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=M.+R.+Schrimpf&author=K.+R.+Tietje&author=R.+B.+Toupence&author=J.+Ji&author=A.+Basha&author=W.+H.+Bunnelle&author=J.+F.+Daanen&author=J.+M.+Pace&author=K.+B.+Sippy&title=Diazabicyclic+central+nervous+system+active+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchrimpf%26aufirst%3DM.%2BR.%26atitle%3DDiazabicyclic%2520central%2520nervous%2520system%2520active%2520agents%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Ji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrimpf, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippy, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faltynek, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surowy, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyhring, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahring, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M. D.</span><span> </span><span class="NLM_article-title">Synthesis and Structure–Activity Relationship Studies of 3,6-Diazabicyclo[3.2.0]heptanes as Novel α4β2 Nicotinic Acetylcholine Receptor Selective Agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5493</span><span class="NLM_x">–</span> <span class="NLM_lpage">5508</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070755h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5493-5508&author=J.+Jiauthor=M.+R.+Schrimpfauthor=K.+B.+Sippyauthor=W.+H.+Bunnelleauthor=T.+Liauthor=D.+J.+Andersonauthor=C.+Faltynekauthor=C.+S.+Surowyauthor=T.+Dyhringauthor=P.+K.+Ahringauthor=M.+D.+Meyer&title=Synthesis+and+Structure%E2%80%93Activity+Relationship+Studies+of+3%2C6-Diazabicyclo%5B3.2.0%5Dheptanes+as+Novel+%CE%B14%CE%B22+Nicotinic+Acetylcholine+Receptor+Selective+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm070755h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070755h%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DSchrimpf%26aufirst%3DM.%2BR.%26aulast%3DSippy%26aufirst%3DK.%2BB.%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DFaltynek%26aufirst%3DC.%26aulast%3DSurowy%26aufirst%3DC.%2BS.%26aulast%3DDyhring%26aufirst%3DT.%26aulast%3DAhring%26aufirst%3DP.%2BK.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26atitle%3DSynthesis%2520and%2520Structure%25E2%2580%2593Activity%2520Relationship%2520Studies%2520of%25203%252C6-Diazabicyclo%255B3.2.0%255Dheptanes%2520as%2520Novel%2520%25CE%25B14%25CE%25B22%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Selective%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5493%26epage%3D5508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brieaddy, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">Synthesis, Nicotinic Acetylcholine Receptor Binding, and Antinociceptive Properties of 2-exo-2-(2′,3′-Disubstituted 5′-pyridinyl)-7-azabicyclo[2.2.1]heptanes: Epibatidine Analogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4755</span><span class="NLM_x">–</span> <span class="NLM_lpage">4761</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0202268" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4755-4761&author=F.+I.+Carrollauthor=J.+R.+Leeauthor=H.+A.+Navarroauthor=W.+Maauthor=L.+E.+Brieaddyauthor=P.+Abrahamauthor=M.+I.+Damajauthor=B.+R.+Martin&title=Synthesis%2C+Nicotinic+Acetylcholine+Receptor+Binding%2C+and+Antinociceptive+Properties+of+2-exo-2-%282%E2%80%B2%2C3%E2%80%B2-Disubstituted+5%E2%80%B2-pyridinyl%29-7-azabicyclo%5B2.2.1%5Dheptanes%3A+Epibatidine+Analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm0202268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0202268%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DLee%26aufirst%3DJ.%2BR.%26aulast%3DNavarro%26aufirst%3DH.%2BA.%26aulast%3DMa%26aufirst%3DW.%26aulast%3DBrieaddy%26aufirst%3DL.%2BE.%26aulast%3DAbraham%26aufirst%3DP.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DSynthesis%252C%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Binding%252C%2520and%2520Antinociceptive%2520Properties%2520of%25202-exo-2-%25282%25E2%2580%25B2%252C3%25E2%2580%25B2-Disubstituted%25205%25E2%2580%25B2-pyridinyl%2529-7-azabicyclo%255B2.2.1%255Dheptanes%253A%2520Epibatidine%2520Analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D4755%26epage%3D4761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ware, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brieaddy, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">Synthesis, Nicotinic Acetylcholine Receptor Binding, and Antinociceptive Properties of 2′-Fluoro-3′-(substituted phenyl)deschloroepibatidine Analogues. Novel Nicotinic Antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4588</span><span class="NLM_x">–</span> <span class="NLM_lpage">4594</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040078g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4588-4594&author=F.+I.+Carrollauthor=R.+Wareauthor=L.+E.+Brieaddyauthor=H.+A.+Navarroauthor=M.+I.+Damajauthor=B.+R.+Martin&title=Synthesis%2C+Nicotinic+Acetylcholine+Receptor+Binding%2C+and+Antinociceptive+Properties+of+2%E2%80%B2-Fluoro-3%E2%80%B2-%28substituted+phenyl%29deschloroepibatidine+Analogues.+Novel+Nicotinic+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm040078g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040078g%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DWare%26aufirst%3DR.%26aulast%3DBrieaddy%26aufirst%3DL.%2BE.%26aulast%3DNavarro%26aufirst%3DH.%2BA.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DSynthesis%252C%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Binding%252C%2520and%2520Antinociceptive%2520Properties%2520of%25202%25E2%2580%25B2-Fluoro-3%25E2%2580%25B2-%2528substituted%2520phenyl%2529deschloroepibatidine%2520Analogues.%2520Novel%2520Nicotinic%2520Antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4588%26epage%3D4594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brieaddy, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">Synthesis and Pharmacological Characterization of <i>exo</i>-2-(2′-Chloro-5-pyridinyl)-7-(endo and exo)-aminobicyclo[2.2.1]heptanes as Novel Epibatidine Analogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7491</span><span class="NLM_x">–</span> <span class="NLM_lpage">7495</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058243v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7491-7495&author=F.+I.+Carrollauthor=L.+E.+Brieaddyauthor=H.+A.+Navarroauthor=M.+I.+Damajauthor=B.+R.+Martin&title=Synthesis+and+Pharmacological+Characterization+of+exo-2-%282%E2%80%B2-Chloro-5-pyridinyl%29-7-%28endo+and+exo%29-aminobicyclo%5B2.2.1%5Dheptanes+as+Novel+Epibatidine+Analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm058243v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058243v%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DBrieaddy%26aufirst%3DL.%2BE.%26aulast%3DNavarro%26aufirst%3DH.%2BA.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DSynthesis%2520and%2520Pharmacological%2520Characterization%2520of%2520exo-2-%25282%25E2%2580%25B2-Chloro-5-pyridinyl%2529-7-%2528endo%2520and%2520exo%2529-aminobicyclo%255B2.2.1%255Dheptanes%2520as%2520Novel%2520Epibatidine%2520Analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7491%26epage%3D7495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Frost, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tietje, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curzon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surowy, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daanen, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlhaas, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyhring, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahring, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M. D.</span><span> </span><span class="NLM_article-title">Synthesis and Structure–Activity Relationships of 3,8-Diazabicyclo[4.2.0]octane Ligands, Potent Nicotinic Acetylcholine Receptor Agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7843</span><span class="NLM_x">–</span> <span class="NLM_lpage">7853</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7843-7853&author=J.+M.+Frostauthor=W.+H.+Bunnelleauthor=K.+R.+Tietjeauthor=D.+J.+Andersonauthor=L.+E.+Rueterauthor=P.+Curzonauthor=C.+S.+Surowyauthor=J.+Jiauthor=J.+F.+Daanenauthor=K.+L.+Kohlhaasauthor=M.+J.+Buckleyauthor=R.+F.+Henryauthor=T.+Dyhringauthor=P.+K.+Ahringauthor=M.+D.+Meyer&title=Synthesis+and+Structure%E2%80%93Activity+Relationships+of+3%2C8-Diazabicyclo%5B4.2.0%5Doctane+Ligands%2C+Potent+Nicotinic+Acetylcholine+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrost%26aufirst%3DJ.%2BM.%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26aulast%3DTietje%26aufirst%3DK.%2BR.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DRueter%26aufirst%3DL.%2BE.%26aulast%3DCurzon%26aufirst%3DP.%26aulast%3DSurowy%26aufirst%3DC.%2BS.%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DDaanen%26aufirst%3DJ.%2BF.%26aulast%3DKohlhaas%26aufirst%3DK.%2BL.%26aulast%3DBuckley%26aufirst%3DM.%2BJ.%26aulast%3DHenry%26aufirst%3DR.%2BF.%26aulast%3DDyhring%26aufirst%3DT.%26aulast%3DAhring%26aufirst%3DP.%2BK.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26atitle%3DSynthesis%2520and%2520Structure%25E2%2580%2593Activity%2520Relationships%2520of%25203%252C8-Diazabicyclo%255B4.2.0%255Doctane%2520Ligands%252C%2520Potent%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7843%26epage%3D7853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Schenke, T.; Petersen, U.</span><span> </span><span class="NLM_article-title">2,7-diazabicyclo[3.3.0]octanes and process for their formation</span>. Eur. Patent 393424, <span class="NLM_month">April</span><span class="NLM_day">4</span>,<span class="NLM_x"> </span><span class="NLM_year">1990</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1990&author=T.+Schenke&author=U.+Petersen&title=2%2C7-diazabicyclo%5B3.3.0%5Doctanes+and+process+for+their+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchenke%26aufirst%3DT.%26atitle%3D2%252C7-diazabicyclo%255B3.3.0%255Doctanes%2520and%2520process%2520for%2520their%2520formation%26date%3D1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Uchimaru, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosasayama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konno, T.</span><span> </span><span class="NLM_article-title">Pyrazine derivatives. I. Synthesis of pyrazinoylmorpholine and related compounds</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1337</span><span class="NLM_x">–</span> <span class="NLM_lpage">1343</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1971&pages=1337-1343&author=F.+Uchimaruauthor=S.+Okadaauthor=A.+Kosasayamaauthor=T.+Konno&title=Pyrazine+derivatives.+I.+Synthesis+of+pyrazinoylmorpholine+and+related+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUchimaru%26aufirst%3DF.%26aulast%3DOkada%26aufirst%3DS.%26aulast%3DKosasayama%26aufirst%3DA.%26aulast%3DKonno%26aufirst%3DT.%26atitle%3DPyrazine%2520derivatives.%2520I.%2520Synthesis%2520of%2520pyrazinoylmorpholine%2520and%2520related%2520compounds%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1971%26volume%3D19%26spage%3D1337%26epage%3D1343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Okada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosasayama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchimaru, F.</span><span> </span><span class="NLM_article-title">Pyrazine derivatives. II. Synthesis, reactions, and spectra of pyrazine <i>N</i>-oxide derivatives</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1344</span><span class="NLM_x">–</span> <span class="NLM_lpage">1357</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1971&pages=1344-1357&author=S.+Okadaauthor=A.+Kosasayamaauthor=T.+Konnoauthor=F.+Uchimaru&title=Pyrazine+derivatives.+II.+Synthesis%2C+reactions%2C+and+spectra+of+pyrazine+N-oxide+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkada%26aufirst%3DS.%26aulast%3DKosasayama%26aufirst%3DA.%26aulast%3DKonno%26aufirst%3DT.%26aulast%3DUchimaru%26aufirst%3DF.%26atitle%3DPyrazine%2520derivatives.%2520II.%2520Synthesis%252C%2520reactions%252C%2520and%2520spectra%2520of%2520pyrazine%2520N-oxide%2520derivatives%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1971%26volume%3D19%26spage%3D1344%26epage%3D1357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Scanio, M. J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drizin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregg, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krambis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shieh, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simler, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honore, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werness, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krafte, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvis, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faltynek, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marron, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kort, M. E.</span><span> </span><span class="NLM_article-title">Discovery and biological evaluation of potent, selective, orally bioavailable, pyrazine-based blockers of the Na<sub>V</sub>1.8 sodium channel with efficacy in a model of neuropathic pain</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">7816</span><span class="NLM_x">–</span> <span class="NLM_lpage">7825</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=7816-7825&author=M.+J.+C.+Scanioauthor=L.+Shiauthor=I.+Drizinauthor=R.+J.+Greggauthor=R.+N.+Atkinsonauthor=J.+B.+Thomasauthor=M.+S.+Johnsonauthor=M.+L.+Chapmanauthor=D.+Liuauthor=M.+J.+Krambisauthor=Y.+Liuauthor=C.-C.+Shiehauthor=X.+F.+Zhangauthor=G.+H.+Simlerauthor=S.+Joshiauthor=P.+Honoreauthor=K.+C.+Marshauthor=A.+Knoxauthor=S.+Wernessauthor=B.+Antonioauthor=D.+S.+Krafteauthor=M.+F.+Jarvisauthor=C.+R.+Faltynekauthor=B.+E.+Marronauthor=M.+E.+Kort&title=Discovery+and+biological+evaluation+of+potent%2C+selective%2C+orally+bioavailable%2C+pyrazine-based+blockers+of+the+NaV1.8+sodium+channel+with+efficacy+in+a+model+of+neuropathic+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScanio%26aufirst%3DM.%2BJ.%2BC.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DDrizin%26aufirst%3DI.%26aulast%3DGregg%26aufirst%3DR.%2BJ.%26aulast%3DAtkinson%26aufirst%3DR.%2BN.%26aulast%3DThomas%26aufirst%3DJ.%2BB.%26aulast%3DJohnson%26aufirst%3DM.%2BS.%26aulast%3DChapman%26aufirst%3DM.%2BL.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DKrambis%26aufirst%3DM.%2BJ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DShieh%26aufirst%3DC.-C.%26aulast%3DZhang%26aufirst%3DX.%2BF.%26aulast%3DSimler%26aufirst%3DG.%2BH.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DHonore%26aufirst%3DP.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DKnox%26aufirst%3DA.%26aulast%3DWerness%26aufirst%3DS.%26aulast%3DAntonio%26aufirst%3DB.%26aulast%3DKrafte%26aufirst%3DD.%2BS.%26aulast%3DJarvis%26aufirst%3DM.%2BF.%26aulast%3DFaltynek%26aufirst%3DC.%2BR.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DKort%26aufirst%3DM.%2BE.%26atitle%3DDiscovery%2520and%2520biological%2520evaluation%2520of%2520potent%252C%2520selective%252C%2520orally%2520bioavailable%252C%2520pyrazine-based%2520blockers%2520of%2520the%2520NaV1.8%2520sodium%2520channel%2520with%2520efficacy%2520in%2520a%2520model%2520of%2520neuropathic%2520pain%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D7816%26epage%3D7825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Imai, K.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anticoccidials., V. I.</span><span> </span><span class="NLM_article-title">An improved synthesis of 1,6-dihydro-6-oxo-2-pyrazinecarboxylic acid 4-oxide and some related derivatives and determination of anticoccidial activity</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1981&pages=88-97&author=K.-i.+Imaiauthor=M.+Manoauthor=T.+Seoauthor=T.+Matsunoauthor=V.+I.+Anticoccidials.&title=An+improved+synthesis+of+1%2C6-dihydro-6-oxo-2-pyrazinecarboxylic+acid+4-oxide+and+some+related+derivatives+and+determination+of+anticoccidial+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DImai%26aufirst%3DK.-i.%26aulast%3DMano%26aufirst%3DM.%26aulast%3DSeo%26aufirst%3DT.%26aulast%3DMatsuno%26aufirst%3DT.%26aulast%3DAnticoccidials.%26aufirst%3DV.%2BI.%26atitle%3DAn%2520improved%2520synthesis%2520of%25201%252C6-dihydro-6-oxo-2-pyrazinecarboxylic%2520acid%25204-oxide%2520and%2520some%2520related%2520derivatives%2520and%2520determination%2520of%2520anticoccidial%2520activity%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1981%26volume%3D29%26spage%3D88%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Sato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, M.</span><span> </span><span class="NLM_article-title">Studies on pyrazines. 29. Highly regioselective synthesis of chloropyrazines from 3-substituted pyrazine 1-oxides</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1177</span><span class="NLM_x">–</span> <span class="NLM_lpage">1180</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1994&pages=1177-1180&author=N.+Satoauthor=M.+Fujii&title=Studies+on+pyrazines.+29.+Highly+regioselective+synthesis+of+chloropyrazines+from+3-substituted+pyrazine+1-oxides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DN.%26aulast%3DFujii%26aufirst%3DM.%26atitle%3DStudies%2520on%2520pyrazines.%252029.%2520Highly%2520regioselective%2520synthesis%2520of%2520chloropyrazines%2520from%25203-substituted%2520pyrazine%25201-oxides%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1994%26volume%3D31%26spage%3D1177%26epage%3D1180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowdy, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polniaszek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaney, E.</span><span> </span><span class="NLM_article-title">A novel method for the mild and selective amidation of diesters and the amidation of monoesters</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1843</span><span class="NLM_x">–</span> <span class="NLM_lpage">1845</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=1843-1845&author=Z.+Guoauthor=E.+D.+Dowdyauthor=W.+S.+Liauthor=R.+Polniaszekauthor=E.+Delaney&title=A+novel+method+for+the+mild+and+selective+amidation+of+diesters+and+the+amidation+of+monoesters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DDowdy%26aufirst%3DE.%2BD.%26aulast%3DLi%26aufirst%3DW.%2BS.%26aulast%3DPolniaszek%26aufirst%3DR.%26aulast%3DDelaney%26aufirst%3DE.%26atitle%3DA%2520novel%2520method%2520for%2520the%2520mild%2520and%2520selective%2520amidation%2520of%2520diesters%2520and%2520the%2520amidation%2520of%2520monoesters%26jtitle%3DTetrahedron%2520Lett.%26date%3D2001%26volume%3D42%26spage%3D1843%26epage%3D1845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Hartwig, J. F.</span><span> </span><span class="NLM_article-title">Carbon-Heteroatom Bond-Forming Reductive Eliminations of Amines, Ethers, and Sulfides</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">852</span><span class="NLM_x">–</span> <span class="NLM_lpage">860</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar970282g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADyaK1cXlslarurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1998&pages=852-860&author=J.+F.+Hartwig&title=Carbon-Heteroatom+Bond-Forming+Reductive+Eliminations+of+Amines%2C+Ethers%2C+and+Sulfides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Carbon-Heteroatom Bond-Forming Reductive Eliminations of Amines, Ethers, and Sulfides</span></div><div class="casAuthors">Hartwig, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">852-860</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review contg. 58 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwhk-NBQWrz7Vg90H21EOLACvtfcHk0ljQBdQYPG8i7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlslarurg%253D&md5=7b47d13c6add8381090525a07c3f25b3</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Far970282g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far970282g%26sid%3Dliteratum%253Aachs%26aulast%3DHartwig%26aufirst%3DJ.%2BF.%26atitle%3DCarbon-Heteroatom%2520Bond-Forming%2520Reductive%2520Eliminations%2520of%2520Amines%252C%2520Ethers%252C%2520and%2520Sulfides%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D1998%26volume%3D31%26spage%3D852%26epage%3D860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Wolfe, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">An Improved Catalyst System for Aromatic Carbon–Nitrogen Bond Formation: The Possible Involvement of Bis(Phosphine) Palladium Complexes as Key Intermediates</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">7215</span><span class="NLM_x">–</span> <span class="NLM_lpage">7216</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja9608306" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=7215-7216&author=J.+P.+Wolfeauthor=S.+Wagawauthor=S.+L.+Buchwald&title=An+Improved+Catalyst+System+for+Aromatic+Carbon%E2%80%93Nitrogen+Bond+Formation%3A+The+Possible+Involvement+of+Bis%28Phosphine%29+Palladium+Complexes+as+Key+Intermediates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fja9608306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9608306%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DJ.%2BP.%26aulast%3DWagaw%26aufirst%3DS.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DAn%2520Improved%2520Catalyst%2520System%2520for%2520Aromatic%2520Carbon%25E2%2580%2593Nitrogen%2520Bond%2520Formation%253A%2520The%2520Possible%2520Involvement%2520of%2520Bis%2528Phosphine%2529%2520Palladium%2520Complexes%2520as%2520Key%2520Intermediates%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1996%26volume%3D118%26spage%3D7215%26epage%3D7216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arneric, S. P.</span><span> </span><span class="NLM_article-title">Nicotinic receptor binding of [<sup>3</sup>H]cytisine, [<sup>3</sup>H]nicotine and [<sup>3</sup>H]methylcarbamylcholine in rat brain</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">253</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.1016%2F0014-2999%2894%2990200-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=8200419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADyaK2cXitlKktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1994&pages=261-267&author=D.+J.+Andersonauthor=S.+P.+Arneric&title=Nicotinic+receptor+binding+of+%5B3H%5Dcytisine%2C+%5B3H%5Dnicotine+and+%5B3H%5Dmethylcarbamylcholine+in+rat+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic receptor binding of [3H]cytisine, [3H]nicotine and [3H]methylcarbamylcholine in rat brain</span></div><div class="casAuthors">Anderson, David J.; Arneric, Stephen P.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">253</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">261-7</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Three radiolabeled nicotinic receptor agonists were examd. for their binding characteristics and for inhibition by cholinergic compds. in order to distinguish possible differential affinities for subtypes of neuronal nicotinic acetylcholine receptors.  KD and Bmax values for [3H]cytisine, [3H]methylcarbamylcholine and [3H]nicotine were detd. from Scatchard anal. using an enriched whole-brain membrane fraction from male Sprague-Dawley rats.  Resp. KD values were 0.15, 1.07 and 0.89 nM while Bmax values were 99, 64 and 115 fmol/mg protein resp.  All 3 ligands fit a one-site model of receptor-ligand interaction.  Concn.-inhibition curves were used to det. Ki values for 16 cholinergic compds.  The rank order of potencies for displacement of the 3 ligands was: (-)-cytisine > (-)-nicotine > (-)-lobeline = methylcarbamylcholine > 1,1-dimethyl-4-phenylpiperazinium, (+)-nicotine, dihydro-β-erythroidine, (±)-nornicotine > carbachol > arecoline » oxotremorine, tetrahydroaminoacridine, AF102B » (-)-cotinine > RS86 = heptylphysostigmine.  Correlations of the affinities of these compds. detd. with the 3 ligands were very near to unity.  In contrast, there was a neg. correlation of affinities for [3H]cytisine compared to affinities for the muscarinic receptor agonist, [3H]oxotremorine-M, and the muscarinic receptor antagonist, [3H]quinuclidinyl benzoate.  Using membranes from whole rat brain yields data suggesting that all 3 nicotinic ligands bind to the same nicotinic acetylcholine receptor subtype, and are unable to distinguish subtypes of neuronal nicotinic acetylcholine receptor at the level examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQv_7GAAHmtrVg90H21EOLACvtfcHk0ljQBdQYPG8i7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlKktL4%253D&md5=90592741d40963821a0021fd01b1ee03</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2894%2990200-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252894%252990200-3%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DArneric%26aufirst%3DS.%2BP.%26atitle%3DNicotinic%2520receptor%2520binding%2520of%2520%255B3H%255Dcytisine%252C%2520%255B3H%255Dnicotine%2520and%2520%255B3H%255Dmethylcarbamylcholine%2520in%2520rat%2520brain%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1994%26volume%3D253%26spage%3D261%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnelle, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surber, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surowy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tribollet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marguerat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span> </span><span class="NLM_article-title">[<sup>3</sup>H]A-585539 [(1<i>S</i>,4<i>S</i>)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane], a novel high-affinity α7 neuronal nicotinic receptor agonist: radioligand binding characterization to rat and human brain</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.1124%2Fjpet.107.130062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=17959745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsF2hsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2008&pages=179-187&author=D.+J.+Andersonauthor=W.+Bunnelleauthor=B.+Surberauthor=J.+Duauthor=C.+Surowyauthor=E.+Tribolletauthor=A.+Margueratauthor=D.+Bertrandauthor=M.+Gopalakrishnan&title=%5B3H%5DA-585539+%5B%281S%2C4S%29-2%2C2-dimethyl-5-%286-phenylpyridazin-3-yl%29-5-aza-2-azoniabicyclo%5B2.2.1%5Dheptane%5D%2C+a+novel+high-affinity+%CE%B17+neuronal+nicotinic+receptor+agonist%3A+radioligand+binding+characterization+to+rat+and+human+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]A-585539 [(1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane], a novel high-affinity α7 neuronal nicotinic receptor agonist: radioligand binding characterization to rat and human brain</span></div><div class="casAuthors">Anderson, David J.; Bunnelle, William; Surber, Bruce; Du, Jia; Surowy, Carol; Tribollet, Eliane; Marguerat, Anouk; Bertrand, Daniel; Gopalakrishnan, Murali</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">179-187</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Receptor binding was characterized for [3H](1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane ([3H]A-585539), a selective high-affinity α7 nicotinic acetylcholine receptor (nAChR) agonist with rapid kinetics, low nonspecific binding, and high specific activity.  At 4, the assocn. was monophasic and rapid (t1/2=8.0 min); dissocn. was slower (t1/2=64.2 min).  The Kd in rat brain at 4 was 0.063 nM, whereas at 22 and 37, the Kd values were 0.188 and 0.95 nM, resp.  In contrast, the Bmax (34 fmol/mg protein) was unaffected by temp.  In human cortex, [3H]A-585539 bound with a Kd of 0.066 nM and a Bmax of 5.8 fmol/mg protein at 4, whereas under similar conditions, specific [3H]methyllycaconitine ([3H]MLA) binding was not measurable.  A no. of agonist and antagonist nAChR ligands displaced binding to rat brain membranes with rank order of affinity similar to that for [3H]MLA, and in general, a 5 to 10-fold higher affinity was obsd. for [3H]A-585539 binding.  There was also a good correlation of Ki values between [3H]A-585539 binding to rat brain and human cortex.  The use of a α7/5-hydroxytryptamine type-3 chimera revealed that the N-terminal domain of α7 nAChR was sufficient to faithfully reproduce the pharmacol. of [3H]A-585539 binding.  Autoradiog. studies comparing [3H]A-585539 and [125I]α-bungarotoxin revealed a similar pattern of labeling in the rat.  In summary, [3H]A-585539 was shown to have excellent binding characteristics in rat and human brain and represents the first high-affinity α7 agonist radioligand with utility in the characterization of this important nAChR subtype that is targeted toward ameliorating cognitive deficits underlying neuropsychiatric and neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqji4MU_Eu8BrVg90H21EOLACvtfcHk0ljQBdQYPG8i7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsF2hsQ%253D%253D&md5=b7ebce829957073aba16e25cb1d4ee63</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.130062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.130062%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DBunnelle%26aufirst%3DW.%26aulast%3DSurber%26aufirst%3DB.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DSurowy%26aufirst%3DC.%26aulast%3DTribollet%26aufirst%3DE.%26aulast%3DMarguerat%26aufirst%3DA.%26aulast%3DBertrand%26aufirst%3DD.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26atitle%3D%255B3H%255DA-585539%2520%255B%25281S%252C4S%2529-2%252C2-dimethyl-5-%25286-phenylpyridazin-3-yl%2529-5-aza-2-azoniabicyclo%255B2.2.1%255Dheptane%255D%252C%2520a%2520novel%2520high-affinity%2520%25CE%25B17%2520neuronal%2520nicotinic%2520receptor%2520agonist%253A%2520radioligand%2520binding%2520characterization%2520to%2520rat%2520and%2520human%2520brain%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D324%26spage%3D179%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Kuntzweiler, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arneric, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnelly-Roberts, D. L.</span><span> </span><span class="NLM_article-title">Rapid assessment of ligand actions with nicotinic acetylcholine receptors using calcium dynamics and FLIPR</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">14</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1998&pages=14-20&author=T.+A.+Kuntzweilerauthor=S.+P.+Arnericauthor=D.+L.+Donnelly-Roberts&title=Rapid+assessment+of+ligand+actions+with+nicotinic+acetylcholine+receptors+using+calcium+dynamics+and+FLIPR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuntzweiler%26aufirst%3DT.%2BA.%26aulast%3DArneric%26aufirst%3DS.%2BP.%26aulast%3DDonnelly-Roberts%26aufirst%3DD.%2BL.%26atitle%3DRapid%2520assessment%2520of%2520ligand%2520actions%2520with%2520nicotinic%2520acetylcholine%2520receptors%2520using%2520calcium%2520dynamics%2520and%2520FLIPR%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1998%26volume%3D44%26spage%3D14%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Gronlien, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakerud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ween, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorin-Hagene, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs Clark, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malysz, J.</span><span> </span><span class="NLM_article-title">Distinct profiles of α7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">715</span><span class="NLM_x">–</span> <span class="NLM_lpage">724</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=715-724&author=J.+H.+Gronlienauthor=M.+Hakerudauthor=H.+Weenauthor=K.+Thorin-Hageneauthor=A.+Briggs+Clarkauthor=M.+Gopalakrishnanauthor=J.+Malysz&title=Distinct+profiles+of+%CE%B17+nAChR+positive+allosteric+modulation+revealed+by+structurally+diverse+chemotypes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGronlien%26aufirst%3DJ.%2BH.%26aulast%3DHakerud%26aufirst%3DM.%26aulast%3DWeen%26aufirst%3DH.%26aulast%3DThorin-Hagene%26aufirst%3DK.%26aulast%3DBriggs%2BClark%26aufirst%3DA.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26aulast%3DMalysz%26aufirst%3DJ.%26atitle%3DDistinct%2520profiles%2520of%2520%25CE%25B17%2520nAChR%2520positive%2520allosteric%2520modulation%2520revealed%2520by%2520structurally%2520diverse%2520chemotypes%26jtitle%3DMol.%2520Pharmacol.%26date%3D2007%26volume%3D72%26spage%3D715%26epage%3D724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukat, M.</span><span> </span><span class="NLM_article-title">α4β2 nACh Receptor pharmacophore models</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1841</span><span class="NLM_x">–</span> <span class="NLM_lpage">1844</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1841-1844&author=R.+A.+Glennonauthor=M.+Dukat&title=%CE%B14%CE%B22+nACh+Receptor+pharmacophore+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DDukat%26aufirst%3DM.%26atitle%3D%25CE%25B14%25CE%25B22%2520nACh%2520Receptor%2520pharmacophore%2520models%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D1841%26epage%3D1844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Tonder, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olesen, P. H.</span><span> </span><span class="NLM_article-title">Agonists at the α4β2 nicotinic acetylcholine receptors: structure–activity relationships and molecular modeling</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">651</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.2174%2F0929867013373165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=11281847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivVClt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=651-674&author=J.+E.+Tonderauthor=P.+H.+Olesen&title=Agonists+at+the+%CE%B14%CE%B22+nicotinic+acetylcholine+receptors%3A+structure%E2%80%93activity+relationships+and+molecular+modeling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Agonists at the α4β2 nicotinic acetylcholine receptors: structure-activity relationships and molecular modeling</span></div><div class="casAuthors">Tonder, J. E.; Olesen, P. H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">651-674</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review with 87 refs.  Agonists of the 42 nicotinic acetylcholine receptors have been synthesized as potential drugs for treatment of a variety of diseases.  In this review, the published nicotinic agonists are presented and, on the basis of the mol. structure, the compds. are divided into three compd. classes, nicotinoids (structurally close to nicotine), bicyclic compds. (structurally close to epibatidine and anatoxin-a), and analogs of imidacloprid (structurally close to the insecticide imidacloprid).  The structure-activity relationships are discussed within and in between the classes.  On the basis of computational studies of ligands for the nicotinic acetylcholine receptors the structure-activity relationships are discussed and a possible binding mode suggested.  The binding mode encompasses: (A) an interaction between an anionic site in the receptor and the protonated nitrogen atom in the ligand, (B) a hydrogen bond between a hydrogen bond donor in the receptor and a hydrogen bond acceptor in the ligand, (C) an interaction between a π-system (heteroarom. ring, carbonyl bond) in the ligand and another π-system or a pos. charged amino acid residue in the binding site, (D) a π-cation interaction between arom. residues in the receptor binding site and the protonated nitrogen atom in the ligand, and (E) steric interactions of pos. and neg. character around the aliph. and the heteroarom. part of the ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIhzcXIYiPlLVg90H21EOLACvtfcHk0lgJxqVQuialyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivVClt7g%253D&md5=cd64d243cfc42ea4696ad43dd1c59bd4</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.2174%2F0929867013373165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867013373165%26sid%3Dliteratum%253Aachs%26aulast%3DTonder%26aufirst%3DJ.%2BE.%26aulast%3DOlesen%26aufirst%3DP.%2BH.%26atitle%3DAgonists%2520at%2520the%2520%25CE%25B14%25CE%25B22%2520nicotinic%2520acetylcholine%2520receptors%253A%2520structure%25E2%2580%2593activity%2520relationships%2520and%2520molecular%2520modeling%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2001%26volume%3D8%26spage%3D651%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Zhong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallivan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lester, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougherty, D. A.</span><span> </span><span class="NLM_article-title">From ab initio quantum mechanics to molecular neurobiology: a cation−π binding site in the nicotinic receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">12088</span><span class="NLM_x">–</span> <span class="NLM_lpage">12093</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=12088-12093&author=W.+Zhongauthor=J.+P.+Gallivanauthor=Y.+Zhangauthor=L.+Liauthor=H.+A.+Lesterauthor=D.+A.+Dougherty&title=From+ab+initio+quantum+mechanics+to+molecular+neurobiology%3A+a+cation%E2%88%92%CF%80+binding+site+in+the+nicotinic+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DGallivan%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLester%26aufirst%3DH.%2BA.%26aulast%3DDougherty%26aufirst%3DD.%2BA.%26atitle%3DFrom%2520ab%2520initio%2520quantum%2520mechanics%2520to%2520molecular%2520neurobiology%253A%2520a%2520cation%25E2%2588%2592%25CF%2580%2520binding%2520site%2520in%2520the%2520nicotinic%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D12088%26epage%3D12093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Beene, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zacharias, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lester, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougherty, D. A.</span><span> </span><span class="NLM_article-title">Cation−π interactions in ligand recognition by serotonergic (5-HT<sub>3A</sub>) and nicotinic acetylcholine receptors: the anomalous binding properties of nicotine</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">10262</span><span class="NLM_x">–</span> <span class="NLM_lpage">10269</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi020266d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=10262-10269&author=D.+L.+Beeneauthor=G.+S.+Brandtauthor=W.+Zhongauthor=N.+M.+Zachariasauthor=H.+A.+Lesterauthor=D.+A.+Dougherty&title=Cation%E2%88%92%CF%80+interactions+in+ligand+recognition+by+serotonergic+%285-HT3A%29+and+nicotinic+acetylcholine+receptors%3A+the+anomalous+binding+properties+of+nicotine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fbi020266d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi020266d%26sid%3Dliteratum%253Aachs%26aulast%3DBeene%26aufirst%3DD.%2BL.%26aulast%3DBrandt%26aufirst%3DG.%2BS.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DZacharias%26aufirst%3DN.%2BM.%26aulast%3DLester%26aufirst%3DH.%2BA.%26aulast%3DDougherty%26aufirst%3DD.%2BA.%26atitle%3DCation%25E2%2588%2592%25CF%2580%2520interactions%2520in%2520ligand%2520recognition%2520by%2520serotonergic%2520%25285-HT3A%2529%2520and%2520nicotinic%2520acetylcholine%2520receptors%253A%2520the%2520anomalous%2520binding%2520properties%2520of%2520nicotine%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D10262%26epage%3D10269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Xiu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puskar, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanata, J. A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lester, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougherty, D. A.</span><span> </span><span class="NLM_article-title">Nicotine binding to brain receptors requires a strong cation−π interaction</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">458</span><span class="NLM_x">, </span> <span class="NLM_fpage">534</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=458&publication_year=2009&pages=534-537&author=X.+Xiuauthor=N.+L.+Puskarauthor=J.+A.+P.+Shanataauthor=H.+A.+Lesterauthor=D.+A.+Dougherty&title=Nicotine+binding+to+brain+receptors+requires+a+strong+cation%E2%88%92%CF%80+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXiu%26aufirst%3DX.%26aulast%3DPuskar%26aufirst%3DN.%2BL.%26aulast%3DShanata%26aufirst%3DJ.%2BA.%2BP.%26aulast%3DLester%26aufirst%3DH.%2BA.%26aulast%3DDougherty%26aufirst%3DD.%2BA.%26atitle%3DNicotine%2520binding%2520to%2520brain%2520receptors%2520requires%2520a%2520strong%2520cation%25E2%2588%2592%25CF%2580%2520interaction%26jtitle%3DNature%26date%3D2009%26volume%3D458%26spage%3D534%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Toma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quadrelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cignarella, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlocco, D.</span><span> </span><span class="NLM_article-title">6-Chloropyridazin-3-yl Derivatives Active as Nicotinic Agents: Synthesis, Binding, and Modeling Studies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4011</span><span class="NLM_x">–</span> <span class="NLM_lpage">4017</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0208830" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4011-4017&author=L.+Tomaauthor=P.+Quadrelliauthor=W.+H.+Bunnelleauthor=D.+J.+Andersonauthor=M.+D.+Meyerauthor=G.+Cignarellaauthor=A.+Gelainauthor=D.+Barlocco&title=6-Chloropyridazin-3-yl+Derivatives+Active+as+Nicotinic+Agents%3A+Synthesis%2C+Binding%2C+and+Modeling+Studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fjm0208830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0208830%26sid%3Dliteratum%253Aachs%26aulast%3DToma%26aufirst%3DL.%26aulast%3DQuadrelli%26aufirst%3DP.%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26aulast%3DCignarella%26aufirst%3DG.%26aulast%3DGelain%26aufirst%3DA.%26aulast%3DBarlocco%26aufirst%3DD.%26atitle%3D6-Chloropyridazin-3-yl%2520Derivatives%2520Active%2520as%2520Nicotinic%2520Agents%253A%2520Synthesis%252C%2520Binding%252C%2520and%2520Modeling%2520Studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D4011%26epage%3D4017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Dukat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Zahabi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Synthesis, receptor binding and QSAR studies on 6-substituted nicotine derivatives as cholinergic ligands</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1999&pages=31-40&author=M.+Dukatauthor=M.+Dowdauthor=M.+I.+Damajauthor=B.+Martinauthor=M.+A.+El-Zahabiauthor=R.+A.+Glennon&title=Synthesis%2C+receptor+binding+and+QSAR+studies+on+6-substituted+nicotine+derivatives+as+cholinergic+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDukat%26aufirst%3DM.%26aulast%3DDowd%26aufirst%3DM.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DMartin%26aufirst%3DB.%26aulast%3DEl-Zahabi%26aufirst%3DM.%2BA.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DSynthesis%252C%2520receptor%2520binding%2520and%2520QSAR%2520studies%2520on%25206-substituted%2520nicotine%2520derivatives%2520as%2520cholinergic%2520ligands%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D1999%26volume%3D34%26spage%3D31%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Briggs, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubbins, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Putman, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thimmapaya, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surowy, C. S.</span><span> </span><span class="NLM_article-title">Untranslated region-dependent exclusive expression of high-sensitivity subforms of α4β2 and α3β2 nicotinic acetylcholine receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=227-240&author=C.+A.+Briggsauthor=E.+J.+Gubbinsauthor=M.+J.+Marksauthor=C.+B.+Putmanauthor=R.+Thimmapayaauthor=M.+D.+Meyerauthor=C.+S.+Surowy&title=Untranslated+region-dependent+exclusive+expression+of+high-sensitivity+subforms+of+%CE%B14%CE%B22+and+%CE%B13%CE%B22+nicotinic+acetylcholine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBriggs%26aufirst%3DC.%2BA.%26aulast%3DGubbins%26aufirst%3DE.%2BJ.%26aulast%3DMarks%26aufirst%3DM.%2BJ.%26aulast%3DPutman%26aufirst%3DC.%2BB.%26aulast%3DThimmapaya%26aufirst%3DR.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26aulast%3DSurowy%26aufirst%3DC.%2BS.%26atitle%3DUntranslated%2520region-dependent%2520exclusive%2520expression%2520of%2520high-sensitivity%2520subforms%2520of%2520%25CE%25B14%25CE%25B22%2520and%2520%25CE%25B13%25CE%25B22%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D227%26epage%3D240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Coe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetelino, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirtz, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sands, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebel, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrikhande, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heym, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaeffer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rollema, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansbach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovetti, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tingley, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span> </span><span class="NLM_article-title">Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3474</span><span class="NLM_x">–</span> <span class="NLM_lpage">3477</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050069n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3474-3477&author=J.+W.+Coeauthor=P.+R.+Brooksauthor=M.+G.+Vetelinoauthor=M.+C.+Wirtzauthor=E.+P.+Arnoldauthor=J.+Huangauthor=S.+B.+Sandsauthor=T.+I.+Davisauthor=L.+A.+Lebelauthor=C.+B.+Foxauthor=A.+Shrikhandeauthor=J.+H.+Heymauthor=E.+Schaefferauthor=H.+Rollemaauthor=Y.+Luauthor=R.+S.+Mansbachauthor=L.+K.+Chambersauthor=C.+C.+Rovettiauthor=D.+W.+Schulzauthor=F.+D.+Tingleyauthor=B.+T.+O%E2%80%99Neill&title=Varenicline%3A+An+%CE%B14%CE%B22+Nicotinic+Receptor+Partial+Agonist+for+Smoking+Cessation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm050069n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050069n%26sid%3Dliteratum%253Aachs%26aulast%3DCoe%26aufirst%3DJ.%2BW.%26aulast%3DBrooks%26aufirst%3DP.%2BR.%26aulast%3DVetelino%26aufirst%3DM.%2BG.%26aulast%3DWirtz%26aufirst%3DM.%2BC.%26aulast%3DArnold%26aufirst%3DE.%2BP.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DSands%26aufirst%3DS.%2BB.%26aulast%3DDavis%26aufirst%3DT.%2BI.%26aulast%3DLebel%26aufirst%3DL.%2BA.%26aulast%3DFox%26aufirst%3DC.%2BB.%26aulast%3DShrikhande%26aufirst%3DA.%26aulast%3DHeym%26aufirst%3DJ.%2BH.%26aulast%3DSchaeffer%26aufirst%3DE.%26aulast%3DRollema%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMansbach%26aufirst%3DR.%2BS.%26aulast%3DChambers%26aufirst%3DL.%2BK.%26aulast%3DRovetti%26aufirst%3DC.%2BC.%26aulast%3DSchulz%26aufirst%3DD.%2BW.%26aulast%3DTingley%26aufirst%3DF.%2BD.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DVarenicline%253A%2520An%2520%25CE%25B14%25CE%25B22%2520Nicotinic%2520Receptor%2520Partial%2520Agonist%2520for%2520Smoking%2520Cessation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3474%26epage%3D3477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Cohen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergis, O. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lochead, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jegham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonardon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avenet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sgard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besnard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coste, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oblin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voltz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caille, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrault, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soubrie, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scatton, B.</span><span> </span><span class="NLM_article-title">SSR591813, a novel selective and partial α4β2 nicotinic receptor agonist with potential as an aid to smoking cessation</span> <span class="citation_source-journal">J. Pharmacol. Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.1124%2Fjpet.103.049262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=12682217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvF2ks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2003&pages=407-420&author=C.+Cohenauthor=O.+E.+Bergisauthor=F.+Galliauthor=A.+W.+Locheadauthor=S.+Jeghamauthor=B.+Bitonauthor=J.+Leonardonauthor=P.+Avenetauthor=F.+Sgardauthor=F.+Besnardauthor=D.+Grahamauthor=A.+Costeauthor=A.+Oblinauthor=O.+Curetauthor=C.+Voltzauthor=A.+Gardesauthor=D.+Cailleauthor=G.+Perraultauthor=P.+Georgeauthor=P.+Soubrieauthor=B.+Scatton&title=SSR591813%2C+a+novel+selective+and+partial+%CE%B14%CE%B22+nicotinic+receptor+agonist+with+potential+as+an+aid+to+smoking+cessation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">SSR591813, a novel selective and partial α4β2 nicotinic receptor agonist with potential as an aid to smoking cessation</span></div><div class="casAuthors">Cohen, C.; Bergis, O. E.; Galli, F.; Lochead, A. W.; Jegham, S.; Biton, B.; Leonardon, J.; Avenet, P.; Sgard, F.; Besnard, F.; Graham, D.; Coste, A.; Oblin, A.; Curet, O.; Voltz, C.; Gardes, A.; Caille, D.; Perrault, G.; George, P.; Soubrie, P.; Scatton, B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">306</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">407-420</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">(5AS,8S,10aR)-5a,6,9,10-Tetrahydro,7H,11H-8,10a-methanopyrido[2',3':5,6]pyrano[2,3-d]azepine (SSR591813) is a novel compd. that binds with high affinity to the rat and human α4β2 nicotinic acetylcholine receptor (nAChR) subtypes (Ki = 107 and 36 nM, resp.) and displays selectivity for the α4β2 nAChR (Ki, human α3β4 > 1000, α3β2 = 116; α1β1δγ > 6000 nM and rat α7 > 6000 nM).  Electrophysiol. expts. indicate that SSR591813 is a partial agonist at the human α4β2 nAChR subtype (EC50 = 1.3 μM, IA = 19% compared with the full agonist 1,1-dimethyl-4-phenyl-piperazinium).  In vivo findings from microdialysis and drug discrimination studies confirm the partial intrinsic activity of SSR591813.  The drug increases dopamine release in the nucleus accumbens shell (30 mg/kg i.p.) and generalizes to nicotine or amphetamine (10-20 mg/kg i.p.) in rats, with an efficacy approx. 2-fold lower than that of nicotine.  Pretreatment with SSR591813 (10 mg/kg i.p.) reduces the dopamine-releasing and discriminative effects of nicotine.  SSR591813 shows activity in animal models of nicotine dependence at doses devoid of unwanted side effects typically obsd. with nicotine (hypothermia and cardiovascular effects).  The compd. (10 mg/kg i.p.) also prevents withdrawal signs pptd. by mecamylamine in nicotine-dependent rats and partially blocks the discriminative cue of an acute pptd. withdrawal.  SSR591813 (20 mg/kg i.p.) reduces i.v. nicotine self-administration and antagonizes nicotine-induced behavioral sensitization in rats.  The present results confirm important role for α4β2 nAChRs in mediating nicotine dependence and suggest that SSR591813, a partial agonist at this particular nAChR subtype, may have therapeutic potential in the clin. management of smoking cessation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv69IRULvV7rVg90H21EOLACvtfcHk0lgB2xBA_ODWJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvF2ks7g%253D&md5=5153094293dbf94ad94165cc830007fa</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.049262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.049262%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DC.%26aulast%3DBergis%26aufirst%3DO.%2BE.%26aulast%3DGalli%26aufirst%3DF.%26aulast%3DLochead%26aufirst%3DA.%2BW.%26aulast%3DJegham%26aufirst%3DS.%26aulast%3DBiton%26aufirst%3DB.%26aulast%3DLeonardon%26aufirst%3DJ.%26aulast%3DAvenet%26aufirst%3DP.%26aulast%3DSgard%26aufirst%3DF.%26aulast%3DBesnard%26aufirst%3DF.%26aulast%3DGraham%26aufirst%3DD.%26aulast%3DCoste%26aufirst%3DA.%26aulast%3DOblin%26aufirst%3DA.%26aulast%3DCuret%26aufirst%3DO.%26aulast%3DVoltz%26aufirst%3DC.%26aulast%3DGardes%26aufirst%3DA.%26aulast%3DCaille%26aufirst%3DD.%26aulast%3DPerrault%26aufirst%3DG.%26aulast%3DGeorge%26aufirst%3DP.%26aulast%3DSoubrie%26aufirst%3DP.%26aulast%3DScatton%26aufirst%3DB.%26atitle%3DSSR591813%252C%2520a%2520novel%2520selective%2520and%2520partial%2520%25CE%25B14%25CE%25B22%2520nicotinic%2520receptor%2520agonist%2520with%2520potential%2520as%2520an%2520aid%2520to%2520smoking%2520cessation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%26date%3D2003%26volume%3D306%26spage%3D407%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Lippiello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letchworth, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatto, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traina, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bencherif, M.</span><span> </span><span class="NLM_article-title">Ispronicline: a novel α4β2 nicotinic acetylcholine receptor-selective agonist with cognition-enhancing and neuroprotective properties</span> <span class="citation_source-journal">J. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.1385%2FJMN%3A30%3A1%3A19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=17192610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlWgtbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2006&pages=19-20&author=P.+Lippielloauthor=S.+R.+Letchworthauthor=G.+J.+Gattoauthor=V.+M.+Trainaauthor=M.+Bencherif&title=Ispronicline%3A+a+novel+%CE%B14%CE%B22+nicotinic+acetylcholine+receptor-selective+agonist+with+cognition-enhancing+and+neuroprotective+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Ispronicline: a novel α4β2 nicotinic acetylcholine receptor-selective agonist with cognition-enhancing and neuroprotective properties</span></div><div class="casAuthors">Lippiello, Patrick; Letchworth, Sharon R.; Gatto, Gregory J.; Traina, Vincent M.; Bencherif, Merouane</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">19-20</span>CODEN:
                <span class="NLM_cas:coden">JMNEES</span>;
        ISSN:<span class="NLM_cas:issn">0895-8696</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A novel nAChR partial agonist, ispronicline, demonstrated a marked sepn. between beneficial effects and side effects in several in vitro and animal models.  Results from phase-I clin. studies demonstrated ispronicline's tolerability and pos. safety profile.  The pharmacol., pharmacokinetic, and safety profile of ispronicline provides an example of a well-tolerated and potent neuronal nAChR modulator that holds promise for the management of neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcfsNtTOo-w7Vg90H21EOLACvtfcHk0ligcNMqEOdsvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlWgtbfF&md5=80a71d8166807732d5ccdc534e2f8d8d</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1385%2FJMN%3A30%3A1%3A19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FJMN%253A30%253A1%253A19%26sid%3Dliteratum%253Aachs%26aulast%3DLippiello%26aufirst%3DP.%26aulast%3DLetchworth%26aufirst%3DS.%2BR.%26aulast%3DGatto%26aufirst%3DG.%2BJ.%26aulast%3DTraina%26aufirst%3DV.%2BM.%26aulast%3DBencherif%26aufirst%3DM.%26atitle%3DIspronicline%253A%2520a%2520novel%2520%25CE%25B14%25CE%25B22%2520nicotinic%2520acetylcholine%2520receptor-selective%2520agonist%2520with%2520cognition-enhancing%2520and%2520neuroprotective%2520properties%26jtitle%3DJ.%2520Mol.%2520Neurosci.%26date%3D2006%26volume%3D30%26spage%3D19%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Mihalak, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luetje, C. W.</span><span> </span><span class="NLM_article-title">Varenicline is a partial agonist at α4β2 and a full agonist at α7 neuronal nicotinic receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">805</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=801-805&author=K.+B.+Mihalakauthor=I.+Carrollauthor=C.+W.+Luetje&title=Varenicline+is+a+partial+agonist+at+%CE%B14%CE%B22+and+a+full+agonist+at+%CE%B17+neuronal+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMihalak%26aufirst%3DK.%2BB.%26aulast%3DCarroll%26aufirst%3DI.%26aulast%3DLuetje%26aufirst%3DC.%2BW.%26atitle%3DVarenicline%2520is%2520a%2520partial%2520agonist%2520at%2520%25CE%25B14%25CE%25B22%2520and%2520a%2520full%2520agonist%2520at%2520%25CE%25B17%2520neuronal%2520nicotinic%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D801%26epage%3D805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 5 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oluseye K.  Onajole</span>, <span class="hlFld-ContribAuthor ">J. Brek  Eaton</span>, <span class="hlFld-ContribAuthor ">Ronald J.  Lukas</span>, <span class="hlFld-ContribAuthor ">Dani  Brunner</span>, <span class="hlFld-ContribAuthor ">Lucinda  Thiede</span>, <span class="hlFld-ContribAuthor ">Barbara J.  Caldarone</span>, and <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>  . </span><span class="cited-content_cbyCitation_article-title">Enantiopure Cyclopropane-Bearing Pyridyldiazabicyclo[3.3.0]octanes as Selective α4β2-nAChR Ligands. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>5 </em>
                                    (11)
                                     , 1196-1201. <a href="https://doi.org/10.1021/ml500129k" title="DOI URL">https://doi.org/10.1021/ml500129k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml500129k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml500129k%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DEnantiopure%252BCyclopropane-Bearing%252BPyridyldiazabicyclo%25255B3.3.0%25255Doctanes%252Bas%252BSelective%252B%2525CE%2525B14%2525CE%2525B22-nAChR%252BLigands%26aulast%3DOnajole%26aufirst%3DOluseye%2BK.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D29032014%26date%3D29092014%26date%3D01102014%26date%3D13112014%26date%3D29092014%26volume%3D5%26issue%3D11%26spage%3D1196%26epage%3D1201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Boris A.  Trofimov</span>, <span class="hlFld-ContribAuthor ">Ludmila V.  Andriyankova</span>, <span class="hlFld-ContribAuthor ">Lina P.  Nikitina</span>, <span class="hlFld-ContribAuthor ">Kseniya V.  Belyaeva</span>, <span class="hlFld-ContribAuthor ">Anastasia G.  Mal’kina</span>, <span class="hlFld-ContribAuthor ">Lubov N.  Sobenina</span>, <span class="hlFld-ContribAuthor ">Andrei V.  Afonin</span>, and <span class="hlFld-ContribAuthor ">Igor A.  Ushakov</span>  . </span><span class="cited-content_cbyCitation_article-title">Stereoselective Tandem Ring Opening of Imidazoles with Electron-Deficient Acetylenes and Water: Synthesis of Functionalized (Z,Z)-1,4-Diaza-2,5-dienes. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2013,</strong> <em>15 </em>
                                    (9)
                                     , 2322-2324. <a href="https://doi.org/10.1021/ol400844x" title="DOI URL">https://doi.org/10.1021/ol400844x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol400844x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol400844x%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DStereoselective%252BTandem%252BRing%252BOpening%252Bof%252BImidazoles%252Bwith%252BElectron-Deficient%252BAcetylenes%252Band%252BWater%25253A%252BSynthesis%252Bof%252BFunctionalized%252B%252528Z%25252CZ%252529-1%25252C4-Diaza-2%25252C5-dienes%26aulast%3DTrofimov%26aufirst%3DBoris%2BA.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D27032013%26date%3D25042013%26date%3D03052013%26volume%3D15%26issue%3D9%26spage%3D2322%26epage%3D2324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shankar D.  Markad</span>, <span class="hlFld-ContribAuthor ">Parvinder  Kaur</span>, <span class="hlFld-ContribAuthor ">B. K.  Kishore Reddy</span>, <span class="hlFld-ContribAuthor ">Murugan  Chinnapattu</span>, <span class="hlFld-ContribAuthor ">Anandkumar  Raichurkar</span>, <span class="hlFld-ContribAuthor ">Radha  Nandishaiah</span>, <span class="hlFld-ContribAuthor ">Manoranjan  Panda</span>, <span class="hlFld-ContribAuthor ">Pravin S.  Iyer</span>. </span><span class="cited-content_cbyCitation_article-title">Novel lead generation of an anti-tuberculosis agent active against non-replicating mycobacteria: exploring hybridization of pyrazinamide with multiple fragments. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2015,</strong> <em>24 </em>
                                    (7)
                                     , 2986-2992. <a href="https://doi.org/10.1007/s00044-015-1352-6" title="DOI URL">https://doi.org/10.1007/s00044-015-1352-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-015-1352-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-015-1352-6%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DNovel%252Blead%252Bgeneration%252Bof%252Ban%252Banti-tuberculosis%252Bagent%252Bactive%252Bagainst%252Bnon-replicating%252Bmycobacteria%25253A%252Bexploring%252Bhybridization%252Bof%252Bpyrazinamide%252Bwith%252Bmultiple%252Bfragments%26aulast%3DMarkad%26aufirst%3DShankar%2BD.%26date%3D2015%26date%3D2015%26volume%3D24%26issue%3D7%26spage%3D2986%26epage%3D2992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Liu</span>, <span class="hlFld-ContribAuthor ">Mikell  Paige</span>, <span class="hlFld-ContribAuthor ">Thao T.  Olson</span>, <span class="hlFld-ContribAuthor ">Nour  Al-Muhtasib</span>, <span class="hlFld-ContribAuthor ">Teresa  Xie</span>, <span class="hlFld-ContribAuthor ">Shujie  Hou</span>, <span class="hlFld-ContribAuthor ">Michael P.  White</span>, <span class="hlFld-ContribAuthor ">Antoinette  Cordova</span>, <span class="hlFld-ContribAuthor ">Jessica L.  Guo</span>, <span class="hlFld-ContribAuthor ">Kenneth J.  Kellar</span>, <span class="hlFld-ContribAuthor ">Yingxian  Xiao</span>, <span class="hlFld-ContribAuthor ">Milton L.  Brown</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and pharmacological characterization of new neuronal nicotinic acetylcholine receptor ligands derived from Sazetidine-A. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (13)
                                     , 2954-2956. <a href="https://doi.org/10.1016/j.bmcl.2014.04.036" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.04.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.04.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.04.036%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bpharmacological%252Bcharacterization%252Bof%252Bnew%252Bneuronal%252Bnicotinic%252Bacetylcholine%252Breceptor%252Bligands%252Bderived%252Bfrom%252BSazetidine-A%26aulast%3DLiu%26aufirst%3DYong%26date%3D2014%26volume%3D24%26issue%3D13%26spage%3D2954%26epage%3D2956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicolai I.  Nikishkin</span>, <span class="hlFld-ContribAuthor ">Jurriaan  Huskens</span>, <span class="hlFld-ContribAuthor ">Seraj A.  Ansari</span>, <span class="hlFld-ContribAuthor ">Prasanta K.  Mohapatra</span>, <span class="hlFld-ContribAuthor ">Willem  Verboom</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrazine-functionalized calix[4]arenes: synthesis by palladium-catalyzed cross-coupling with phosphorus pronucleophiles and metal ion extraction properties. </span><span class="cited-content_cbyCitation_journal-name">New J. Chem.</span><span> <strong>2013,</strong> <em>37 </em>
                                    (2)
                                     , 391-402. <a href="https://doi.org/10.1039/C2NJ40791D" title="DOI URL">https://doi.org/10.1039/C2NJ40791D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C2NJ40791D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC2NJ40791D%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520J.%2520Chem.%26atitle%3DPyrazine-functionalized%252Bcalix%25255B4%25255Darenes%25253A%252Bsynthesis%252Bby%252Bpalladium-catalyzed%252Bcross-coupling%252Bwith%252Bphosphorus%252Bpronucleophiles%252Band%252Bmetal%252Bion%252Bextraction%252Bproperties%26aulast%3DNikishkin%26aufirst%3DNicolai%2BI.%26date%3D2013%26date%3D2013%26volume%3D37%26issue%3D2%26spage%3D391%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/medium/jm-2011-01045m_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201045m&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/medium/jm-2011-01045m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0001.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. ABT-089 and new α4β2 nAChR ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201045m&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/medium/jm-2011-01045m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201045m&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) K<sub>2</sub>CO<sub>3</sub>, DMSO; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/medium/jm-2011-01045m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201045m&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) <i>m</i>CPBA, 1,2-dichloroethane; (b) SOCl<sub>2</sub>.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/medium/jm-2011-01045m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201045m&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) Na<sub>2</sub>CO<sub>3</sub>, DMSO; (b) NaOH, H<sub>2</sub>O/EtOH; (c) H<sub>2</sub>NR, EDCI, HOBt, DMAP, CH<sub>2</sub>Cl<sub>2</sub>; (d) TFA, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/medium/jm-2011-01045m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201045m&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) MgCl<sub>2</sub>, NHR<sup>1</sup>R<sup>2</sup>, THF; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/medium/jm-2011-01045m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201045m&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) MgCl<sub>2</sub>, 2-methylbenzylamine, THF; (b) <b>38</b>, <b>60</b>, or <b>61</b>, Na<sub>2</sub>CO<sub>3</sub>, DMSO; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub></p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/medium/jm-2011-01045m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201045m&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) NaOH, H<sub>2</sub>O/EtOH; (b) oxalyl chloride, cat. DMF, CH<sub>2</sub>Cl<sub>2</sub>; (c) NH<sub>2</sub>R<sup>1</sup>, TEA, CH<sub>2</sub>Cl<sub>2</sub>; (d) <b>38</b> or <b>61</b>, Na<sub>2</sub>CO<sub>3</sub>, DMSO; (e) TFA, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure data-id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/medium/jm-2011-01045m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201045m&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) NHR<sup>1</sup>R<sup>2</sup>, EDCI, HOBt, DMAP, CH<sub>2</sub>Cl<sub>2</sub>; (b) <b>38</b> or <b>60</b>, Pd<sub>2</sub>(dba)<sub>3</sub>, BINAP, NaO<i>t</i>Bu, toluene; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure data-id="sch8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/medium/jm-2011-01045m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 8. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201045m&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) <b>38</b>, Pd<sub>2</sub>(dba)<sub>3</sub>, xantphos, Cs<sub>2</sub>CO<sub>3</sub>, dioxane; (b) NaOH, H<sub>2</sub>O/EtOH; (c) NHR<sup>1</sup>R<sup>2</sup>, EDCI, HOBt, DMAP, CH<sub>2</sub>Cl<sub>2</sub>; (d) TFA, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure data-id="sch9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/medium/jm-2011-01045m_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 9. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-21/jm201045m/production/images/large/jm-2011-01045m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201045m&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) <b>38</b>, K<sub>2</sub>CO<sub>3</sub>, DMSO; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i81">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31006" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31006" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 72 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">D’Hoedt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, D.</span><span> </span><span class="NLM_article-title">Nicotinic acetylcholine receptors: an overview on drug discovery</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.1517%2F14728220902841045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=19335063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvVWgu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=395-411&author=D.+D%E2%80%99Hoedtauthor=D.+Bertrand&title=Nicotinic+acetylcholine+receptors%3A+an+overview+on+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic acetylcholine receptors: an overview on drug discovery</span></div><div class="casAuthors">D'hoedt, Dieter; Bertrand, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">395-411</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels that participate in many physiol. functions.  Receptors result from the assembly of five homologous or heterologous subunits that form the ligand-binding site and an ionic pore.  In vertebrates, 17 subunits have been identified, α (1-10), β (1-4), γ, δ, and ε.  Assembly of different subunit combinations allows a diversity of physiol. and pharmacol. properties.  To review the putative involvement of nAChRs in several diseases.  We discuss the expression pattern of the subunits, the pharmacol. tools for distinguishing them and their role in pathogenesis.  Long-standing efforts in this field should soon result in the finding of new mols. that might be applicable to situations ranging from neurol. diseases to immune treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNauxQ9KPdwbVg90H21EOLACvtfcHk0lhfYMOcoZUMow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvVWgu7c%253D&md5=e06b154c3c32685edf6778332e239bc6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1517%2F14728220902841045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728220902841045%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Hoedt%26aufirst%3DD.%26aulast%3DBertrand%26aufirst%3DD.%26atitle%3DNicotinic%2520acetylcholine%2520receptors%253A%2520an%2520overview%2520on%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2009%26volume%3D13%26spage%3D395%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Arneric, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holladay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span> </span><span class="NLM_article-title">Neuronal nicotinic receptors: A perspective on two decades of drug discovery research</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1092</span><span class="NLM_x">–</span> <span class="NLM_lpage">1101</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2007&pages=1092-1101&author=S.+P.+Arnericauthor=M.+Holladayauthor=M.+Williams&title=Neuronal+nicotinic+receptors%3A+A+perspective+on+two+decades+of+drug+discovery+research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArneric%26aufirst%3DS.%2BP.%26aulast%3DHolladay%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DM.%26atitle%3DNeuronal%2520nicotinic%2520receptors%253A%2520A%2520perspective%2520on%2520two%2520decades%2520of%2520drug%2520discovery%2520research%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2007%26volume%3D74%26spage%3D1092%26epage%3D1101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Langmead, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reavill, C.</span><span> </span><span class="NLM_article-title">Muscarinic acetylcholine receptors as CNS drug targets</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">232</span><span class="NLM_x">–</span> <span class="NLM_lpage">243</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.1016%2Fj.pharmthera.2007.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=18082893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtV2itrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2008&pages=232-243&author=C.+J.+Langmeadauthor=J.+Watsonauthor=C.+Reavill&title=Muscarinic+acetylcholine+receptors+as+CNS+drug+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Muscarinic acetylcholine receptors as CNS drug targets</span></div><div class="casAuthors">Langmead, Christopher J.; Watson, Jeannette; Reavill, Charlie</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">232-243</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Muscarinic acetylcholine receptors (mAChRs) are widely expressed in the CNS where they control a variety of neuronal functions.  Due to their roles in a no. of CNS processes, mAChRs have long been a target of the drug discovery industry; however, the only mAChR ligands approved for use in the clinic are non-selective antagonists for the treatment of Parkinson's disease.  This article briefly reviews recent progress made in mAChR drug discovery for Alzheimer's disease (AD), schizophrenia and Parkinson's disease, with particular emphasis on novel target validation, as well as highlighting novel indications such as drug addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosxKbNG-yy87Vg90H21EOLACvtfcHk0lhfYMOcoZUMow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtV2itrc%253D&md5=a65c212d434f0172b4e6800cc19df427</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2007.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2007.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DWatson%26aufirst%3DJ.%26aulast%3DReavill%26aufirst%3DC.%26atitle%3DMuscarinic%2520acetylcholine%2520receptors%2520as%2520CNS%2520drug%2520targets%26jtitle%3DPharmacol.%2520Ther.%26date%3D2008%26volume%3D117%26spage%3D232%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Gregory, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span> </span><span class="NLM_article-title">Allosteric modulation of muscarinic acetylcholine receptors</span> <span class="citation_source-journal">Curr. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.2174%2F157015907781695946" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=19305798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKqsLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=157-167&author=K.+J.+Gregoryauthor=P.+M.+Sextonauthor=A.+Christopoulos&title=Allosteric+modulation+of+muscarinic+acetylcholine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulation of muscarinic acetylcholine receptors</span></div><div class="casAuthors">Gregory, Karen J.; Sexton, Patrick M.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">157-167</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1570-159X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Muscarinic acetylcholine receptors (mAChRs) are prototypical Family A G protein coupled-receptors.  The five mAChR subtypes are widespread throughout the periphery and the central nervous system and, accordingly, are widely involved in a variety of both physiol. and pathophysiol. processes.  There currently remains an unmet need for better therapeutic agents that can selectively target a given mAChR subtype to the relative exclusion of others.  The main reason for the lack of such selective mAChR ligands is the high sequence homol. within the acetylcholine-binding site (orthosteric site) across all mAChRs.  However, the mAChRs possess at least one, and likely two, extracellular allosteric binding sites that can recognize small mol. allosteric modulators to regulate the binding and function of orthosteric ligands.  Extensive studies of prototypical mAChR modulators, such as gallamine and alcuronium, have provided strong pharmacol. evidence, and assocd. structure-activity relationships (SAR), for a "common" allosteric site on all five mAChRs.  These studies are also supported by mutagenesis expts. implicating the second extracellular loop and the interface between the third extracellular loop and the top of transmembrane domain 7 as contributing to the common allosteric site.  Other studies are also delineating the pharmacol. of a second allosteric site, recognized by compds. such as staurosporine.  In addn., allosteric agonists, such as McN-A-343, AC-42 and N-desmethylclozapine, have also been identified.  Current challenges to the field include the ability to effectively detect and validate allosteric mechanisms, and to quantify allosteric effects on binding affinity and signaling efficacy to inform allosteric modulator SAR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMjqjcw6KlILVg90H21EOLACvtfcHk0lizYpmxi4B20w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKqsLnP&md5=a30c0102440ffbdc1fc6efe9da084521</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F157015907781695946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157015907781695946%26sid%3Dliteratum%253Aachs%26aulast%3DGregory%26aufirst%3DK.%2BJ.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DAllosteric%2520modulation%2520of%2520muscarinic%2520acetylcholine%2520receptors%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2007%26volume%3D5%26spage%3D157%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Wess, J.</span><span> </span><span class="NLM_article-title">Muscarinic acetylcholine receptors</span> <span class="citation_source-journal">Handb. Contemp. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsVegtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2007&pages=147-192&author=J.+Wess&title=Muscarinic+acetylcholine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Muscarinic acetylcholine receptors</span></div><div class="casAuthors">Wess, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Contemporary Neuropharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">147-192</span>CODEN:
                <span class="NLM_cas:coden">69JRSF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  A review on mol. cloning studies which have shown that the muscarinic effects of acetylcholine (ACh) are mediated by a family of cell surface receptors referred to as muscarinic ACh receptors (M1-M5 mAChRs).  Studies with M1-M5 mAChR single-KO and various mAChR double-KO strains have led to a wealth of novel information about the physiol. and pathophysiol. roles of the individual mAChR subtypes.  The development of a new generation of mAChR mutant mice in which specific receptor subtypes can be inactivated in a tissue-specific and/or time-dependent fashion should provide even more powerful research tools.  These studies should pave the way towards the development of novel strategies for the treatment of a variety of important pathophysiol. conditions including pain, obesity, diabetes, and various disorders of the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_KAdC4eV1sLVg90H21EOLACvtfcHk0lizYpmxi4B20w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsVegtLg%253D&md5=797807a37a788a12cf2f5b72832b839c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWess%26aufirst%3DJ.%26atitle%3DMuscarinic%2520acetylcholine%2520receptors%26jtitle%3DHandb.%2520Contemp.%2520Neuropharmacol.%26date%3D2007%26volume%3D1%26spage%3D147%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Ishii, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurachi, Y.</span><span> </span><span class="NLM_article-title">Muscarinic acetylcholine receptors</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3573</span><span class="NLM_x">–</span> <span class="NLM_lpage">3581</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.2174%2F138161206778522056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=17073660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFalsL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=3573-3581&author=M.+Ishiiauthor=Y.+Kurachi&title=Muscarinic+acetylcholine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Muscarinic acetylcholine receptors</span></div><div class="casAuthors">Ishii, Masaru; Kurachi, Yoshihisa</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">3573-3581</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Muscarinic acetylcholine receptors mediate diverse physiol. functions.  At present, five receptor subtypes (M1-M5) have been identified.  The odd-numbered receptors (M1, M3, and M5) are preferentially coupled to Gq/11 and activate phospholipase C, which initiates the phosphatidylinositol trisphosphate cascade leading to intracellular Ca2+ mobilization and activation of protein kinase C.  On the other hand, the even-numbered receptors (M2 and M4) are coupled to Gi/o, and inhibit adenylyl cyclase activity.  They also activate G protein-gated potassium channels, which leads to hyperpolarization of the plasma membrane in different excitable cells.  Individual members of the family are expressed in an overlapping fashion in various tissues and cell types.  Recent gene targeting approaches have unraveled the specific function of these muscarinic receptor subtypes, which were not able to be fully elucidated with pharmacol. approaches because of the non-selective effects of the available ligands.  Based on these findings, muscarinic receptors have been emerging as an important therapeutic target for various diseases, including dry mouth, incontinence and chronic obstructive pulmonary disease.  Here we review the latest advances in the structural and functional characterization of muscarinic acetylcholine receptors and the pharmaceutical development of muscarinic receptor ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5caUvtB5RB7Vg90H21EOLACvtfcHk0lizYpmxi4B20w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFalsL7E&md5=a03f69bb2bdeca1003f5fd96eeea8c45</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F138161206778522056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206778522056%26sid%3Dliteratum%253Aachs%26aulast%3DIshii%26aufirst%3DM.%26aulast%3DKurachi%26aufirst%3DY.%26atitle%3DMuscarinic%2520acetylcholine%2520receptors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D3573%26epage%3D3581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Lloyd, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span> </span><span class="NLM_article-title">Neuronal nicotinic acetylcholine receptors as novel drug targets</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">292</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=10640281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotFegsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2000&pages=461-467&author=G.+K.+Lloydauthor=M.+Williams&title=Neuronal+nicotinic+acetylcholine+receptors+as+novel+drug+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal nicotinic acetylcholine receptors as novel drug targets</span></div><div class="casAuthors">Lloyd, G. Kenneth; Williams, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">461-467</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review with ∼45 refs.  Nicotinic acetylcholine receptors (nAChRs)are discussed in relation to nicotinic acetylcholine receptor agonists and antagonists, functional responses to nAChRs activation, therapeutic opportunities and future prospects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnGGNvhT5cv7Vg90H21EOLACvtfcHk0lhqL8RF61-MHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotFegsA%253D%253D&md5=d39d43ba975325f8c16cefd0446efce1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLloyd%26aufirst%3DG.%2BK.%26aulast%3DWilliams%26aufirst%3DM.%26atitle%3DNeuronal%2520nicotinic%2520acetylcholine%2520receptors%2520as%2520novel%2520drug%2520targets%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D292%26spage%3D461%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Newhouse, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corwin, J.</span><span> </span><span class="NLM_article-title">Nicotinic treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">278</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.1016%2FS0006-3223%2800%2901069-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=11230878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsFSjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2001&pages=268-278&author=P.+A.+Newhouseauthor=A.+Potterauthor=M.+Keltonauthor=J.+Corwin&title=Nicotinic+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic treatment of Alzheimer's disease</span></div><div class="casAuthors">Newhouse, P. A.; Potter, A.; Kelton, M.; Corwin, J.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">268-278</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 67 refs.  Ongoing investigations of the mol. substructure of central nervous system nicotinic receptors, their accompanying pharmacol., and the effects of nicotinic agents on cognitive function have suggested the possibility that nicotinic stimulation may have beneficial effects in Alzheimer's disease and other neuropsychiatric disorders.  Studies have explored the role of central nervous system nicotinic mechanisms in normal human cognitive and behavioral functioning as well as their role in Alzheimer's disease.  Results from acute therapeutic trials with nicotine and novel nicotinic agents suggest that nicotinic stimulation in Alzheimer's disease patients can improve the acquisition and retention of verbal and visual information and decrease errors in cognitive tasks, as well as improve accuracy and response time.  Whether such results will translate into improved clin. functioning remains to be fully tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsJkcLd03N0bVg90H21EOLACvtfcHk0lhqL8RF61-MHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsFSjtbc%253D&md5=7678c16f6ebc960860f56898347bdd50</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2800%2901069-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252800%252901069-6%26sid%3Dliteratum%253Aachs%26aulast%3DNewhouse%26aufirst%3DP.%2BA.%26aulast%3DPotter%26aufirst%3DA.%26aulast%3DKelton%26aufirst%3DM.%26aulast%3DCorwin%26aufirst%3DJ.%26atitle%3DNicotinic%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBiol.%2520Psychiatry%26date%3D2001%26volume%3D49%26spage%3D268%26epage%3D278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daanen, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryther, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrimpf, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dart, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curzon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Y.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puttfarcken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Searle, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Putman, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surowy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlocco, D.</span><span> </span><span class="NLM_article-title">Structure–Activity Studies and Analgesic Efficacy of <i>N</i>-(3-Pyridinyl)-Bridged Bicyclic Diamines, Exceptionally Potent Agonists at Nicotinic Acetylcholine Receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3627</span><span class="NLM_x">–</span> <span class="NLM_lpage">3644</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070018l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3627-3644&author=W.+H.+Bunnelleauthor=J.+F.+Daanenauthor=K.+B.+Rytherauthor=M.+R.+Schrimpfauthor=M.+J.+Dartauthor=A.+Gelainauthor=M.+D.+Meyerauthor=J.+M.+Frostauthor=D.+J.+Andersonauthor=M.+Buckleyauthor=P.+Curzonauthor=Y.-J.+Caoauthor=P.+Puttfarckenauthor=X.+Searleauthor=J.+Jiauthor=C.+B.+Putmanauthor=C.+Surowyauthor=L.+Tomaauthor=D.+Barlocco&title=Structure%E2%80%93Activity+Studies+and+Analgesic+Efficacy+of+N-%283-Pyridinyl%29-Bridged+Bicyclic+Diamines%2C+Exceptionally+Potent+Agonists+at+Nicotinic+Acetylcholine+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm070018l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070018l%26sid%3Dliteratum%253Aachs%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26aulast%3DDaanen%26aufirst%3DJ.%2BF.%26aulast%3DRyther%26aufirst%3DK.%2BB.%26aulast%3DSchrimpf%26aufirst%3DM.%2BR.%26aulast%3DDart%26aufirst%3DM.%2BJ.%26aulast%3DGelain%26aufirst%3DA.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26aulast%3DFrost%26aufirst%3DJ.%2BM.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DBuckley%26aufirst%3DM.%26aulast%3DCurzon%26aufirst%3DP.%26aulast%3DCao%26aufirst%3DY.-J.%26aulast%3DPuttfarcken%26aufirst%3DP.%26aulast%3DSearle%26aufirst%3DX.%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DPutman%26aufirst%3DC.%2BB.%26aulast%3DSurowy%26aufirst%3DC.%26aulast%3DToma%26aufirst%3DL.%26aulast%3DBarlocco%26aufirst%3DD.%26atitle%3DStructure%25E2%2580%2593Activity%2520Studies%2520and%2520Analgesic%2520Efficacy%2520of%2520N-%25283-Pyridinyl%2529-Bridged%2520Bicyclic%2520Diamines%252C%2520Exceptionally%2520Potent%2520Agonists%2520at%2520Nicotinic%2520Acetylcholine%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3627%26epage%3D3644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Adler, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olincy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flach, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickford, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, R.</span><span> </span><span class="NLM_article-title">Schizophrenia, sensory gating, and nicotinic receptors</span> <span class="citation_source-journal">Schizophrenia Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.1093%2Foxfordjournals.schbul.a033320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=9613620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A280%3ADyaK1c3ntlKktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1998&pages=189-202&author=L.+E.+Adlerauthor=A.+Olincyauthor=M.+Waldoauthor=J.+G.+Harrisauthor=J.+Griffithauthor=K.+Stevensauthor=K.+Flachauthor=H.+Nagamotoauthor=P.+Bickfordauthor=S.+Leonardauthor=R.+Freedman&title=Schizophrenia%2C+sensory+gating%2C+and+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Schizophrenia, sensory gating, and nicotinic receptors</span></div><div class="casAuthors">Adler L E; Olincy A; Waldo M; Harris J G; Griffith J; Stevens K; Flach K; Nagamoto H; Bickford P; Leonard S; Freedman R</div><div class="citationInfo"><span class="NLM_cas:title">Schizophrenia bulletin</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">189-202</span>
        ISSN:<span class="NLM_cas:issn">0586-7614</span>.
    </div><div class="casAbstract">A series of human and animal investigations has suggested that altered expression and function of the alpha7-nicotinic cholinergic receptor may be responsible for the auditory sensory gating deficit characterized in schizophrenia patients and their relatives as diminished suppression of an auditory-evoked response (P50) to repeated stimuli.  This finding, in conjunction with evidence for familial transmission of this sensory gating deficit, suggests a pathogenic role of the gene for the alpha7-nicotinic receptor in schizophrenia.  This article considers the possible effects of this dysfunction in a broader context.  Not only is this dysfunction consistent with difficulties in sensory gating, but it might also predispose patients to problems with learning efficiency and accuracy.  Such learning problems could underlie schizophrenia patients' delusional thinking, hallucinations, and social dysfunction.  In addition, heavy smoking in many schizophrenia patients is consistent with the high concentration of nicotine necessary to activate the receptor and with the receptor's extremely rapid desensitization.  Finally, the receptor's possible role in cell growth and differentiation should be considered in connection with developmental deficits and other cellular abnormalities in schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRztFXXY9w4_eqrn-c4Of3KfW6udTcc2ebKpQrpOWjYR7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1c3ntlKktA%253D%253D&md5=e2c098d4c96aa258dfeda282c393a34b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1093%2Foxfordjournals.schbul.a033320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Foxfordjournals.schbul.a033320%26sid%3Dliteratum%253Aachs%26aulast%3DAdler%26aufirst%3DL.%2BE.%26aulast%3DOlincy%26aufirst%3DA.%26aulast%3DWaldo%26aufirst%3DM.%26aulast%3DHarris%26aufirst%3DJ.%2BG.%26aulast%3DGriffith%26aufirst%3DJ.%26aulast%3DStevens%26aufirst%3DK.%26aulast%3DFlach%26aufirst%3DK.%26aulast%3DNagamoto%26aufirst%3DH.%26aulast%3DBickford%26aufirst%3DP.%26aulast%3DLeonard%26aufirst%3DS.%26aulast%3DFreedman%26aufirst%3DR.%26atitle%3DSchizophrenia%252C%2520sensory%2520gating%252C%2520and%2520nicotinic%2520receptors%26jtitle%3DSchizophrenia%2520Bull.%26date%3D1998%26volume%3D24%26spage%3D189%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Potter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corwin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piasecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenox, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newhouse, P. A.</span><span> </span><span class="NLM_article-title">Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer’s disease</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">334</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=1999&pages=334-342&author=A.+Potterauthor=J.+Corwinauthor=J.+Langauthor=M.+Piaseckiauthor=R.+Lenoxauthor=P.+A.+Newhouse&title=Acute+effects+of+the+selective+cholinergic+channel+activator+%28nicotinic+agonist%29+ABT-418+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPotter%26aufirst%3DA.%26aulast%3DCorwin%26aufirst%3DJ.%26aulast%3DLang%26aufirst%3DJ.%26aulast%3DPiasecki%26aufirst%3DM.%26aulast%3DLenox%26aufirst%3DR.%26aulast%3DNewhouse%26aufirst%3DP.%2BA.%26atitle%3DAcute%2520effects%2520of%2520the%2520selective%2520cholinergic%2520channel%2520activator%2520%2528nicotinic%2520agonist%2529%2520ABT-418%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPsychopharmacology%26date%3D1999%26volume%3D142%26spage%3D334%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Ross, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrovitch, H.</span><span> </span><span class="NLM_article-title">Current evidence for neuroprotective effects of nicotine and caffeine against Parkinson’s disease</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">797</span><span class="NLM_x">–</span> <span class="NLM_lpage">806</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.2165%2F00002512-200118110-00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=11772120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVSjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2001&pages=797-806&author=G.+W.+Rossauthor=H.+Petrovitch&title=Current+evidence+for+neuroprotective+effects+of+nicotine+and+caffeine+against+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Current evidence for neuroprotective effects of nicotine and caffeine against Parkinson's disease</span></div><div class="casAuthors">Ross, G. Webster; Petrovitch, Helen</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">797-806</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is the second most common neurodegenerative disorder affecting 1-3% of individuals over the age of 65 yr.  While effective therapy exists for treating the bradykinesia, rigidity, and tremor assocd. with the disease, the cause is unknown.  There is no treatment available to prevent or slow the progressive neuronal loss in the substantia nigra and assocd. decreased levels of dopamine in the striatum that underlie the cardinal features of the disease.  Both retrospective and prospective epidemiol. studies have consistently demonstrated an inverse assocn. between cigarette smoking and PD, leading to theories that smoking in general and nicotine in particular might be neuroprotective.  Nicotine has been shown in animals to stimulate the release of dopamine in the striatum, and to preserve nigral neurons and striatal dopamine levels in lab. animals with lesioned nigrostriatal pathways.  Coffee and caffeine consumption have also been shown in epidemiol. studies to be inversely related to PD risk.  Caffeine is an adenosine A2A receptor antagonist that enhances locomotor activity in animal models of parkinsonism.  Theophylline, a related compd. that has A2A receptor blocking properties, has been shown in one small trial to improve motor function in patients with PD.  Recently, potent and highly selective A2A receptor antagonists have been developed that have demonstrated improvement in motor function in animal models of parkinsonism.  Exciting findings are emerging that demonstrate attenuation of dopaminergic neurotoxicity with caffeine and other adenosine receptor antagonists in mice given the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), suggesting that these compds. may be neuroprotective.  Evidence for the neuroprotective potential of nicotine and caffeine is compelling, but further work is needed before testing these and related compds. in clin. trials for both individuals at high risk of developing PD and those with early, untreated disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHnRfJLnSyQ7Vg90H21EOLACvtfcHk0liztsCImkY-EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVSjtQ%253D%253D&md5=bb8a6fe64576e359efa3874df57ef98c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2165%2F00002512-200118110-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002512-200118110-00001%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DG.%2BW.%26aulast%3DPetrovitch%26aufirst%3DH.%26atitle%3DCurrent%2520evidence%2520for%2520neuroprotective%2520effects%2520of%2520nicotine%2520and%2520caffeine%2520against%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DDrugs%2520Aging%26date%3D2001%26volume%3D18%26spage%3D797%26epage%3D806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Jorenby, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hays, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigotti, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azoulay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watsky, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billing, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christen, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilderman, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Make, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merideth, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachs, D. P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swartz, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weerasinghe, M. U.</span><span> </span><span class="NLM_article-title">Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs. placebo or sustained-release bupropion for smoking cessation. A randomized controlled trial</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2006&pages=56-63&author=D.+E.+Jorenbyauthor=J.+T.+Haysauthor=N.+A.+Rigottiauthor=S.+Azoulayauthor=E.+J.+Watskyauthor=K.+E.+Williamsauthor=C.+B.+Billingauthor=J.+Gongauthor=K.+R.+Reevesauthor=B.+Bockauthor=A.+G.+Christenauthor=L.+I.+Gildermanauthor=S.+K.+Goldsteinauthor=T.+C.+Jacksonauthor=B.+J.+Makeauthor=C.+H.+Meridethauthor=D.+P.+L.+Sachsauthor=S.+C.+Sharpauthor=S.+H.+Swartzauthor=M.+U.+Weerasinghe&title=Efficacy+of+varenicline%2C+an+%CE%B14%CE%B22+nicotinic+acetylcholine+receptor+partial+agonist%2C+vs.+placebo+or+sustained-release+bupropion+for+smoking+cessation.+A+randomized+controlled+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJorenby%26aufirst%3DD.%2BE.%26aulast%3DHays%26aufirst%3DJ.%2BT.%26aulast%3DRigotti%26aufirst%3DN.%2BA.%26aulast%3DAzoulay%26aufirst%3DS.%26aulast%3DWatsky%26aufirst%3DE.%2BJ.%26aulast%3DWilliams%26aufirst%3DK.%2BE.%26aulast%3DBilling%26aufirst%3DC.%2BB.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DReeves%26aufirst%3DK.%2BR.%26aulast%3DBock%26aufirst%3DB.%26aulast%3DChristen%26aufirst%3DA.%2BG.%26aulast%3DGilderman%26aufirst%3DL.%2BI.%26aulast%3DGoldstein%26aufirst%3DS.%2BK.%26aulast%3DJackson%26aufirst%3DT.%2BC.%26aulast%3DMake%26aufirst%3DB.%2BJ.%26aulast%3DMerideth%26aufirst%3DC.%2BH.%26aulast%3DSachs%26aufirst%3DD.%2BP.%2BL.%26aulast%3DSharp%26aufirst%3DS.%2BC.%26aulast%3DSwartz%26aufirst%3DS.%2BH.%26aulast%3DWeerasinghe%26aufirst%3DM.%2BU.%26atitle%3DEfficacy%2520of%2520varenicline%252C%2520an%2520%25CE%25B14%25CE%25B22%2520nicotinic%2520acetylcholine%2520receptor%2520partial%2520agonist%252C%2520vs.%2520placebo%2520or%2520sustained-release%2520bupropion%2520for%2520smoking%2520cessation.%2520A%2520randomized%2520controlled%2520trial%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2006%26volume%3D296%26spage%3D56%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Paleari, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesario, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, P.</span><span> </span><span class="NLM_article-title">α7-Nicotinic receptor antagonists at the beginning of a clinical era for NSCLC and mesothelioma?</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">822</span><span class="NLM_x">–</span> <span class="NLM_lpage">836</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=822-836&author=L.+Paleariauthor=A.+Cesarioauthor=M.+Finiauthor=P.+Russo&title=%CE%B17-Nicotinic+receptor+antagonists+at+the+beginning+of+a+clinical+era+for+NSCLC+and+mesothelioma%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaleari%26aufirst%3DL.%26aulast%3DCesario%26aufirst%3DA.%26aulast%3DFini%26aufirst%3DM.%26aulast%3DRusso%26aufirst%3DP.%26atitle%3D%25CE%25B17-Nicotinic%2520receptor%2520antagonists%2520at%2520the%2520beginning%2520of%2520a%2520clinical%2520era%2520for%2520NSCLC%2520and%2520mesothelioma%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26spage%3D822%26epage%3D836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Meyer, M. D.</span><span> </span><span class="NLM_article-title">Neuronal nicotinic acetylcholine receptors as a target for the treatment of neuropathic pain</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=355-359&author=M.+D.+Meyer&title=Neuronal+nicotinic+acetylcholine+receptors+as+a+target+for+the+treatment+of+neuropathic+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26atitle%3DNeuronal%2520nicotinic%2520acetylcholine%2520receptors%2520as%2520a%2520target%2520for%2520the%2520treatment%2520of%2520neuropathic%2520pain%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2006%26volume%3D67%26spage%3D355%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Sarter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parikh, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, W. M.</span><span> </span><span class="NLM_article-title">nAChR agonist-induced cognition enhancement: Integration of cognitive and neuronal mechanisms</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">667</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=658-667&author=M.+Sarterauthor=V.+Parikhauthor=W.+M.+Howe&title=nAChR+agonist-induced+cognition+enhancement%3A+Integration+of+cognitive+and+neuronal+mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarter%26aufirst%3DM.%26aulast%3DParikh%26aufirst%3DV.%26aulast%3DHowe%26aufirst%3DW.%2BM.%26atitle%3DnAChR%2520agonist-induced%2520cognition%2520enhancement%253A%2520Integration%2520of%2520cognitive%2520and%2520neuronal%2520mechanisms%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D658%26epage%3D667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Dwoskin, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wooters, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crooks, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardo, M. T.</span><span> </span><span class="NLM_article-title">Nicotinic receptor-based therapeutics and candidates for smoking cessation</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">732</span><span class="NLM_x">–</span> <span class="NLM_lpage">743</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=732-743&author=L.+P.+Dwoskinauthor=A.+M.+Smithauthor=T.+E.+Wootersauthor=Z.+Zhangauthor=P.+A.+Crooksauthor=M.+T.+Bardo&title=Nicotinic+receptor-based+therapeutics+and+candidates+for+smoking+cessation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDwoskin%26aufirst%3DL.%2BP.%26aulast%3DSmith%26aufirst%3DA.%2BM.%26aulast%3DWooters%26aufirst%3DT.%2BE.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26aulast%3DBardo%26aufirst%3DM.%2BT.%26atitle%3DNicotinic%2520receptor-based%2520therapeutics%2520and%2520candidates%2520for%2520smoking%2520cessation%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D732%26epage%3D743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Holladay, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasicak, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryther, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannon, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D. J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntzweiler, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnelly-Roberts, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piattoni-Kaplan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arneric, S. P.</span><span> </span><span class="NLM_article-title">Identification and Structure–Activity Relationships of (<i>R</i>)-5-(2-Azetidinylmethoxy)-2-chloropyridine (ABT-594), a Potent, Orally Active, Non-Opiate Analgesic Agent Acting via Neuronal Nicotinic Acetylcholine Receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9706224" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=407-412&author=M.+W.+Holladayauthor=J.+T.+Wasicakauthor=N.-H.+Linauthor=Y.+Heauthor=K.+B.+Rytherauthor=A.+W.+Bannonauthor=M.+J.+Buckleyauthor=D.+J.+B.+Kimauthor=M.+W.+Deckerauthor=D.+J.+Andersonauthor=J.+E.+Campbellauthor=T.+A.+Kuntzweilerauthor=D.+L.+Donnelly-Robertsauthor=M.+Piattoni-Kaplanauthor=C.+A.+Briggsauthor=M.+Williamsauthor=S.+P.+Arneric&title=Identification+and+Structure%E2%80%93Activity+Relationships+of+%28R%29-5-%282-Azetidinylmethoxy%29-2-chloropyridine+%28ABT-594%29%2C+a+Potent%2C+Orally+Active%2C+Non-Opiate+Analgesic+Agent+Acting+via+Neuronal+Nicotinic+Acetylcholine+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm9706224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9706224%26sid%3Dliteratum%253Aachs%26aulast%3DHolladay%26aufirst%3DM.%2BW.%26aulast%3DWasicak%26aufirst%3DJ.%2BT.%26aulast%3DLin%26aufirst%3DN.-H.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DRyther%26aufirst%3DK.%2BB.%26aulast%3DBannon%26aufirst%3DA.%2BW.%26aulast%3DBuckley%26aufirst%3DM.%2BJ.%26aulast%3DKim%26aufirst%3DD.%2BJ.%2BB.%26aulast%3DDecker%26aufirst%3DM.%2BW.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DCampbell%26aufirst%3DJ.%2BE.%26aulast%3DKuntzweiler%26aufirst%3DT.%2BA.%26aulast%3DDonnelly-Roberts%26aufirst%3DD.%2BL.%26aulast%3DPiattoni-Kaplan%26aufirst%3DM.%26aulast%3DBriggs%26aufirst%3DC.%2BA.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DArneric%26aufirst%3DS.%2BP.%26atitle%3DIdentification%2520and%2520Structure%25E2%2580%2593Activity%2520Relationships%2520of%2520%2528R%2529-5-%25282-Azetidinylmethoxy%2529-2-chloropyridine%2520%2528ABT-594%2529%252C%2520a%2520Potent%252C%2520Orally%2520Active%252C%2520Non-Opiate%2520Analgesic%2520Agent%2520Acting%2520via%2520Neuronal%2520Nicotinic%2520Acetylcholine%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D407%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Coe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rollema, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span> </span><span class="NLM_article-title">Case history: Chantix/Champix (varenicline tartrate), a nicotinic acetylcholine receptor partial agonist as a smoking cessation aid</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=71-101&author=J.+W.+Coeauthor=H.+Rollemaauthor=B.+T.+O%E2%80%99Neill&title=Case+history%3A+Chantix%2FChampix+%28varenicline+tartrate%29%2C+a+nicotinic+acetylcholine+receptor+partial+agonist+as+a+smoking+cessation+aid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoe%26aufirst%3DJ.%2BW.%26aulast%3DRollema%26aufirst%3DH.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DCase%2520history%253A%2520Chantix%252FChampix%2520%2528varenicline%2520tartrate%2529%252C%2520a%2520nicotinic%2520acetylcholine%2520receptor%2520partial%2520agonist%2520as%2520a%2520smoking%2520cessation%2520aid%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D71%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Taly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corringer, P.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guedin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lestage, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changeux, J.-P.</span><span> </span><span class="NLM_article-title">Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">733</span><span class="NLM_x">–</span> <span class="NLM_lpage">750</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=733-750&author=A.+Talyauthor=P.-J.+Corringerauthor=D.+Guedinauthor=P.+Lestageauthor=J.-P.+Changeux&title=Nicotinic+receptors%3A+allosteric+transitions+and+therapeutic+targets+in+the+nervous+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaly%26aufirst%3DA.%26aulast%3DCorringer%26aufirst%3DP.-J.%26aulast%3DGuedin%26aufirst%3DD.%26aulast%3DLestage%26aufirst%3DP.%26aulast%3DChangeux%26aufirst%3DJ.-P.%26atitle%3DNicotinic%2520receptors%253A%2520allosteric%2520transitions%2520and%2520therapeutic%2520targets%2520in%2520the%2520nervous%2520system%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D733%26epage%3D750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Dani, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, D.</span><span> </span><span class="NLM_article-title">Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">699</span><span class="NLM_x">–</span> <span class="NLM_lpage">729</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.1146%2Fannurev.pharmtox.47.120505.105214" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=17009926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1alurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=699-729&author=J.+A.+Daniauthor=D.+Bertrand&title=Nicotinic+acetylcholine+receptors+and+nicotinic+cholinergic+mechanisms+of+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system</span></div><div class="casAuthors">Dani, John A.; Bertrand, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">699-729</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Subtypes of neuronal nicotinic acetylcholine receptors (nAChRs) are constructed from numerous subunit combinations that compose channel-receptor complexes with varied functional and pharmacol. characteristics.  Structural and functional diversity and the broad presynaptic, postsynaptic, and nonsynaptic locations of nAChRs underlie their mainly modulatory roles throughout the mammalian brain.  Presynaptic and preterminal nicotinic receptors enhance neurotransmitter release, postsynaptic nAChRs contribute a small minority of fast excitatory transmission, and nonsynaptic nAChRs modulate many neurotransmitter systems by influencing neuronal excitability.  Nicotinic receptors have roles in development and synaptic plasticity, and nicotinic mechanisms participate in learning, memory, and attention.  Decline, disruption, or alterations of nicotinic cholinergic mechanisms contribute to dysfunctions such as epilepsy, schizophrenia, Parkinson's disease, autism, dementia with Lewy bodies, Alzheimer's disease, and addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp70HAk5CzKZbVg90H21EOLACvtfcHk0li1ayn-a-lpOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1alurk%253D&md5=72cacc238ec2a67f7ebae0b74582682f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.47.120505.105214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.47.120505.105214%26sid%3Dliteratum%253Aachs%26aulast%3DDani%26aufirst%3DJ.%2BA.%26aulast%3DBertrand%26aufirst%3DD.%26atitle%3DNicotinic%2520acetylcholine%2520receptors%2520and%2520nicotinic%2520cholinergic%2520mechanisms%2520of%2520the%2520central%2520nervous%2520system%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2007%26volume%3D47%26spage%3D699%26epage%3D729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Sargent, P. B.</span><span> </span><span class="NLM_article-title">The diversity of neuronal nicotinic acetylcoline receptors</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">443</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.1146%2Fannurev.ne.16.030193.002155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=7681637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADyaK3sXitVGgs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1993&pages=403-443&author=P.+B.+Sargent&title=The+diversity+of+neuronal+nicotinic+acetylcoline+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The diversity of neuronal nicotinic acetylcoline receptors</span></div><div class="casAuthors">Sargent, Peter B.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">403-43</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    </div><div class="casAbstract">A review, with ∼225 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplKEuljNK4m7Vg90H21EOLACvtfcHk0li1ayn-a-lpOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXitVGgs7k%253D&md5=fc0aa05d52fdecf3cb50fe0376a29bf5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1146%2Fannurev.ne.16.030193.002155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.ne.16.030193.002155%26sid%3Dliteratum%253Aachs%26aulast%3DSargent%26aufirst%3DP.%2BB.%26atitle%3DThe%2520diversity%2520of%2520neuronal%2520nicotinic%2520acetylcoline%2520receptors%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D1993%26volume%3D16%26spage%3D403%26epage%3D443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Lukas, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changeux, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Novere, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albuquerque, E. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balfour, D. J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiappinelli, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dani, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grady, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wonnacott, S.</span><span> </span><span class="NLM_article-title">International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1999&pages=397-401&author=R.+J.+Lukasauthor=J.-P.+Changeuxauthor=N.+Le+Novereauthor=E.+X.+Albuquerqueauthor=D.+J.+K.+Balfourauthor=D.+K.+Bergauthor=D.+Bertrandauthor=V.+A.+Chiappinelliauthor=P.+B.+S.+Clarkeauthor=A.+C.+Collinsauthor=J.+A.+Daniauthor=S.+R.+Gradyauthor=K.+J.+Kellarauthor=J.+M.+Lindstromauthor=M.+J.+Marksauthor=M.+Quikauthor=P.+W.+Taylorauthor=S.+Wonnacott&title=International+Union+of+Pharmacology.+XX.+Current+status+of+the+nomenclature+for+nicotinic+acetylcholine+receptors+and+their+subunits"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26aulast%3DChangeux%26aufirst%3DJ.-P.%26aulast%3DLe%2BNovere%26aufirst%3DN.%26aulast%3DAlbuquerque%26aufirst%3DE.%2BX.%26aulast%3DBalfour%26aufirst%3DD.%2BJ.%2BK.%26aulast%3DBerg%26aufirst%3DD.%2BK.%26aulast%3DBertrand%26aufirst%3DD.%26aulast%3DChiappinelli%26aufirst%3DV.%2BA.%26aulast%3DClarke%26aufirst%3DP.%2BB.%2BS.%26aulast%3DCollins%26aufirst%3DA.%2BC.%26aulast%3DDani%26aufirst%3DJ.%2BA.%26aulast%3DGrady%26aufirst%3DS.%2BR.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26aulast%3DLindstrom%26aufirst%3DJ.%2BM.%26aulast%3DMarks%26aufirst%3DM.%2BJ.%26aulast%3DQuik%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DP.%2BW.%26aulast%3DWonnacott%26aufirst%3DS.%26atitle%3DInternational%2520Union%2520of%2520Pharmacology.%2520XX.%2520Current%2520status%2520of%2520the%2520nomenclature%2520for%2520nicotinic%2520acetylcholine%2520receptors%2520and%2520their%2520subunits%26jtitle%3DPharmacol.%2520Rev.%26date%3D1999%26volume%3D51%26spage%3D397%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malysz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gronlien Jens, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Kouhen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakerud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetterstrand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs Clark, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span> </span><span class="NLM_article-title">Stimulation of dopamine release by nicotinic acetylcholine receptor ligands in rat brain slices correlates with the profile of high, but not low, sensitivity α4β2 subunit combination</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">844</span><span class="NLM_x">–</span> <span class="NLM_lpage">851</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=844-851&author=D.+J.+Andersonauthor=J.+Malyszauthor=H.+Gronlien+Jensauthor=R.+El+Kouhenauthor=M.+Hakerudauthor=C.+Wetterstrandauthor=A.+Briggs+Clarkauthor=M.+Gopalakrishnan&title=Stimulation+of+dopamine+release+by+nicotinic+acetylcholine+receptor+ligands+in+rat+brain+slices+correlates+with+the+profile+of+high%2C+but+not+low%2C+sensitivity+%CE%B14%CE%B22+subunit+combination"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DMalysz%26aufirst%3DJ.%26aulast%3DGronlien%2BJens%26aufirst%3DH.%26aulast%3DEl%2BKouhen%26aufirst%3DR.%26aulast%3DHakerud%26aufirst%3DM.%26aulast%3DWetterstrand%26aufirst%3DC.%26aulast%3DBriggs%2BClark%26aufirst%3DA.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26atitle%3DStimulation%2520of%2520dopamine%2520release%2520by%2520nicotinic%2520acetylcholine%2520receptor%2520ligands%2520in%2520rat%2520brain%2520slices%2520correlates%2520with%2520the%2520profile%2520of%2520high%252C%2520but%2520not%2520low%252C%2520sensitivity%2520%25CE%25B14%25CE%25B22%2520subunit%2520combination%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D844%26epage%3D851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Gotti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clementi, F.</span><span> </span><span class="NLM_article-title">Brain nicotinic acetylcholine receptors: native subtypes and their relevance</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">482</span><span class="NLM_x">–</span> <span class="NLM_lpage">491</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.1016%2Fj.tips.2006.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=16876883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD28XotlGktrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=482-491&author=C.+Gottiauthor=M.+Zoliauthor=F.+Clementi&title=Brain+nicotinic+acetylcholine+receptors%3A+native+subtypes+and+their+relevance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Brain nicotinic acetylcholine receptors: native subtypes and their relevance</span></div><div class="casAuthors">Gotti, Cecilia; Zoli, Michele; Clementi, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">482-491</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Neuronal nicotinic acetylcholine receptors comprise a heterogeneous class of cationic channels that is present throughout the nervous system.  These channels are involved both in physiol. functions (including cognition, reward, motor activity and analgesia) and in pathol. conditions such as Alzheimer's disease, Parkinson's disease, some forms of epilepsy, depression, autism and schizophrenia.  They are also the targets of tobacco-smoking effects and addiction.  Neuronal nicotinic acetylcholine receptors are pentamers of homomeric or heteromeric combinations of α (α2-α10) and β (β2-β4) subunits, which have different pharmacol. and biophys. properties and locations in the brain.  The lack of subtype-specific ligands and the fact that many neuronal cells express multiple subtypes initially hampered the identification of the different native nicotinic acetylcholine receptor subtypes, but the increasing knowledge of subtype compn. and roles will be of considerable interest for the development of new and clin. useful nicotinic acetylcholine receptor ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEGpOWmD0nkrVg90H21EOLACvtfcHk0lgyiItKMCZRsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotlGktrw%253D&md5=3c913a4e614585b2f3f52fdfb523d28f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2006.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2006.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DGotti%26aufirst%3DC.%26aulast%3DZoli%26aufirst%3DM.%26aulast%3DClementi%26aufirst%3DF.%26atitle%3DBrain%2520nicotinic%2520acetylcholine%2520receptors%253A%2520native%2520subtypes%2520and%2520their%2520relevance%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2006%26volume%3D27%26spage%3D482%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Gotti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaimarri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanardi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clementi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoli, M.</span><span> </span><span class="NLM_article-title">Heterogeneity and complexity of native brain nicotinic receptors</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1102</span><span class="NLM_x">–</span> <span class="NLM_lpage">1111</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2007&pages=1102-1111&author=C.+Gottiauthor=M.+Morettiauthor=A.+Gaimarriauthor=A.+Zanardiauthor=F.+Clementiauthor=M.+Zoli&title=Heterogeneity+and+complexity+of+native+brain+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGotti%26aufirst%3DC.%26aulast%3DMoretti%26aufirst%3DM.%26aulast%3DGaimarri%26aufirst%3DA.%26aulast%3DZanardi%26aufirst%3DA.%26aulast%3DClementi%26aufirst%3DF.%26aulast%3DZoli%26aufirst%3DM.%26atitle%3DHeterogeneity%2520and%2520complexity%2520of%2520native%2520brain%2520nicotinic%2520receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2007%26volume%3D74%26spage%3D1102%26epage%3D1111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Gotti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clementi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fornari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaimarri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiducci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manfredi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedrazzi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pucci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoli, M.</span><span> </span><span class="NLM_article-title">Structural and functional diversity of native brain neuronal nicotinic receptors</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">–</span> <span class="NLM_lpage">711</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=703-711&author=C.+Gottiauthor=F.+Clementiauthor=A.+Fornariauthor=A.+Gaimarriauthor=S.+Guiducciauthor=I.+Manfrediauthor=M.+Morettiauthor=P.+Pedrazziauthor=L.+Pucciauthor=M.+Zoli&title=Structural+and+functional+diversity+of+native+brain+neuronal+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGotti%26aufirst%3DC.%26aulast%3DClementi%26aufirst%3DF.%26aulast%3DFornari%26aufirst%3DA.%26aulast%3DGaimarri%26aufirst%3DA.%26aulast%3DGuiducci%26aufirst%3DS.%26aulast%3DManfredi%26aufirst%3DI.%26aulast%3DMoretti%26aufirst%3DM.%26aulast%3DPedrazzi%26aufirst%3DP.%26aulast%3DPucci%26aufirst%3DL.%26aulast%3DZoli%26aufirst%3DM.%26atitle%3DStructural%2520and%2520functional%2520diversity%2520of%2520native%2520brain%2520neuronal%2520nicotinic%2520receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D703%26epage%3D711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Decker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M. D.</span><span> </span><span class="NLM_article-title">The potential of neuronal nicotinic acetylcholine receptor agonists for treating CNS conditions</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1027</span><span class="NLM_x">–</span> <span class="NLM_lpage">1040</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1027-1040&author=M.+W.+Deckerauthor=M.+Gopalakrishnanauthor=M.+D.+Meyer&title=The+potential+of+neuronal+nicotinic+acetylcholine+receptor+agonists+for+treating+CNS+conditions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDecker%26aufirst%3DM.%2BW.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26atitle%3DThe%2520potential%2520of%2520neuronal%2520nicotinic%2520acetylcholine%2520receptor%2520agonists%2520for%2520treating%2520CNS%2520conditions%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2008%26volume%3D3%26spage%3D1027%26epage%3D1040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Poorthuis, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goriounova, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couey, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansvelder, H. D.</span><span> </span><span class="NLM_article-title">Nicotinic actions on neuronal networks for cognition: General principles and long-term consequences</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">668</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=668-676&author=R.+B.+Poorthuisauthor=N.+A.+Goriounovaauthor=J.+J.+Coueyauthor=H.+D.+Mansvelder&title=Nicotinic+actions+on+neuronal+networks+for+cognition%3A+General+principles+and+long-term+consequences"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPoorthuis%26aufirst%3DR.%2BB.%26aulast%3DGoriounova%26aufirst%3DN.%2BA.%26aulast%3DCouey%26aufirst%3DJ.%2BJ.%26aulast%3DMansvelder%26aufirst%3DH.%2BD.%26atitle%3DNicotinic%2520actions%2520on%2520neuronal%2520networks%2520for%2520cognition%253A%2520General%2520principles%2520and%2520long-term%2520consequences%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D668%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Marks, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wageman, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grady, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, C. A.</span><span> </span><span class="NLM_article-title">Selectivity of ABT-089 for α4β2* and α6β2* nicotinic acetylcholine receptors in brain</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">910</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=910&author=M.+J.+Marksauthor=C.+R.+Wagemanauthor=S.+R.+Gradyauthor=M.+Gopalakrishnanauthor=C.+A.+Briggs&title=Selectivity+of+ABT-089+for+%CE%B14%CE%B22*+and+%CE%B16%CE%B22*+nicotinic+acetylcholine+receptors+in+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DM.%2BJ.%26aulast%3DWageman%26aufirst%3DC.%2BR.%26aulast%3DGrady%26aufirst%3DS.%2BR.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26aulast%3DBriggs%26aufirst%3DC.%2BA.%26atitle%3DSelectivity%2520of%2520ABT-089%2520for%2520%25CE%25B14%25CE%25B22%252A%2520and%2520%25CE%25B16%25CE%25B22%252A%2520nicotinic%2520acetylcholine%2520receptors%2520in%2520brain%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Sullivan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannon, A. W.</span><span> </span><span class="NLM_article-title">Epibatidine: pharmacological properties of a novel nicotinic acetylcholine receptor agonist and analgesic agent</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1996&pages=21-39&author=J.+P.+Sullivanauthor=A.+W.+Bannon&title=Epibatidine%3A+pharmacological+properties+of+a+novel+nicotinic+acetylcholine+receptor+agonist+and+analgesic+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26aulast%3DBannon%26aufirst%3DA.%2BW.%26atitle%3DEpibatidine%253A%2520pharmacological%2520properties%2520of%2520a%2520novel%2520nicotinic%2520acetylcholine%2520receptor%2520agonist%2520and%2520analgesic%2520agent%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D1996%26volume%3D2%26spage%3D21%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Lin, N.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryther, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvey, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnelly-Roberts, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brioni, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccafusco, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prendergast, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arneric, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holladay, M. W.</span><span> </span><span class="NLM_article-title">Structure–Activity Studies on 2-Methyl-3-(2(<i>S</i>)-pyrrolidinylmethoxy)pyridine (ABT-089): An Orally Bioavailable 3-Pyridyl Ether Nicotinic Acetylcholine Receptor Ligand with Cognition-Enhancing Properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm960233u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=385-390&author=N.-H.+Linauthor=D.+E.+Gunnauthor=K.+B.+Rytherauthor=D.+S.+Garveyauthor=D.+L.+Donnelly-Robertsauthor=M.+W.+Deckerauthor=J.+D.+Brioniauthor=M.+J.+Buckleyauthor=A.+D.+Rodriguesauthor=K+G.+Marshauthor=D.+J.+Andersonauthor=J.+J.+Buccafuscoauthor=M.+A.+Prendergastauthor=J.+P.+Sullivanauthor=M.+Williamsauthor=S.+P.+Arnericauthor=M.+W.+Holladay&title=Structure%E2%80%93Activity+Studies+on+2-Methyl-3-%282%28S%29-pyrrolidinylmethoxy%29pyridine+%28ABT-089%29%3A+An+Orally+Bioavailable+3-Pyridyl+Ether+Nicotinic+Acetylcholine+Receptor+Ligand+with+Cognition-Enhancing+Properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm960233u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960233u%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DN.-H.%26aulast%3DGunn%26aufirst%3DD.%2BE.%26aulast%3DRyther%26aufirst%3DK.%2BB.%26aulast%3DGarvey%26aufirst%3DD.%2BS.%26aulast%3DDonnelly-Roberts%26aufirst%3DD.%2BL.%26aulast%3DDecker%26aufirst%3DM.%2BW.%26aulast%3DBrioni%26aufirst%3DJ.%2BD.%26aulast%3DBuckley%26aufirst%3DM.%2BJ.%26aulast%3DRodrigues%26aufirst%3DA.%2BD.%26aulast%3DMarsh%26aufirst%3DK%2BG.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DBuccafusco%26aufirst%3DJ.%2BJ.%26aulast%3DPrendergast%26aufirst%3DM.%2BA.%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DArneric%26aufirst%3DS.%2BP.%26aulast%3DHolladay%26aufirst%3DM.%2BW.%26atitle%3DStructure%25E2%2580%2593Activity%2520Studies%2520on%25202-Methyl-3-%25282%2528S%2529-pyrrolidinylmethoxy%2529pyridine%2520%2528ABT-089%2529%253A%2520An%2520Orally%2520Bioavailable%25203-Pyridyl%2520Ether%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Ligand%2520with%2520Cognition-Enhancing%2520Properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D385%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Sullivan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnelly-Roberts, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piattoni-Kaplan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenna, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryther, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holladay, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wonnacott, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arneric, S. P.</span><span> </span><span class="NLM_article-title">ABT-089 [2-methyl-3-(2-(<i>S</i>)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective properties</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=9336329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADyaK2sXmslCltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=235-246&author=J.+P.+Sullivanauthor=D.+Donnelly-Robertsauthor=C.+A.+Briggsauthor=D.+J.+Andersonauthor=M.+Gopalakrishnanauthor=I.+C.+Xueauthor=M.+Piattoni-Kaplanauthor=E.+Molinariauthor=J.+E.+Campbellauthor=D.+G.+McKennaauthor=D.+E.+Gunnauthor=N.-H.+Linauthor=K.+B.+Rytherauthor=Y.+Heauthor=M.+W.+Holladayauthor=S.+Wonnacottauthor=M.+Williamsauthor=S.+P.+Arneric&title=ABT-089+%5B2-methyl-3-%282-%28S%29-pyrrolidinylmethoxy%29pyridine%5D%3A+I.+A+potent+and+selective+cholinergic+channel+modulator+with+neuroprotective+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective properties</span></div><div class="casAuthors">Sullivan, James P.; Donnelly-Roberts, Diana; Briggs, Clark A.; Anderson, David J.; Gopalakrishnan, Murali; Xue, Iris C.; Piattoni-Kaplan, Marietta; Molinari, Eduardo; Campbell, Jeffrey E.; Mckenna, David G.; Gunn, David E.; Lin, Nan-Horng; Ryther, Keith B.; He, Yun; Holladay, Mark W.; Wonnacott, Susan; Williams, Michael; Arneric, Stephen P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-246</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">Accumulating preclin. and clin. evidence data suggests that compds. that selectively activate neuronal nicotinic acetylcholine receptor (nAChR) subtypes may have therapeutic utility for the treatment of several neurol. disorders.  In the present study, the in vitro pharmacol. properties of the novel cholinergic channel modulator ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine], are described.  In radioligand binding studies, ABT-089 was shown to display selectivity toward the high-affinity (-)-cytisine binding site present on the α4β2 nAChR subtype (Ki = 16 nM) relative to the [125I]α-bungarotoxin binding site present on the α7 (Ki ≥ 10,000 nM) and α1β1δγ(Ki > 1000 nM) nAChR subtypes.  In cation flux and channel current studies, ABT-089 displayed a more complex profile than (-)-nicotine having agonist, partial agonist and inhibitory activities depending on the nAChR subtype with which it interacts.  ABT-089 differentially stimulated neurotransmitter release.  The compd. displayed a similar potency and efficacy to (-)-nicotine to facilitate ACh release (ABT-089, EC50 = 3 μM; (-)-nicotine, EC50 = 1 μM), but was markedly less potent and less efficacious than (-)-nicotine to stimulate dopamine release (ABT-089, EC50 = 1.1 μM; (-)-nicotine, EC50 = 0.04 μM).  Addnl., ABT-089 was neuroprotective against the excitotoxic insults elicited by exposure to glutamate in both rat cortical cell cultures (EC50 = 10 ± 3 μM) and differentiated human IMR32 cells (EC50 = 3 ± 2 μM).  The differential full agonist/partial agonist profile of ABT-089, as compared with (-)-nicotine and ABT-418, illustrates the complexity of nAChR activation and the potential to target responses at subclasses of the neuronal and peripheral receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqLb9I4NYSt7Vg90H21EOLACvtfcHk0lgjzQLI3nbZhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslCltLs%253D&md5=1e8c857bc451d094a273cc07d590b9fd</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26aulast%3DDonnelly-Roberts%26aufirst%3DD.%26aulast%3DBriggs%26aufirst%3DC.%2BA.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26aulast%3DXue%26aufirst%3DI.%2BC.%26aulast%3DPiattoni-Kaplan%26aufirst%3DM.%26aulast%3DMolinari%26aufirst%3DE.%26aulast%3DCampbell%26aufirst%3DJ.%2BE.%26aulast%3DMcKenna%26aufirst%3DD.%2BG.%26aulast%3DGunn%26aufirst%3DD.%2BE.%26aulast%3DLin%26aufirst%3DN.-H.%26aulast%3DRyther%26aufirst%3DK.%2BB.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DHolladay%26aufirst%3DM.%2BW.%26aulast%3DWonnacott%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DArneric%26aufirst%3DS.%2BP.%26atitle%3DABT-089%2520%255B2-methyl-3-%25282-%2528S%2529-pyrrolidinylmethoxy%2529pyridine%255D%253A%2520I.%2520A%2520potent%2520and%2520selective%2520cholinergic%2520channel%2520modulator%2520with%2520neuroprotective%2520properties%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D235%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Decker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannon, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curzon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunther, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brioni, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holladay, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daanen, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccafusco, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prendergast, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arneric, S. P.</span><span> </span><span class="NLM_article-title">ABT-089 [2-methyl-3-(2-(<i>S</i>)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=9336330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADyaK2sXmslCltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=247-258&author=M.+W.+Deckerauthor=A.+W.+Bannonauthor=P.+Curzonauthor=K.+L.+Guntherauthor=J.+D.+Brioniauthor=M.+W.+Holladayauthor=N.-H.+Linauthor=Y.+Liauthor=J.+F.+Daanenauthor=J.+J.+Buccafuscoauthor=M.+A.+Prendergastauthor=W.+J.+Jacksonauthor=S.+P.+Arneric&title=ABT-089+%5B2-methyl-3-%282-%28S%29-pyrrolidinylmethoxy%29pyridine+dihydrochloride%5D%3A+II.+A+novel+cholinergic+channel+modulator+with+effects+on+cognitive+performance+in+rats+and+monkeys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys</span></div><div class="casAuthors">Decker, Michael W.; Bannon, Anthony W.; Curzon, Peter; Gunther, Karen L.; Brioni, Jorge D.; Holladay, Mark W.; Lin, Nan-Horng; Li, Yihong; Daanen, Jerome F.; Buccafusco, Jerry J.; Prendergast, Mark A.; Jackson, William J.; Arneric, Stephen P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">247-258</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride], a novel ligand at neuronal nicotinic acetylcholine receptors with reduced adverse effects and improved oral bio-availability relative to (-)-nicotine, was tested in a variety of cognitive tests in rats and monkeys.  Administered acutely, ABT-089 only marginally improved the spatial discrimination water maze performance of septal-lesioned rats.  However, more robust improvement (45% error redn. on the last training day) was obsd. when ABT-089 was administered continuously via s.c. osmotic pumps (min. ED: 1.3 μmol/kg/day).  Continuous infusion of (-)-nicotine produced comparable improvement in the spatial discrimination water maze performance of septal-lesioned rats, but a 40-fold higher dose of (-)-nicotine was required (62 μmol/kg/day).  Continuous infusion of ABT-089 to aged rats enhanced spatial learning in a std. Morris water maze, as indexed by spatial bias exhibited during a probe trial conducted after 4 days of training, but not when they were subsequently trained in a two-platform spatial discrimination water maze.  The compd. induced a small impairment in young rats on the std. water maze, but not on the two-platform task.  A probe trial conducted after addnl. training in the std. water maze revealed no age or drug effects.  ABT-089 did not affect performance of either the aged or young rats during inhibitory (passive) avoidance training.  Also, continuous infusion of ABT-089 did not affect responses to acoustic startle or prepulse inhibition of acoustic startle in young, aged or septal-lesioned rats and did not affect locomotor activity in either sham-lesioned or septal-lesioned rats.  In monkeys, acute administration of ABT-089 modestly improved the delayed matching-to-sample performance of mature, adult monkeys and more robustly improved performance in aged monkeys.  Improved performance in the aged monkeys was restricted to the longest delay intervals and was not accompanied by changes in response latencies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4aVDc0gQwlbVg90H21EOLACvtfcHk0lgjzQLI3nbZhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslCltLg%253D&md5=a86796c0f9d8a4ef0eeba49dbf2f23a0</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDecker%26aufirst%3DM.%2BW.%26aulast%3DBannon%26aufirst%3DA.%2BW.%26aulast%3DCurzon%26aufirst%3DP.%26aulast%3DGunther%26aufirst%3DK.%2BL.%26aulast%3DBrioni%26aufirst%3DJ.%2BD.%26aulast%3DHolladay%26aufirst%3DM.%2BW.%26aulast%3DLin%26aufirst%3DN.-H.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DDaanen%26aufirst%3DJ.%2BF.%26aulast%3DBuccafusco%26aufirst%3DJ.%2BJ.%26aulast%3DPrendergast%26aufirst%3DM.%2BA.%26aulast%3DJackson%26aufirst%3DW.%2BJ.%26aulast%3DArneric%26aufirst%3DS.%2BP.%26atitle%3DABT-089%2520%255B2-methyl-3-%25282-%2528S%2529-pyrrolidinylmethoxy%2529pyridine%2520dihydrochloride%255D%253A%2520II.%2520A%2520novel%2520cholinergic%2520channel%2520modulator%2520with%2520effects%2520on%2520cognitive%2520performance%2520in%2520rats%2520and%2520monkeys%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D247%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Rueter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnelly-Roberts, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gintant, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osinski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhart, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preusser, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seifert, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, J. P.</span><span> </span><span class="NLM_article-title">ABT-089: Pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disorders</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=167-182&author=L.+E.+Rueterauthor=D.+J.+Andersonauthor=C.+A.+Briggsauthor=D.+L.+Donnelly-Robertsauthor=G.+A.+Gintantauthor=M.+Gopalakrishnanauthor=N.-H.+Linauthor=M.+A.+Osinskiauthor=G.+A.+Reinhartauthor=M.+J.+Buckleyauthor=R.+L.+Martinauthor=J.+S.+McDermottauthor=L.+C.+Preusserauthor=T.+R.+Seifertauthor=Z.+Suauthor=B.+F.+Coxauthor=M.+W.+Deckerauthor=J.+P.+Sullivan&title=ABT-089%3A+Pharmacological+properties+of+a+neuronal+nicotinic+acetylcholine+receptor+agonist+for+the+potential+treatment+of+cognitive+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRueter%26aufirst%3DL.%2BE.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DBriggs%26aufirst%3DC.%2BA.%26aulast%3DDonnelly-Roberts%26aufirst%3DD.%2BL.%26aulast%3DGintant%26aufirst%3DG.%2BA.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DN.-H.%26aulast%3DOsinski%26aufirst%3DM.%2BA.%26aulast%3DReinhart%26aufirst%3DG.%2BA.%26aulast%3DBuckley%26aufirst%3DM.%2BJ.%26aulast%3DMartin%26aufirst%3DR.%2BL.%26aulast%3DMcDermott%26aufirst%3DJ.%2BS.%26aulast%3DPreusser%26aufirst%3DL.%2BC.%26aulast%3DSeifert%26aufirst%3DT.%2BR.%26aulast%3DSu%26aufirst%3DZ.%26aulast%3DCox%26aufirst%3DB.%2BF.%26aulast%3DDecker%26aufirst%3DM.%2BW.%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26atitle%3DABT-089%253A%2520Pharmacological%2520properties%2520of%2520a%2520neuronal%2520nicotinic%2520acetylcholine%2520receptor%2520agonist%2520for%2520the%2520potential%2520treatment%2520of%2520cognitive%2520disorders%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2004%26volume%3D10%26spage%3D167%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Prendergast, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terry, A. V.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arneric, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccafusco, J. J.</span><span> </span><span class="NLM_article-title">Central nicotinic receptor agonists ABT-418, ABT-089, and (−)-nicotine reduce distractibility in adult monkeys</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=1998&pages=50-58&author=M.+A.+Prendergastauthor=W.+J.+Jacksonauthor=A.+V.+Terryauthor=M.+W.+Deckerauthor=S.+P.+Arnericauthor=J.+J.+Buccafusco&title=Central+nicotinic+receptor+agonists+ABT-418%2C+ABT-089%2C+and+%28%E2%88%92%29-nicotine+reduce+distractibility+in+adult+monkeys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrendergast%26aufirst%3DM.%2BA.%26aulast%3DJackson%26aufirst%3DW.%2BJ.%26aulast%3DTerry%26aufirst%3DA.%2BV.%26aulast%3DDecker%26aufirst%3DM.%2BW.%26aulast%3DArneric%26aufirst%3DS.%2BP.%26aulast%3DBuccafusco%26aufirst%3DJ.%2BJ.%26atitle%3DCentral%2520nicotinic%2520receptor%2520agonists%2520ABT-418%252C%2520ABT-089%252C%2520and%2520%2528%25E2%2588%2592%2529-nicotine%2520reduce%2520distractibility%2520in%2520adult%2520monkeys%26jtitle%3DPsychopharmacology%26date%3D1998%26volume%3D136%26spage%3D50%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Wilens, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verlinden, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adler, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wozniak, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S. A.</span><span> </span><span class="NLM_article-title">ABT-089, A Neuronal Nicotinic Receptor Partial Agonist, for the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Pilot Study</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1065</span><span class="NLM_x">–</span> <span class="NLM_lpage">1070</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.1016%2Fj.biopsych.2005.10.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=16499880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD28Xls1eju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2006&pages=1065-1070&author=T.+E.+Wilensauthor=M.+H.+Verlindenauthor=L.+A.+Adlerauthor=P.+J.+Wozniakauthor=S.+A.+West&title=ABT-089%2C+A+Neuronal+Nicotinic+Receptor+Partial+Agonist%2C+for+the+Treatment+of+Attention-Deficit%2FHyperactivity+Disorder+in+Adults%3A+Results+of+a+Pilot+Study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">ABT-089, A Neuronal Nicotinic Receptor Partial Agonist, for the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Pilot Study</span></div><div class="casAuthors">Wilens, Timothy E.; Verlinden, Marleen H.; Adler, Lenard A.; Wozniak, Patricia J.; West, Scott A.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1065-1070</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">This pilot study was designed to evaluate ABT-089, a neuronal nicotinic receptor partial agonist, as treatment for adult attention-deficit/hyperactivity disorder (ADHD).  Adults with ADHD received placebo, 2 mg, 4 mg, or 20 mg of ABT-089 for 2 wk each in a randomized, double-blind, placebo-controlled, 4 × 4 Latin square design for a total of 8 wk.  In addn. to the primary outcome, the Conner's Adult ADHD Rating Scale (CAARS), secondary rating scales, and neuropsychol. and safety assessments were completed.  A total of 11 adults with well-characterized ADHD completed this crossover study.  ABT-089 b.i.d. was superior to placebo for the CAARS Total Symptom Score, which was the primary endpoint (placebo: 38.0 ± 1.9; 2 mg b.i.d.: 32.2 ± 1.9, one-tail p = .021; 4 mg b.i.d.: 33.2 ± 1.9, p = .047; 20 mg b.i.d.: 33.5 ± 1.9, p = .056).  ABT-089 was also superior to placebo for the CAARS ADHD Index and Hyperactive/Impulsive scores and the Clin. Global Impression-ADHD Severity score.  On the clin. efficacy endpoints, CAARS Total Symptom Score and CAARS Hyperactive/Impulsive score, a shallow inverted U-shaped dose-response curve was obsd.; however, the dose-response curve for attention and memory effects as measured by computerized cognitive testing seemed dose-linear.  No clin. meaningful findings in safety assessments or side effect profile were obsd.  Data from this pilot study suggest that ABT-089 might be effective in treating adult ADHD and that it is well tolerated.  On the basis of these promising results, larger, parallel-group ABT-089 studies of longer duration are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf9cpJKRq47LVg90H21EOLACvtfcHk0lh56JFN6ZHN7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xls1eju7c%253D&md5=2fb0da77ee46952d8fa05e33204707e5</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2005.10.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2005.10.029%26sid%3Dliteratum%253Aachs%26aulast%3DWilens%26aufirst%3DT.%2BE.%26aulast%3DVerlinden%26aufirst%3DM.%2BH.%26aulast%3DAdler%26aufirst%3DL.%2BA.%26aulast%3DWozniak%26aufirst%3DP.%2BJ.%26aulast%3DWest%26aufirst%3DS.%2BA.%26atitle%3DABT-089%252C%2520A%2520Neuronal%2520Nicotinic%2520Receptor%2520Partial%2520Agonist%252C%2520for%2520the%2520Treatment%2520of%2520Attention-Deficit%252FHyperactivity%2520Disorder%2520in%2520Adults%253A%2520Results%2520of%2520a%2520Pilot%2520Study%26jtitle%3DBiol.%2520Psychiatry%26date%3D2006%26volume%3D59%26spage%3D1065%26epage%3D1070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Wilens, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M. W.</span><span> </span><span class="NLM_article-title">Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1212</span><span class="NLM_x">–</span> <span class="NLM_lpage">1223</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2007&pages=1212-1223&author=T.+E.+Wilensauthor=M.+W.+Decker&title=Neuronal+nicotinic+receptor+agonists+for+the+treatment+of+attention-deficit%2Fhyperactivity+disorder%3A+focus+on+cognition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilens%26aufirst%3DT.%2BE.%26aulast%3DDecker%26aufirst%3DM.%2BW.%26atitle%3DNeuronal%2520nicotinic%2520receptor%2520agonists%2520for%2520the%2520treatment%2520of%2520attention-deficit%252Fhyperactivity%2520disorder%253A%2520focus%2520on%2520cognition%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2007%26volume%3D74%26spage%3D1212%26epage%3D1223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musachio, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Z.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chellappan, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. J.</span><span> </span><span class="NLM_article-title">Sazetidine-A, a novel ligand that desensitizes α4β2 nicotinic acetylcholine receptors without activating them</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1454</span><span class="NLM_x">–</span> <span class="NLM_lpage">1460</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=1454-1460&author=Y.+Xiaoauthor=H.+Fanauthor=J.+L.+Musachioauthor=Z.-L.+Weiauthor=S.+K.+Chellappanauthor=A.+P.+Kozikowskiauthor=K.+J.+Kellar&title=Sazetidine-A%2C+a+novel+ligand+that+desensitizes+%CE%B14%CE%B22+nicotinic+acetylcholine+receptors+without+activating+them"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DMusachio%26aufirst%3DJ.%2BL.%26aulast%3DWei%26aufirst%3DZ.-L.%26aulast%3DChellappan%26aufirst%3DS.%2BK.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DKellar%26aufirst%3DK.%2BJ.%26atitle%3DSazetidine-A%252C%2520a%2520novel%2520ligand%2520that%2520desensitizes%2520%25CE%25B14%25CE%25B22%2520nicotinic%2520acetylcholine%2520receptors%2520without%2520activating%2520them%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D1454%26epage%3D1460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarone, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Chemistry and Pharmacological Characterization of Novel Nitrogen Analogues of AMOP-H-OH (Sazetidine-A, 6-[5-(Azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol) as α4β2-Nicotinic Acetylcholine Receptor-Selective Partial Agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">6973</span><span class="NLM_x">–</span> <span class="NLM_lpage">6985</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100765u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6973-6985&author=J.+Liuauthor=J.+B.+Eatonauthor=B.+Caldaroneauthor=R.+J.+Lukasauthor=A.+P.+Kozikowski&title=Chemistry+and+Pharmacological+Characterization+of+Novel+Nitrogen+Analogues+of+AMOP-H-OH+%28Sazetidine-A%2C+6-%5B5-%28Azetidin-2-ylmethoxy%29pyridin-3-yl%5Dhex-5-yn-1-ol%29+as+%CE%B14%CE%B22-Nicotinic+Acetylcholine+Receptor-Selective+Partial+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm100765u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100765u%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DEaton%26aufirst%3DJ.%2BB.%26aulast%3DCaldarone%26aufirst%3DB.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DChemistry%2520and%2520Pharmacological%2520Characterization%2520of%2520Novel%2520Nitrogen%2520Analogues%2520of%2520AMOP-H-OH%2520%2528Sazetidine-A%252C%25206-%255B5-%2528Azetidin-2-ylmethoxy%2529pyridin-3-yl%255Dhex-5-yn-1-ol%2529%2520as%2520%25CE%25B14%25CE%25B22-Nicotinic%2520Acetylcholine%2520Receptor-Selective%2520Partial%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6973%26epage%3D6985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tietje, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scanio, M. J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyhring, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gronlien, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ween, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorin-Hagene, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M. D.</span><span> </span><span class="NLM_article-title">Octahydropyrrolo[3,4-<i>c</i>]pyrrole: a diamine scaffold for construction of either α4β2 or α7-selective nicotinic acetylcholine receptor (nAChR) ligands. substitutions that switch subtype selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4126</span><span class="NLM_x">–</span> <span class="NLM_lpage">4141</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900249k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4126-4141&author=W.+H.+Bunnelleauthor=K.+R.+Tietjeauthor=J.+M.+Frostauthor=D.+Petersauthor=J.+Jiauthor=T.+Liauthor=M.+J.+C.+Scanioauthor=L.+Shiauthor=D.+J.+Andersonauthor=T.+Dyhringauthor=J.+H.+Gronlienauthor=H.+Weenauthor=K.+Thorin-Hageneauthor=M.+D.+Meyer&title=Octahydropyrrolo%5B3%2C4-c%5Dpyrrole%3A+a+diamine+scaffold+for+construction+of+either+%CE%B14%CE%B22+or+%CE%B17-selective+nicotinic+acetylcholine+receptor+%28nAChR%29+ligands.+substitutions+that+switch+subtype+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm900249k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900249k%26sid%3Dliteratum%253Aachs%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26aulast%3DTietje%26aufirst%3DK.%2BR.%26aulast%3DFrost%26aufirst%3DJ.%2BM.%26aulast%3DPeters%26aufirst%3DD.%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DScanio%26aufirst%3DM.%2BJ.%2BC.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DDyhring%26aufirst%3DT.%26aulast%3DGronlien%26aufirst%3DJ.%2BH.%26aulast%3DWeen%26aufirst%3DH.%26aulast%3DThorin-Hagene%26aufirst%3DK.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26atitle%3DOctahydropyrrolo%255B3%252C4-c%255Dpyrrole%253A%2520a%2520diamine%2520scaffold%2520for%2520construction%2520of%2520either%2520%25CE%25B14%25CE%25B22%2520or%2520%25CE%25B17-selective%2520nicotinic%2520acetylcholine%2520receptor%2520%2528nAChR%2529%2520ligands.%2520substitutions%2520that%2520switch%2520subtype%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4126%26epage%3D4141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Schrimpf, M. R.; Tietje, K. R.; Toupence, R. B.; Ji, J.; Basha, A.; Bunnelle, W. H.; Daanen, J. F.; Pace, J. M.; Sippy, K. B.</span><span> </span><span class="NLM_article-title">Diazabicyclic central nervous system active agents</span>. Patent WO0181347, <span class="NLM_month">Nov</span><span class="NLM_day">1</span>,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=M.+R.+Schrimpf&author=K.+R.+Tietje&author=R.+B.+Toupence&author=J.+Ji&author=A.+Basha&author=W.+H.+Bunnelle&author=J.+F.+Daanen&author=J.+M.+Pace&author=K.+B.+Sippy&title=Diazabicyclic+central+nervous+system+active+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchrimpf%26aufirst%3DM.%2BR.%26atitle%3DDiazabicyclic%2520central%2520nervous%2520system%2520active%2520agents%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Ji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrimpf, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippy, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faltynek, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surowy, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyhring, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahring, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M. D.</span><span> </span><span class="NLM_article-title">Synthesis and Structure–Activity Relationship Studies of 3,6-Diazabicyclo[3.2.0]heptanes as Novel α4β2 Nicotinic Acetylcholine Receptor Selective Agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5493</span><span class="NLM_x">–</span> <span class="NLM_lpage">5508</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070755h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5493-5508&author=J.+Jiauthor=M.+R.+Schrimpfauthor=K.+B.+Sippyauthor=W.+H.+Bunnelleauthor=T.+Liauthor=D.+J.+Andersonauthor=C.+Faltynekauthor=C.+S.+Surowyauthor=T.+Dyhringauthor=P.+K.+Ahringauthor=M.+D.+Meyer&title=Synthesis+and+Structure%E2%80%93Activity+Relationship+Studies+of+3%2C6-Diazabicyclo%5B3.2.0%5Dheptanes+as+Novel+%CE%B14%CE%B22+Nicotinic+Acetylcholine+Receptor+Selective+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm070755h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070755h%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DSchrimpf%26aufirst%3DM.%2BR.%26aulast%3DSippy%26aufirst%3DK.%2BB.%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DFaltynek%26aufirst%3DC.%26aulast%3DSurowy%26aufirst%3DC.%2BS.%26aulast%3DDyhring%26aufirst%3DT.%26aulast%3DAhring%26aufirst%3DP.%2BK.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26atitle%3DSynthesis%2520and%2520Structure%25E2%2580%2593Activity%2520Relationship%2520Studies%2520of%25203%252C6-Diazabicyclo%255B3.2.0%255Dheptanes%2520as%2520Novel%2520%25CE%25B14%25CE%25B22%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Selective%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5493%26epage%3D5508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brieaddy, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">Synthesis, Nicotinic Acetylcholine Receptor Binding, and Antinociceptive Properties of 2-exo-2-(2′,3′-Disubstituted 5′-pyridinyl)-7-azabicyclo[2.2.1]heptanes: Epibatidine Analogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4755</span><span class="NLM_x">–</span> <span class="NLM_lpage">4761</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0202268" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4755-4761&author=F.+I.+Carrollauthor=J.+R.+Leeauthor=H.+A.+Navarroauthor=W.+Maauthor=L.+E.+Brieaddyauthor=P.+Abrahamauthor=M.+I.+Damajauthor=B.+R.+Martin&title=Synthesis%2C+Nicotinic+Acetylcholine+Receptor+Binding%2C+and+Antinociceptive+Properties+of+2-exo-2-%282%E2%80%B2%2C3%E2%80%B2-Disubstituted+5%E2%80%B2-pyridinyl%29-7-azabicyclo%5B2.2.1%5Dheptanes%3A+Epibatidine+Analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm0202268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0202268%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DLee%26aufirst%3DJ.%2BR.%26aulast%3DNavarro%26aufirst%3DH.%2BA.%26aulast%3DMa%26aufirst%3DW.%26aulast%3DBrieaddy%26aufirst%3DL.%2BE.%26aulast%3DAbraham%26aufirst%3DP.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DSynthesis%252C%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Binding%252C%2520and%2520Antinociceptive%2520Properties%2520of%25202-exo-2-%25282%25E2%2580%25B2%252C3%25E2%2580%25B2-Disubstituted%25205%25E2%2580%25B2-pyridinyl%2529-7-azabicyclo%255B2.2.1%255Dheptanes%253A%2520Epibatidine%2520Analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D4755%26epage%3D4761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ware, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brieaddy, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">Synthesis, Nicotinic Acetylcholine Receptor Binding, and Antinociceptive Properties of 2′-Fluoro-3′-(substituted phenyl)deschloroepibatidine Analogues. Novel Nicotinic Antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4588</span><span class="NLM_x">–</span> <span class="NLM_lpage">4594</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040078g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4588-4594&author=F.+I.+Carrollauthor=R.+Wareauthor=L.+E.+Brieaddyauthor=H.+A.+Navarroauthor=M.+I.+Damajauthor=B.+R.+Martin&title=Synthesis%2C+Nicotinic+Acetylcholine+Receptor+Binding%2C+and+Antinociceptive+Properties+of+2%E2%80%B2-Fluoro-3%E2%80%B2-%28substituted+phenyl%29deschloroepibatidine+Analogues.+Novel+Nicotinic+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm040078g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040078g%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DWare%26aufirst%3DR.%26aulast%3DBrieaddy%26aufirst%3DL.%2BE.%26aulast%3DNavarro%26aufirst%3DH.%2BA.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DSynthesis%252C%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Binding%252C%2520and%2520Antinociceptive%2520Properties%2520of%25202%25E2%2580%25B2-Fluoro-3%25E2%2580%25B2-%2528substituted%2520phenyl%2529deschloroepibatidine%2520Analogues.%2520Novel%2520Nicotinic%2520Antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4588%26epage%3D4594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brieaddy, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">Synthesis and Pharmacological Characterization of <i>exo</i>-2-(2′-Chloro-5-pyridinyl)-7-(endo and exo)-aminobicyclo[2.2.1]heptanes as Novel Epibatidine Analogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7491</span><span class="NLM_x">–</span> <span class="NLM_lpage">7495</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058243v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7491-7495&author=F.+I.+Carrollauthor=L.+E.+Brieaddyauthor=H.+A.+Navarroauthor=M.+I.+Damajauthor=B.+R.+Martin&title=Synthesis+and+Pharmacological+Characterization+of+exo-2-%282%E2%80%B2-Chloro-5-pyridinyl%29-7-%28endo+and+exo%29-aminobicyclo%5B2.2.1%5Dheptanes+as+Novel+Epibatidine+Analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm058243v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058243v%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DBrieaddy%26aufirst%3DL.%2BE.%26aulast%3DNavarro%26aufirst%3DH.%2BA.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DSynthesis%2520and%2520Pharmacological%2520Characterization%2520of%2520exo-2-%25282%25E2%2580%25B2-Chloro-5-pyridinyl%2529-7-%2528endo%2520and%2520exo%2529-aminobicyclo%255B2.2.1%255Dheptanes%2520as%2520Novel%2520Epibatidine%2520Analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7491%26epage%3D7495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Frost, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tietje, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curzon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surowy, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daanen, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlhaas, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyhring, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahring, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M. D.</span><span> </span><span class="NLM_article-title">Synthesis and Structure–Activity Relationships of 3,8-Diazabicyclo[4.2.0]octane Ligands, Potent Nicotinic Acetylcholine Receptor Agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7843</span><span class="NLM_x">–</span> <span class="NLM_lpage">7853</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7843-7853&author=J.+M.+Frostauthor=W.+H.+Bunnelleauthor=K.+R.+Tietjeauthor=D.+J.+Andersonauthor=L.+E.+Rueterauthor=P.+Curzonauthor=C.+S.+Surowyauthor=J.+Jiauthor=J.+F.+Daanenauthor=K.+L.+Kohlhaasauthor=M.+J.+Buckleyauthor=R.+F.+Henryauthor=T.+Dyhringauthor=P.+K.+Ahringauthor=M.+D.+Meyer&title=Synthesis+and+Structure%E2%80%93Activity+Relationships+of+3%2C8-Diazabicyclo%5B4.2.0%5Doctane+Ligands%2C+Potent+Nicotinic+Acetylcholine+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrost%26aufirst%3DJ.%2BM.%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26aulast%3DTietje%26aufirst%3DK.%2BR.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DRueter%26aufirst%3DL.%2BE.%26aulast%3DCurzon%26aufirst%3DP.%26aulast%3DSurowy%26aufirst%3DC.%2BS.%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DDaanen%26aufirst%3DJ.%2BF.%26aulast%3DKohlhaas%26aufirst%3DK.%2BL.%26aulast%3DBuckley%26aufirst%3DM.%2BJ.%26aulast%3DHenry%26aufirst%3DR.%2BF.%26aulast%3DDyhring%26aufirst%3DT.%26aulast%3DAhring%26aufirst%3DP.%2BK.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26atitle%3DSynthesis%2520and%2520Structure%25E2%2580%2593Activity%2520Relationships%2520of%25203%252C8-Diazabicyclo%255B4.2.0%255Doctane%2520Ligands%252C%2520Potent%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7843%26epage%3D7853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Schenke, T.; Petersen, U.</span><span> </span><span class="NLM_article-title">2,7-diazabicyclo[3.3.0]octanes and process for their formation</span>. Eur. Patent 393424, <span class="NLM_month">April</span><span class="NLM_day">4</span>,<span class="NLM_x"> </span><span class="NLM_year">1990</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1990&author=T.+Schenke&author=U.+Petersen&title=2%2C7-diazabicyclo%5B3.3.0%5Doctanes+and+process+for+their+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchenke%26aufirst%3DT.%26atitle%3D2%252C7-diazabicyclo%255B3.3.0%255Doctanes%2520and%2520process%2520for%2520their%2520formation%26date%3D1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Uchimaru, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosasayama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konno, T.</span><span> </span><span class="NLM_article-title">Pyrazine derivatives. I. Synthesis of pyrazinoylmorpholine and related compounds</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1337</span><span class="NLM_x">–</span> <span class="NLM_lpage">1343</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1971&pages=1337-1343&author=F.+Uchimaruauthor=S.+Okadaauthor=A.+Kosasayamaauthor=T.+Konno&title=Pyrazine+derivatives.+I.+Synthesis+of+pyrazinoylmorpholine+and+related+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUchimaru%26aufirst%3DF.%26aulast%3DOkada%26aufirst%3DS.%26aulast%3DKosasayama%26aufirst%3DA.%26aulast%3DKonno%26aufirst%3DT.%26atitle%3DPyrazine%2520derivatives.%2520I.%2520Synthesis%2520of%2520pyrazinoylmorpholine%2520and%2520related%2520compounds%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1971%26volume%3D19%26spage%3D1337%26epage%3D1343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Okada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosasayama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchimaru, F.</span><span> </span><span class="NLM_article-title">Pyrazine derivatives. II. Synthesis, reactions, and spectra of pyrazine <i>N</i>-oxide derivatives</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1344</span><span class="NLM_x">–</span> <span class="NLM_lpage">1357</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1971&pages=1344-1357&author=S.+Okadaauthor=A.+Kosasayamaauthor=T.+Konnoauthor=F.+Uchimaru&title=Pyrazine+derivatives.+II.+Synthesis%2C+reactions%2C+and+spectra+of+pyrazine+N-oxide+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkada%26aufirst%3DS.%26aulast%3DKosasayama%26aufirst%3DA.%26aulast%3DKonno%26aufirst%3DT.%26aulast%3DUchimaru%26aufirst%3DF.%26atitle%3DPyrazine%2520derivatives.%2520II.%2520Synthesis%252C%2520reactions%252C%2520and%2520spectra%2520of%2520pyrazine%2520N-oxide%2520derivatives%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1971%26volume%3D19%26spage%3D1344%26epage%3D1357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Scanio, M. J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drizin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregg, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krambis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shieh, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simler, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honore, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werness, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krafte, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvis, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faltynek, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marron, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kort, M. E.</span><span> </span><span class="NLM_article-title">Discovery and biological evaluation of potent, selective, orally bioavailable, pyrazine-based blockers of the Na<sub>V</sub>1.8 sodium channel with efficacy in a model of neuropathic pain</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">7816</span><span class="NLM_x">–</span> <span class="NLM_lpage">7825</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=7816-7825&author=M.+J.+C.+Scanioauthor=L.+Shiauthor=I.+Drizinauthor=R.+J.+Greggauthor=R.+N.+Atkinsonauthor=J.+B.+Thomasauthor=M.+S.+Johnsonauthor=M.+L.+Chapmanauthor=D.+Liuauthor=M.+J.+Krambisauthor=Y.+Liuauthor=C.-C.+Shiehauthor=X.+F.+Zhangauthor=G.+H.+Simlerauthor=S.+Joshiauthor=P.+Honoreauthor=K.+C.+Marshauthor=A.+Knoxauthor=S.+Wernessauthor=B.+Antonioauthor=D.+S.+Krafteauthor=M.+F.+Jarvisauthor=C.+R.+Faltynekauthor=B.+E.+Marronauthor=M.+E.+Kort&title=Discovery+and+biological+evaluation+of+potent%2C+selective%2C+orally+bioavailable%2C+pyrazine-based+blockers+of+the+NaV1.8+sodium+channel+with+efficacy+in+a+model+of+neuropathic+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScanio%26aufirst%3DM.%2BJ.%2BC.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DDrizin%26aufirst%3DI.%26aulast%3DGregg%26aufirst%3DR.%2BJ.%26aulast%3DAtkinson%26aufirst%3DR.%2BN.%26aulast%3DThomas%26aufirst%3DJ.%2BB.%26aulast%3DJohnson%26aufirst%3DM.%2BS.%26aulast%3DChapman%26aufirst%3DM.%2BL.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DKrambis%26aufirst%3DM.%2BJ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DShieh%26aufirst%3DC.-C.%26aulast%3DZhang%26aufirst%3DX.%2BF.%26aulast%3DSimler%26aufirst%3DG.%2BH.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DHonore%26aufirst%3DP.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DKnox%26aufirst%3DA.%26aulast%3DWerness%26aufirst%3DS.%26aulast%3DAntonio%26aufirst%3DB.%26aulast%3DKrafte%26aufirst%3DD.%2BS.%26aulast%3DJarvis%26aufirst%3DM.%2BF.%26aulast%3DFaltynek%26aufirst%3DC.%2BR.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DKort%26aufirst%3DM.%2BE.%26atitle%3DDiscovery%2520and%2520biological%2520evaluation%2520of%2520potent%252C%2520selective%252C%2520orally%2520bioavailable%252C%2520pyrazine-based%2520blockers%2520of%2520the%2520NaV1.8%2520sodium%2520channel%2520with%2520efficacy%2520in%2520a%2520model%2520of%2520neuropathic%2520pain%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D7816%26epage%3D7825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Imai, K.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anticoccidials., V. I.</span><span> </span><span class="NLM_article-title">An improved synthesis of 1,6-dihydro-6-oxo-2-pyrazinecarboxylic acid 4-oxide and some related derivatives and determination of anticoccidial activity</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1981&pages=88-97&author=K.-i.+Imaiauthor=M.+Manoauthor=T.+Seoauthor=T.+Matsunoauthor=V.+I.+Anticoccidials.&title=An+improved+synthesis+of+1%2C6-dihydro-6-oxo-2-pyrazinecarboxylic+acid+4-oxide+and+some+related+derivatives+and+determination+of+anticoccidial+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DImai%26aufirst%3DK.-i.%26aulast%3DMano%26aufirst%3DM.%26aulast%3DSeo%26aufirst%3DT.%26aulast%3DMatsuno%26aufirst%3DT.%26aulast%3DAnticoccidials.%26aufirst%3DV.%2BI.%26atitle%3DAn%2520improved%2520synthesis%2520of%25201%252C6-dihydro-6-oxo-2-pyrazinecarboxylic%2520acid%25204-oxide%2520and%2520some%2520related%2520derivatives%2520and%2520determination%2520of%2520anticoccidial%2520activity%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1981%26volume%3D29%26spage%3D88%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Sato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, M.</span><span> </span><span class="NLM_article-title">Studies on pyrazines. 29. Highly regioselective synthesis of chloropyrazines from 3-substituted pyrazine 1-oxides</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1177</span><span class="NLM_x">–</span> <span class="NLM_lpage">1180</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1994&pages=1177-1180&author=N.+Satoauthor=M.+Fujii&title=Studies+on+pyrazines.+29.+Highly+regioselective+synthesis+of+chloropyrazines+from+3-substituted+pyrazine+1-oxides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DN.%26aulast%3DFujii%26aufirst%3DM.%26atitle%3DStudies%2520on%2520pyrazines.%252029.%2520Highly%2520regioselective%2520synthesis%2520of%2520chloropyrazines%2520from%25203-substituted%2520pyrazine%25201-oxides%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1994%26volume%3D31%26spage%3D1177%26epage%3D1180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowdy, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polniaszek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaney, E.</span><span> </span><span class="NLM_article-title">A novel method for the mild and selective amidation of diesters and the amidation of monoesters</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1843</span><span class="NLM_x">–</span> <span class="NLM_lpage">1845</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=1843-1845&author=Z.+Guoauthor=E.+D.+Dowdyauthor=W.+S.+Liauthor=R.+Polniaszekauthor=E.+Delaney&title=A+novel+method+for+the+mild+and+selective+amidation+of+diesters+and+the+amidation+of+monoesters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DDowdy%26aufirst%3DE.%2BD.%26aulast%3DLi%26aufirst%3DW.%2BS.%26aulast%3DPolniaszek%26aufirst%3DR.%26aulast%3DDelaney%26aufirst%3DE.%26atitle%3DA%2520novel%2520method%2520for%2520the%2520mild%2520and%2520selective%2520amidation%2520of%2520diesters%2520and%2520the%2520amidation%2520of%2520monoesters%26jtitle%3DTetrahedron%2520Lett.%26date%3D2001%26volume%3D42%26spage%3D1843%26epage%3D1845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Hartwig, J. F.</span><span> </span><span class="NLM_article-title">Carbon-Heteroatom Bond-Forming Reductive Eliminations of Amines, Ethers, and Sulfides</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">852</span><span class="NLM_x">–</span> <span class="NLM_lpage">860</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar970282g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADyaK1cXlslarurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1998&pages=852-860&author=J.+F.+Hartwig&title=Carbon-Heteroatom+Bond-Forming+Reductive+Eliminations+of+Amines%2C+Ethers%2C+and+Sulfides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Carbon-Heteroatom Bond-Forming Reductive Eliminations of Amines, Ethers, and Sulfides</span></div><div class="casAuthors">Hartwig, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">852-860</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review contg. 58 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwhk-NBQWrz7Vg90H21EOLACvtfcHk0ljtSe4RpLUzPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlslarurg%253D&md5=7b47d13c6add8381090525a07c3f25b3</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Far970282g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far970282g%26sid%3Dliteratum%253Aachs%26aulast%3DHartwig%26aufirst%3DJ.%2BF.%26atitle%3DCarbon-Heteroatom%2520Bond-Forming%2520Reductive%2520Eliminations%2520of%2520Amines%252C%2520Ethers%252C%2520and%2520Sulfides%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D1998%26volume%3D31%26spage%3D852%26epage%3D860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Wolfe, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">An Improved Catalyst System for Aromatic Carbon–Nitrogen Bond Formation: The Possible Involvement of Bis(Phosphine) Palladium Complexes as Key Intermediates</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">7215</span><span class="NLM_x">–</span> <span class="NLM_lpage">7216</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja9608306" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=7215-7216&author=J.+P.+Wolfeauthor=S.+Wagawauthor=S.+L.+Buchwald&title=An+Improved+Catalyst+System+for+Aromatic+Carbon%E2%80%93Nitrogen+Bond+Formation%3A+The+Possible+Involvement+of+Bis%28Phosphine%29+Palladium+Complexes+as+Key+Intermediates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fja9608306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9608306%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DJ.%2BP.%26aulast%3DWagaw%26aufirst%3DS.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DAn%2520Improved%2520Catalyst%2520System%2520for%2520Aromatic%2520Carbon%25E2%2580%2593Nitrogen%2520Bond%2520Formation%253A%2520The%2520Possible%2520Involvement%2520of%2520Bis%2528Phosphine%2529%2520Palladium%2520Complexes%2520as%2520Key%2520Intermediates%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1996%26volume%3D118%26spage%3D7215%26epage%3D7216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arneric, S. P.</span><span> </span><span class="NLM_article-title">Nicotinic receptor binding of [<sup>3</sup>H]cytisine, [<sup>3</sup>H]nicotine and [<sup>3</sup>H]methylcarbamylcholine in rat brain</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">253</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.1016%2F0014-2999%2894%2990200-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=8200419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADyaK2cXitlKktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1994&pages=261-267&author=D.+J.+Andersonauthor=S.+P.+Arneric&title=Nicotinic+receptor+binding+of+%5B3H%5Dcytisine%2C+%5B3H%5Dnicotine+and+%5B3H%5Dmethylcarbamylcholine+in+rat+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic receptor binding of [3H]cytisine, [3H]nicotine and [3H]methylcarbamylcholine in rat brain</span></div><div class="casAuthors">Anderson, David J.; Arneric, Stephen P.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">253</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">261-7</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Three radiolabeled nicotinic receptor agonists were examd. for their binding characteristics and for inhibition by cholinergic compds. in order to distinguish possible differential affinities for subtypes of neuronal nicotinic acetylcholine receptors.  KD and Bmax values for [3H]cytisine, [3H]methylcarbamylcholine and [3H]nicotine were detd. from Scatchard anal. using an enriched whole-brain membrane fraction from male Sprague-Dawley rats.  Resp. KD values were 0.15, 1.07 and 0.89 nM while Bmax values were 99, 64 and 115 fmol/mg protein resp.  All 3 ligands fit a one-site model of receptor-ligand interaction.  Concn.-inhibition curves were used to det. Ki values for 16 cholinergic compds.  The rank order of potencies for displacement of the 3 ligands was: (-)-cytisine > (-)-nicotine > (-)-lobeline = methylcarbamylcholine > 1,1-dimethyl-4-phenylpiperazinium, (+)-nicotine, dihydro-β-erythroidine, (±)-nornicotine > carbachol > arecoline » oxotremorine, tetrahydroaminoacridine, AF102B » (-)-cotinine > RS86 = heptylphysostigmine.  Correlations of the affinities of these compds. detd. with the 3 ligands were very near to unity.  In contrast, there was a neg. correlation of affinities for [3H]cytisine compared to affinities for the muscarinic receptor agonist, [3H]oxotremorine-M, and the muscarinic receptor antagonist, [3H]quinuclidinyl benzoate.  Using membranes from whole rat brain yields data suggesting that all 3 nicotinic ligands bind to the same nicotinic acetylcholine receptor subtype, and are unable to distinguish subtypes of neuronal nicotinic acetylcholine receptor at the level examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQv_7GAAHmtrVg90H21EOLACvtfcHk0lhOWhKjxcmmlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlKktL4%253D&md5=90592741d40963821a0021fd01b1ee03</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2894%2990200-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252894%252990200-3%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DArneric%26aufirst%3DS.%2BP.%26atitle%3DNicotinic%2520receptor%2520binding%2520of%2520%255B3H%255Dcytisine%252C%2520%255B3H%255Dnicotine%2520and%2520%255B3H%255Dmethylcarbamylcholine%2520in%2520rat%2520brain%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1994%26volume%3D253%26spage%3D261%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnelle, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surber, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surowy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tribollet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marguerat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span> </span><span class="NLM_article-title">[<sup>3</sup>H]A-585539 [(1<i>S</i>,4<i>S</i>)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane], a novel high-affinity α7 neuronal nicotinic receptor agonist: radioligand binding characterization to rat and human brain</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.1124%2Fjpet.107.130062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=17959745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsF2hsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2008&pages=179-187&author=D.+J.+Andersonauthor=W.+Bunnelleauthor=B.+Surberauthor=J.+Duauthor=C.+Surowyauthor=E.+Tribolletauthor=A.+Margueratauthor=D.+Bertrandauthor=M.+Gopalakrishnan&title=%5B3H%5DA-585539+%5B%281S%2C4S%29-2%2C2-dimethyl-5-%286-phenylpyridazin-3-yl%29-5-aza-2-azoniabicyclo%5B2.2.1%5Dheptane%5D%2C+a+novel+high-affinity+%CE%B17+neuronal+nicotinic+receptor+agonist%3A+radioligand+binding+characterization+to+rat+and+human+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]A-585539 [(1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane], a novel high-affinity α7 neuronal nicotinic receptor agonist: radioligand binding characterization to rat and human brain</span></div><div class="casAuthors">Anderson, David J.; Bunnelle, William; Surber, Bruce; Du, Jia; Surowy, Carol; Tribollet, Eliane; Marguerat, Anouk; Bertrand, Daniel; Gopalakrishnan, Murali</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">179-187</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Receptor binding was characterized for [3H](1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane ([3H]A-585539), a selective high-affinity α7 nicotinic acetylcholine receptor (nAChR) agonist with rapid kinetics, low nonspecific binding, and high specific activity.  At 4, the assocn. was monophasic and rapid (t1/2=8.0 min); dissocn. was slower (t1/2=64.2 min).  The Kd in rat brain at 4 was 0.063 nM, whereas at 22 and 37, the Kd values were 0.188 and 0.95 nM, resp.  In contrast, the Bmax (34 fmol/mg protein) was unaffected by temp.  In human cortex, [3H]A-585539 bound with a Kd of 0.066 nM and a Bmax of 5.8 fmol/mg protein at 4, whereas under similar conditions, specific [3H]methyllycaconitine ([3H]MLA) binding was not measurable.  A no. of agonist and antagonist nAChR ligands displaced binding to rat brain membranes with rank order of affinity similar to that for [3H]MLA, and in general, a 5 to 10-fold higher affinity was obsd. for [3H]A-585539 binding.  There was also a good correlation of Ki values between [3H]A-585539 binding to rat brain and human cortex.  The use of a α7/5-hydroxytryptamine type-3 chimera revealed that the N-terminal domain of α7 nAChR was sufficient to faithfully reproduce the pharmacol. of [3H]A-585539 binding.  Autoradiog. studies comparing [3H]A-585539 and [125I]α-bungarotoxin revealed a similar pattern of labeling in the rat.  In summary, [3H]A-585539 was shown to have excellent binding characteristics in rat and human brain and represents the first high-affinity α7 agonist radioligand with utility in the characterization of this important nAChR subtype that is targeted toward ameliorating cognitive deficits underlying neuropsychiatric and neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqji4MU_Eu8BrVg90H21EOLACvtfcHk0ljuOEedlNpBMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsF2hsQ%253D%253D&md5=b7ebce829957073aba16e25cb1d4ee63</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.130062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.130062%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DBunnelle%26aufirst%3DW.%26aulast%3DSurber%26aufirst%3DB.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DSurowy%26aufirst%3DC.%26aulast%3DTribollet%26aufirst%3DE.%26aulast%3DMarguerat%26aufirst%3DA.%26aulast%3DBertrand%26aufirst%3DD.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26atitle%3D%255B3H%255DA-585539%2520%255B%25281S%252C4S%2529-2%252C2-dimethyl-5-%25286-phenylpyridazin-3-yl%2529-5-aza-2-azoniabicyclo%255B2.2.1%255Dheptane%255D%252C%2520a%2520novel%2520high-affinity%2520%25CE%25B17%2520neuronal%2520nicotinic%2520receptor%2520agonist%253A%2520radioligand%2520binding%2520characterization%2520to%2520rat%2520and%2520human%2520brain%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D324%26spage%3D179%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Kuntzweiler, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arneric, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnelly-Roberts, D. L.</span><span> </span><span class="NLM_article-title">Rapid assessment of ligand actions with nicotinic acetylcholine receptors using calcium dynamics and FLIPR</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">14</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1998&pages=14-20&author=T.+A.+Kuntzweilerauthor=S.+P.+Arnericauthor=D.+L.+Donnelly-Roberts&title=Rapid+assessment+of+ligand+actions+with+nicotinic+acetylcholine+receptors+using+calcium+dynamics+and+FLIPR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuntzweiler%26aufirst%3DT.%2BA.%26aulast%3DArneric%26aufirst%3DS.%2BP.%26aulast%3DDonnelly-Roberts%26aufirst%3DD.%2BL.%26atitle%3DRapid%2520assessment%2520of%2520ligand%2520actions%2520with%2520nicotinic%2520acetylcholine%2520receptors%2520using%2520calcium%2520dynamics%2520and%2520FLIPR%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1998%26volume%3D44%26spage%3D14%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Gronlien, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakerud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ween, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorin-Hagene, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs Clark, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malysz, J.</span><span> </span><span class="NLM_article-title">Distinct profiles of α7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">715</span><span class="NLM_x">–</span> <span class="NLM_lpage">724</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=715-724&author=J.+H.+Gronlienauthor=M.+Hakerudauthor=H.+Weenauthor=K.+Thorin-Hageneauthor=A.+Briggs+Clarkauthor=M.+Gopalakrishnanauthor=J.+Malysz&title=Distinct+profiles+of+%CE%B17+nAChR+positive+allosteric+modulation+revealed+by+structurally+diverse+chemotypes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGronlien%26aufirst%3DJ.%2BH.%26aulast%3DHakerud%26aufirst%3DM.%26aulast%3DWeen%26aufirst%3DH.%26aulast%3DThorin-Hagene%26aufirst%3DK.%26aulast%3DBriggs%2BClark%26aufirst%3DA.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26aulast%3DMalysz%26aufirst%3DJ.%26atitle%3DDistinct%2520profiles%2520of%2520%25CE%25B17%2520nAChR%2520positive%2520allosteric%2520modulation%2520revealed%2520by%2520structurally%2520diverse%2520chemotypes%26jtitle%3DMol.%2520Pharmacol.%26date%3D2007%26volume%3D72%26spage%3D715%26epage%3D724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukat, M.</span><span> </span><span class="NLM_article-title">α4β2 nACh Receptor pharmacophore models</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1841</span><span class="NLM_x">–</span> <span class="NLM_lpage">1844</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1841-1844&author=R.+A.+Glennonauthor=M.+Dukat&title=%CE%B14%CE%B22+nACh+Receptor+pharmacophore+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DDukat%26aufirst%3DM.%26atitle%3D%25CE%25B14%25CE%25B22%2520nACh%2520Receptor%2520pharmacophore%2520models%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D1841%26epage%3D1844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Tonder, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olesen, P. H.</span><span> </span><span class="NLM_article-title">Agonists at the α4β2 nicotinic acetylcholine receptors: structure–activity relationships and molecular modeling</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">651</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.2174%2F0929867013373165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=11281847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivVClt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=651-674&author=J.+E.+Tonderauthor=P.+H.+Olesen&title=Agonists+at+the+%CE%B14%CE%B22+nicotinic+acetylcholine+receptors%3A+structure%E2%80%93activity+relationships+and+molecular+modeling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Agonists at the α4β2 nicotinic acetylcholine receptors: structure-activity relationships and molecular modeling</span></div><div class="casAuthors">Tonder, J. E.; Olesen, P. H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">651-674</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review with 87 refs.  Agonists of the 42 nicotinic acetylcholine receptors have been synthesized as potential drugs for treatment of a variety of diseases.  In this review, the published nicotinic agonists are presented and, on the basis of the mol. structure, the compds. are divided into three compd. classes, nicotinoids (structurally close to nicotine), bicyclic compds. (structurally close to epibatidine and anatoxin-a), and analogs of imidacloprid (structurally close to the insecticide imidacloprid).  The structure-activity relationships are discussed within and in between the classes.  On the basis of computational studies of ligands for the nicotinic acetylcholine receptors the structure-activity relationships are discussed and a possible binding mode suggested.  The binding mode encompasses: (A) an interaction between an anionic site in the receptor and the protonated nitrogen atom in the ligand, (B) a hydrogen bond between a hydrogen bond donor in the receptor and a hydrogen bond acceptor in the ligand, (C) an interaction between a π-system (heteroarom. ring, carbonyl bond) in the ligand and another π-system or a pos. charged amino acid residue in the binding site, (D) a π-cation interaction between arom. residues in the receptor binding site and the protonated nitrogen atom in the ligand, and (E) steric interactions of pos. and neg. character around the aliph. and the heteroarom. part of the ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIhzcXIYiPlLVg90H21EOLACvtfcHk0ljCGttT70OFpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivVClt7g%253D&md5=cd64d243cfc42ea4696ad43dd1c59bd4</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.2174%2F0929867013373165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867013373165%26sid%3Dliteratum%253Aachs%26aulast%3DTonder%26aufirst%3DJ.%2BE.%26aulast%3DOlesen%26aufirst%3DP.%2BH.%26atitle%3DAgonists%2520at%2520the%2520%25CE%25B14%25CE%25B22%2520nicotinic%2520acetylcholine%2520receptors%253A%2520structure%25E2%2580%2593activity%2520relationships%2520and%2520molecular%2520modeling%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2001%26volume%3D8%26spage%3D651%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Zhong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallivan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lester, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougherty, D. A.</span><span> </span><span class="NLM_article-title">From ab initio quantum mechanics to molecular neurobiology: a cation−π binding site in the nicotinic receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">12088</span><span class="NLM_x">–</span> <span class="NLM_lpage">12093</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=12088-12093&author=W.+Zhongauthor=J.+P.+Gallivanauthor=Y.+Zhangauthor=L.+Liauthor=H.+A.+Lesterauthor=D.+A.+Dougherty&title=From+ab+initio+quantum+mechanics+to+molecular+neurobiology%3A+a+cation%E2%88%92%CF%80+binding+site+in+the+nicotinic+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DGallivan%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLester%26aufirst%3DH.%2BA.%26aulast%3DDougherty%26aufirst%3DD.%2BA.%26atitle%3DFrom%2520ab%2520initio%2520quantum%2520mechanics%2520to%2520molecular%2520neurobiology%253A%2520a%2520cation%25E2%2588%2592%25CF%2580%2520binding%2520site%2520in%2520the%2520nicotinic%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D12088%26epage%3D12093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Beene, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zacharias, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lester, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougherty, D. A.</span><span> </span><span class="NLM_article-title">Cation−π interactions in ligand recognition by serotonergic (5-HT<sub>3A</sub>) and nicotinic acetylcholine receptors: the anomalous binding properties of nicotine</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">10262</span><span class="NLM_x">–</span> <span class="NLM_lpage">10269</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi020266d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=10262-10269&author=D.+L.+Beeneauthor=G.+S.+Brandtauthor=W.+Zhongauthor=N.+M.+Zachariasauthor=H.+A.+Lesterauthor=D.+A.+Dougherty&title=Cation%E2%88%92%CF%80+interactions+in+ligand+recognition+by+serotonergic+%285-HT3A%29+and+nicotinic+acetylcholine+receptors%3A+the+anomalous+binding+properties+of+nicotine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fbi020266d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi020266d%26sid%3Dliteratum%253Aachs%26aulast%3DBeene%26aufirst%3DD.%2BL.%26aulast%3DBrandt%26aufirst%3DG.%2BS.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DZacharias%26aufirst%3DN.%2BM.%26aulast%3DLester%26aufirst%3DH.%2BA.%26aulast%3DDougherty%26aufirst%3DD.%2BA.%26atitle%3DCation%25E2%2588%2592%25CF%2580%2520interactions%2520in%2520ligand%2520recognition%2520by%2520serotonergic%2520%25285-HT3A%2529%2520and%2520nicotinic%2520acetylcholine%2520receptors%253A%2520the%2520anomalous%2520binding%2520properties%2520of%2520nicotine%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D10262%26epage%3D10269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Xiu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puskar, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanata, J. A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lester, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougherty, D. A.</span><span> </span><span class="NLM_article-title">Nicotine binding to brain receptors requires a strong cation−π interaction</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">458</span><span class="NLM_x">, </span> <span class="NLM_fpage">534</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=458&publication_year=2009&pages=534-537&author=X.+Xiuauthor=N.+L.+Puskarauthor=J.+A.+P.+Shanataauthor=H.+A.+Lesterauthor=D.+A.+Dougherty&title=Nicotine+binding+to+brain+receptors+requires+a+strong+cation%E2%88%92%CF%80+interaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXiu%26aufirst%3DX.%26aulast%3DPuskar%26aufirst%3DN.%2BL.%26aulast%3DShanata%26aufirst%3DJ.%2BA.%2BP.%26aulast%3DLester%26aufirst%3DH.%2BA.%26aulast%3DDougherty%26aufirst%3DD.%2BA.%26atitle%3DNicotine%2520binding%2520to%2520brain%2520receptors%2520requires%2520a%2520strong%2520cation%25E2%2588%2592%25CF%2580%2520interaction%26jtitle%3DNature%26date%3D2009%26volume%3D458%26spage%3D534%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Toma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quadrelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cignarella, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlocco, D.</span><span> </span><span class="NLM_article-title">6-Chloropyridazin-3-yl Derivatives Active as Nicotinic Agents: Synthesis, Binding, and Modeling Studies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4011</span><span class="NLM_x">–</span> <span class="NLM_lpage">4017</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0208830" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4011-4017&author=L.+Tomaauthor=P.+Quadrelliauthor=W.+H.+Bunnelleauthor=D.+J.+Andersonauthor=M.+D.+Meyerauthor=G.+Cignarellaauthor=A.+Gelainauthor=D.+Barlocco&title=6-Chloropyridazin-3-yl+Derivatives+Active+as+Nicotinic+Agents%3A+Synthesis%2C+Binding%2C+and+Modeling+Studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fjm0208830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0208830%26sid%3Dliteratum%253Aachs%26aulast%3DToma%26aufirst%3DL.%26aulast%3DQuadrelli%26aufirst%3DP.%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26aulast%3DCignarella%26aufirst%3DG.%26aulast%3DGelain%26aufirst%3DA.%26aulast%3DBarlocco%26aufirst%3DD.%26atitle%3D6-Chloropyridazin-3-yl%2520Derivatives%2520Active%2520as%2520Nicotinic%2520Agents%253A%2520Synthesis%252C%2520Binding%252C%2520and%2520Modeling%2520Studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D4011%26epage%3D4017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Dukat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Zahabi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Synthesis, receptor binding and QSAR studies on 6-substituted nicotine derivatives as cholinergic ligands</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1999&pages=31-40&author=M.+Dukatauthor=M.+Dowdauthor=M.+I.+Damajauthor=B.+Martinauthor=M.+A.+El-Zahabiauthor=R.+A.+Glennon&title=Synthesis%2C+receptor+binding+and+QSAR+studies+on+6-substituted+nicotine+derivatives+as+cholinergic+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDukat%26aufirst%3DM.%26aulast%3DDowd%26aufirst%3DM.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DMartin%26aufirst%3DB.%26aulast%3DEl-Zahabi%26aufirst%3DM.%2BA.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DSynthesis%252C%2520receptor%2520binding%2520and%2520QSAR%2520studies%2520on%25206-substituted%2520nicotine%2520derivatives%2520as%2520cholinergic%2520ligands%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D1999%26volume%3D34%26spage%3D31%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Briggs, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubbins, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Putman, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thimmapaya, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surowy, C. S.</span><span> </span><span class="NLM_article-title">Untranslated region-dependent exclusive expression of high-sensitivity subforms of α4β2 and α3β2 nicotinic acetylcholine receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=227-240&author=C.+A.+Briggsauthor=E.+J.+Gubbinsauthor=M.+J.+Marksauthor=C.+B.+Putmanauthor=R.+Thimmapayaauthor=M.+D.+Meyerauthor=C.+S.+Surowy&title=Untranslated+region-dependent+exclusive+expression+of+high-sensitivity+subforms+of+%CE%B14%CE%B22+and+%CE%B13%CE%B22+nicotinic+acetylcholine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBriggs%26aufirst%3DC.%2BA.%26aulast%3DGubbins%26aufirst%3DE.%2BJ.%26aulast%3DMarks%26aufirst%3DM.%2BJ.%26aulast%3DPutman%26aufirst%3DC.%2BB.%26aulast%3DThimmapaya%26aufirst%3DR.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26aulast%3DSurowy%26aufirst%3DC.%2BS.%26atitle%3DUntranslated%2520region-dependent%2520exclusive%2520expression%2520of%2520high-sensitivity%2520subforms%2520of%2520%25CE%25B14%25CE%25B22%2520and%2520%25CE%25B13%25CE%25B22%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D227%26epage%3D240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Coe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetelino, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirtz, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sands, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebel, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrikhande, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heym, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaeffer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rollema, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansbach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovetti, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tingley, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span> </span><span class="NLM_article-title">Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3474</span><span class="NLM_x">–</span> <span class="NLM_lpage">3477</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050069n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3474-3477&author=J.+W.+Coeauthor=P.+R.+Brooksauthor=M.+G.+Vetelinoauthor=M.+C.+Wirtzauthor=E.+P.+Arnoldauthor=J.+Huangauthor=S.+B.+Sandsauthor=T.+I.+Davisauthor=L.+A.+Lebelauthor=C.+B.+Foxauthor=A.+Shrikhandeauthor=J.+H.+Heymauthor=E.+Schaefferauthor=H.+Rollemaauthor=Y.+Luauthor=R.+S.+Mansbachauthor=L.+K.+Chambersauthor=C.+C.+Rovettiauthor=D.+W.+Schulzauthor=F.+D.+Tingleyauthor=B.+T.+O%E2%80%99Neill&title=Varenicline%3A+An+%CE%B14%CE%B22+Nicotinic+Receptor+Partial+Agonist+for+Smoking+Cessation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm050069n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050069n%26sid%3Dliteratum%253Aachs%26aulast%3DCoe%26aufirst%3DJ.%2BW.%26aulast%3DBrooks%26aufirst%3DP.%2BR.%26aulast%3DVetelino%26aufirst%3DM.%2BG.%26aulast%3DWirtz%26aufirst%3DM.%2BC.%26aulast%3DArnold%26aufirst%3DE.%2BP.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DSands%26aufirst%3DS.%2BB.%26aulast%3DDavis%26aufirst%3DT.%2BI.%26aulast%3DLebel%26aufirst%3DL.%2BA.%26aulast%3DFox%26aufirst%3DC.%2BB.%26aulast%3DShrikhande%26aufirst%3DA.%26aulast%3DHeym%26aufirst%3DJ.%2BH.%26aulast%3DSchaeffer%26aufirst%3DE.%26aulast%3DRollema%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMansbach%26aufirst%3DR.%2BS.%26aulast%3DChambers%26aufirst%3DL.%2BK.%26aulast%3DRovetti%26aufirst%3DC.%2BC.%26aulast%3DSchulz%26aufirst%3DD.%2BW.%26aulast%3DTingley%26aufirst%3DF.%2BD.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DVarenicline%253A%2520An%2520%25CE%25B14%25CE%25B22%2520Nicotinic%2520Receptor%2520Partial%2520Agonist%2520for%2520Smoking%2520Cessation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3474%26epage%3D3477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Cohen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergis, O. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lochead, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jegham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonardon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avenet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sgard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besnard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coste, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oblin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voltz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caille, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrault, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soubrie, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scatton, B.</span><span> </span><span class="NLM_article-title">SSR591813, a novel selective and partial α4β2 nicotinic receptor agonist with potential as an aid to smoking cessation</span> <span class="citation_source-journal">J. Pharmacol. Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.1124%2Fjpet.103.049262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=12682217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvF2ks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2003&pages=407-420&author=C.+Cohenauthor=O.+E.+Bergisauthor=F.+Galliauthor=A.+W.+Locheadauthor=S.+Jeghamauthor=B.+Bitonauthor=J.+Leonardonauthor=P.+Avenetauthor=F.+Sgardauthor=F.+Besnardauthor=D.+Grahamauthor=A.+Costeauthor=A.+Oblinauthor=O.+Curetauthor=C.+Voltzauthor=A.+Gardesauthor=D.+Cailleauthor=G.+Perraultauthor=P.+Georgeauthor=P.+Soubrieauthor=B.+Scatton&title=SSR591813%2C+a+novel+selective+and+partial+%CE%B14%CE%B22+nicotinic+receptor+agonist+with+potential+as+an+aid+to+smoking+cessation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">SSR591813, a novel selective and partial α4β2 nicotinic receptor agonist with potential as an aid to smoking cessation</span></div><div class="casAuthors">Cohen, C.; Bergis, O. E.; Galli, F.; Lochead, A. W.; Jegham, S.; Biton, B.; Leonardon, J.; Avenet, P.; Sgard, F.; Besnard, F.; Graham, D.; Coste, A.; Oblin, A.; Curet, O.; Voltz, C.; Gardes, A.; Caille, D.; Perrault, G.; George, P.; Soubrie, P.; Scatton, B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">306</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">407-420</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">(5AS,8S,10aR)-5a,6,9,10-Tetrahydro,7H,11H-8,10a-methanopyrido[2',3':5,6]pyrano[2,3-d]azepine (SSR591813) is a novel compd. that binds with high affinity to the rat and human α4β2 nicotinic acetylcholine receptor (nAChR) subtypes (Ki = 107 and 36 nM, resp.) and displays selectivity for the α4β2 nAChR (Ki, human α3β4 > 1000, α3β2 = 116; α1β1δγ > 6000 nM and rat α7 > 6000 nM).  Electrophysiol. expts. indicate that SSR591813 is a partial agonist at the human α4β2 nAChR subtype (EC50 = 1.3 μM, IA = 19% compared with the full agonist 1,1-dimethyl-4-phenyl-piperazinium).  In vivo findings from microdialysis and drug discrimination studies confirm the partial intrinsic activity of SSR591813.  The drug increases dopamine release in the nucleus accumbens shell (30 mg/kg i.p.) and generalizes to nicotine or amphetamine (10-20 mg/kg i.p.) in rats, with an efficacy approx. 2-fold lower than that of nicotine.  Pretreatment with SSR591813 (10 mg/kg i.p.) reduces the dopamine-releasing and discriminative effects of nicotine.  SSR591813 shows activity in animal models of nicotine dependence at doses devoid of unwanted side effects typically obsd. with nicotine (hypothermia and cardiovascular effects).  The compd. (10 mg/kg i.p.) also prevents withdrawal signs pptd. by mecamylamine in nicotine-dependent rats and partially blocks the discriminative cue of an acute pptd. withdrawal.  SSR591813 (20 mg/kg i.p.) reduces i.v. nicotine self-administration and antagonizes nicotine-induced behavioral sensitization in rats.  The present results confirm important role for α4β2 nAChRs in mediating nicotine dependence and suggest that SSR591813, a partial agonist at this particular nAChR subtype, may have therapeutic potential in the clin. management of smoking cessation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv69IRULvV7rVg90H21EOLACvtfcHk0lia8kjWFT28Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvF2ks7g%253D&md5=5153094293dbf94ad94165cc830007fa</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.049262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.049262%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DC.%26aulast%3DBergis%26aufirst%3DO.%2BE.%26aulast%3DGalli%26aufirst%3DF.%26aulast%3DLochead%26aufirst%3DA.%2BW.%26aulast%3DJegham%26aufirst%3DS.%26aulast%3DBiton%26aufirst%3DB.%26aulast%3DLeonardon%26aufirst%3DJ.%26aulast%3DAvenet%26aufirst%3DP.%26aulast%3DSgard%26aufirst%3DF.%26aulast%3DBesnard%26aufirst%3DF.%26aulast%3DGraham%26aufirst%3DD.%26aulast%3DCoste%26aufirst%3DA.%26aulast%3DOblin%26aufirst%3DA.%26aulast%3DCuret%26aufirst%3DO.%26aulast%3DVoltz%26aufirst%3DC.%26aulast%3DGardes%26aufirst%3DA.%26aulast%3DCaille%26aufirst%3DD.%26aulast%3DPerrault%26aufirst%3DG.%26aulast%3DGeorge%26aufirst%3DP.%26aulast%3DSoubrie%26aufirst%3DP.%26aulast%3DScatton%26aufirst%3DB.%26atitle%3DSSR591813%252C%2520a%2520novel%2520selective%2520and%2520partial%2520%25CE%25B14%25CE%25B22%2520nicotinic%2520receptor%2520agonist%2520with%2520potential%2520as%2520an%2520aid%2520to%2520smoking%2520cessation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%26date%3D2003%26volume%3D306%26spage%3D407%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Lippiello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letchworth, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatto, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traina, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bencherif, M.</span><span> </span><span class="NLM_article-title">Ispronicline: a novel α4β2 nicotinic acetylcholine receptor-selective agonist with cognition-enhancing and neuroprotective properties</span> <span class="citation_source-journal">J. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm201045m&amp;key=10.1385%2FJMN%3A30%3A1%3A19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm201045m&amp;key=17192610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm201045m&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlWgtbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2006&pages=19-20&author=P.+Lippielloauthor=S.+R.+Letchworthauthor=G.+J.+Gattoauthor=V.+M.+Trainaauthor=M.+Bencherif&title=Ispronicline%3A+a+novel+%CE%B14%CE%B22+nicotinic+acetylcholine+receptor-selective+agonist+with+cognition-enhancing+and+neuroprotective+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Ispronicline: a novel α4β2 nicotinic acetylcholine receptor-selective agonist with cognition-enhancing and neuroprotective properties</span></div><div class="casAuthors">Lippiello, Patrick; Letchworth, Sharon R.; Gatto, Gregory J.; Traina, Vincent M.; Bencherif, Merouane</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">19-20</span>CODEN:
                <span class="NLM_cas:coden">JMNEES</span>;
        ISSN:<span class="NLM_cas:issn">0895-8696</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A novel nAChR partial agonist, ispronicline, demonstrated a marked sepn. between beneficial effects and side effects in several in vitro and animal models.  Results from phase-I clin. studies demonstrated ispronicline's tolerability and pos. safety profile.  The pharmacol., pharmacokinetic, and safety profile of ispronicline provides an example of a well-tolerated and potent neuronal nAChR modulator that holds promise for the management of neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcfsNtTOo-w7Vg90H21EOLACvtfcHk0lia8kjWFT28Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlWgtbfF&md5=80a71d8166807732d5ccdc534e2f8d8d</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1385%2FJMN%3A30%3A1%3A19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FJMN%253A30%253A1%253A19%26sid%3Dliteratum%253Aachs%26aulast%3DLippiello%26aufirst%3DP.%26aulast%3DLetchworth%26aufirst%3DS.%2BR.%26aulast%3DGatto%26aufirst%3DG.%2BJ.%26aulast%3DTraina%26aufirst%3DV.%2BM.%26aulast%3DBencherif%26aufirst%3DM.%26atitle%3DIspronicline%253A%2520a%2520novel%2520%25CE%25B14%25CE%25B22%2520nicotinic%2520acetylcholine%2520receptor-selective%2520agonist%2520with%2520cognition-enhancing%2520and%2520neuroprotective%2520properties%26jtitle%3DJ.%2520Mol.%2520Neurosci.%26date%3D2006%26volume%3D30%26spage%3D19%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Mihalak, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luetje, C. W.</span><span> </span><span class="NLM_article-title">Varenicline is a partial agonist at α4β2 and a full agonist at α7 neuronal nicotinic receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">805</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=801-805&author=K.+B.+Mihalakauthor=I.+Carrollauthor=C.+W.+Luetje&title=Varenicline+is+a+partial+agonist+at+%CE%B14%CE%B22+and+a+full+agonist+at+%CE%B17+neuronal+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMihalak%26aufirst%3DK.%2BB.%26aulast%3DCarroll%26aufirst%3DI.%26aulast%3DLuetje%26aufirst%3DC.%2BW.%26atitle%3DVarenicline%2520is%2520a%2520partial%2520agonist%2520at%2520%25CE%25B14%25CE%25B22%2520and%2520a%2520full%2520agonist%2520at%2520%25CE%25B17%2520neuronal%2520nicotinic%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D801%26epage%3D805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm201045m&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-21%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm201045m" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm201045m" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679934ba6aa024c7","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
